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Abstract
In this thesis, a multiplexed microfabricated cell culture device is presented
to probe the soluble microenvironment of stem cells. A large number of
biological, physical and chemical variables determine the microenvironment
of stem cells and affect therefore their fate. The soluble microenvironment
is believed to play a pivotal role in controlling stem cell fate and its optimi-
sation may therefore allow exploitation of applications such as regenerative
medicine or drug discovery.
However, novel tools are required to probe and optimise the soluble microen-
vironment. The ability to move small volumes of liquid and the minimal
use of resources are important characteristics of microfluidic systems and
thus, they are perfectly suited to study the microenvironment of stem cells.
A microfluidic cell culture device must fulfil three important requirements
to be of utility in stem cell bioprocess development.
The first aspect addresses the need for adaptability and flexibility to imple-
ment changes in microfluidic designs to take account of the rapid progress
in stem cell research. To this end, a packaging solution specifically designed
for a microfluidic cell culture device has been developed. The packaging
system has thus been complemented with a rapid fabrication method using
a micro-milling machine to quickly fabricate disposable and easily recon-
figurable microfluidic chips. The packaging solution has a maximum burst
pressure of approximately 7.5 bar and the fabrication method has a dimen-
sional fidelity with less than 10% deviation from the nominal value.
The second aspect focuses on the scalability and comparability of results
and the feasibility of continuous culture of stem cells - both critical elements
for the success of a microfluidic cell culture system for stem cell bioprocess
development. A novel cell seeding method has been developed using a
pipette to directly and carefully seed cells into a culture chamber within a
microfluidic cell culture device. To prevent a wash-out of viable cells during
continuous culture, a low hydrodynamic shear stress microfluidic chip has
been developed. The cell culture device has been successfully tested using
human embryonic stem cells (hESC) on feeder cells.
The third aspect concerns the automated monitoring of stem cell biopro-
cesses in the cell culture device. A multiplexed microfluidic bioreactor plat-
form with time-lapse imaging has been developed to obtain data-rich ex-
perimental sets. The platform consisting of a cooled media reservoir and a
pumping mechanism has been characterised and tested using mouse embry-
onic stem cells (mESC) as a proof of concept.
The combination of these three aspects provides a basis towards a mul-
tiplexed microfabricated cell culture device, which allows data-rich exper-
imentation and comparability with current benchscale culture vessels for
stem cell expansion and differentiation.
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Glossary
ASC Adult stem cell; a tissue specific stem cell which gives rise to a few progenitor and functional cells
CAD Computer-aided design; virtual environment for the design process
CAM Computer-aided manufacturing; use of computer software to control machine tools
CNC Computer numerical control; automation of machine tools by abstractly programmed commands
DAPI 4’,6-diamidino-2-phenylindole; a fluorescent stain that binds strongly to DNA and serves to marks
the nucleus in fluorescence microscopy
DMEM Dulbecco’s minimal essential medium; cell culture medium used to maintain cells in tissue culture
ECM Extracellular matrix; provides structural support to cells
EDTA Ethylene-diamine-tetraacetic acid; a chelating molecule used to sequester most divalent metal
ions, such as calcium (Ca2+) or magnesium (Mg2+)
ESC Embryonic stem cell; a stem cell which gives rise to nearly every type of cell
FBS Fetal bovine serum; portion of the plasma remaining after coagulation of blood
FEM Finite element method; numerical technique to find approximate solutions of partial differential
equations or integral equations
FGF Fibroblast growth factor; family of factors involved in angiogenesis, wound healing and embryonic
development
GMEM Glasgow’s minimal essential medium; modification of Eagle’s medium
hESC Human embryonic stem cell; embryonic stem cells derived from a human blastocyst
iPSC Induced pluripotent stem cell; a reprogrammed adult somatic cell exhibiting embryonic stem
cell-like characteristics
ITO Indium tin oxide; a transparent and electrically conductive coating
LIF Leukemia inhibitor factor; interleukin 6 cytokine that affects cell growth and development
MEF Murine embryonic fibroblasts; a cell that synthesizes the extracellular matrix and collagen
mESC Mouse embryonic stem cell; embryonic stem cells derived from a mouse blastocyst
MSC Mesenchymal stem cell; multipotent stem cells that can differentiate into various cells such as
osteoblasts or chondrocytes
Oct-4 Octamer transcription factor 4; a protein which is critically involved in the self renewal of undif-
ferentiated embryonic stem cells
PBS Phosphate buffered saline; a usually isotonic buffer solution
PC Poly(carbonate); a highly transparent thermoplastic polymer with high impact-resistance and
strength
PDMS Poly-(dimethylsiloxane); a silicone originally developed as an encapsulant, but widely used in
microfluidics
PMMA Poly(methyl methacrylate); a transparent thermoplastic polymer
PS Poly(styrene); a widely used transparent thermoplastic polymer
SOX1 Sex determining region Y-box 1; a transcription factor of which the expression is restricted to
the neuroectoderm
SSEA-3 Stage-specific embryonic antigen 3; one surface marker for pluripotency of embryonic stem cells
or embryonic stem cell-like characteristics
TC-PS Tissue culture poly(styrene); commonly used material for culture ware for adherent cells
Tra-1-81 Tumor rejection antigen; a surface marker for pluripotency of embryonic stem cells or embryonic
stem cell-like characteristics
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1Introduction
Historically, medical advances have largely been limited to the management of the acute
effects of diseases and symptoms, and the treatment of infections caused by pathogens,
for example the discovery of penicillin. However, as we move into the twenty-first
century, the attention of clinicians and researchers has begun to focus more on the
treatment of a number of chronic diseases. The prevalence of such chronic diseases
is increasing due to the demographic shift across the western world. For example,
Parkinson’s disease occurs in 1% of the population over the age of 60 (Morizane et al.,
2007). The majority of chronic diseases such as Parkinson’s or Alzheimer’s disease
are largely managed by palliative care in the absence of disease reversing agents or
therapies.
With the advances in medicine and life sciences, new possibilities arise to move on
from merely fighting symptoms using compounds derived in chemical or biochemical
processes to tackling the underlying causes of diseases or even repairing or replacing
organs with more complex medicines.
A number of therapies are in development which use molecules such as cytokines to
cure diseases like cancer, or in vitro grown cells to repair or even replace damaged
tissues (Margolin, 2008).
Such future medicines will require cells with specific properties, either as a model tissue
in drug discovery and development to test these molecules, or for direct use in cell based
therapies (Nirmalanandhan & Sittampalam, 2009).
The discovery of stem cells, in particular embryonic stem cells (ESCs), has had an
enormous impact on our society and has created a remarkable interest in this research
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field - in the scientific community as well as in the broader public audience. The
common belief that stem cells are the holy grail for numerous challenges and problems
in healthcare, both as a cure for a variety of chronic diseases and for use in tissue
engineering, is legitimate only so long as the solutions to these challenges and problems
can be translated into products. In this context, an often neglected key aspect is the
rapid translation of scientific discoveries or innovations into reproducible and scalable
bioprocesses to obtain the cell numbers required for clinical testing or drug discovery
applications. An understanding of the different types of stem cells and the variables
involved which determine the fate of stem cells is necessary to develop a microfabricated
cell culture device.
1.1 Stem cell sources
The potential of stem cells for regenerative medicine and tissue engineering applications
is best described by starting with the definition of the properties of a stem cell. The
classical definition of stem cells comprises two aspects: the capability of self-renewal
and the potency of stem cells or differentiation into functional phenotypes (Darr &
Benvenisty, 2006).
The self-renewal capability consists of two mechanisms to ensure that a stem cell popu-
lation is maintained (Shenghui et al., 2009). The asymmetric replication of a stem cell
is one mechanism (Morrison & Kimble, 2006). This is the division of a stem cell into a
daughter cell, which is identical to the original cell, and another daughter cell, which is
a progeny. The second mechanism is the stochastic division of a stem cell, where one
stem cell divides into two identical stem cells and another stem cell divides into two
differentiated cells (Ho, 2005).
Potency is a measure of the differentiation capability of a stem cell or, in other words,
at what level in the cell specialisation hierarchy a stem cell sits (Smith et al., 2009).
For example, embryonic stem cells are pluripotent, thus able to differentiate into one
of the three germ layers - ectoderm, mesoderm and endoderm. Each of these layers
gives rise to a specific subset of phenotypes after differentiation. It has been found
that the ectoderm includes skin and neural cells, the mesoderm includes cardiovascular
and blood cells and the endoderm includes cells from the gastrointestinal tissue. In
contrast to ESCs, adult stem cells (ASCs), a type of stem cell found in mature animals,
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are multipotent. Their differentiation capability is limited to a few progenitor cells and
tissue-specific cells.
The two aspects - self-renewal and differentiation - are shown in figure 1.1 and formu-
Figure 1.1: Hierarchy of self-renewal and differentiation - Stem cells either re-
new themselves or differentiate into progenitor cells that lead to terminally differentiated,
functional cells. Further down the differentiation hierarchy, the differentiation capability
decreases, but the cell functionality increases. Not every type of stem cell has the same
differentiation potential and are thus classified for example into pluripotent and multipotent
to name the most important.
lated in a definition by Melton & Cowen (2009):
A stem cell is a clonal, self-renewing entity that is multipotent and thus can
generate several differentiated cell types.
Unlike microbial bioprocesses, where a product such as a monoclonal antibody is re-
covered from cells, stem cell bioprocesses aim to produce cells with specific proper-
ties/deliver products, where cells themselves are the product. Regardless of the cell
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donor origin, autologous1, allogeneic2 or xenogeneic3, the selection of the appropriate
cell source will influence the quality of the product in terms of functionality, safety and
purity, and will affect the cost effectiveness of the bioprocess.
Stem cells can originate from multiple sources, either from adult or embryonic tissue
or, more recently, by reprogramming functional, mature cells into induced pluripotent
stem (iPS) cells - all with advantages and disadvantages (see table 1.1). A more de-
tailed overview of the properties of the different types of established stem cell types
is given in the following sections. Note that many of these definitions are based on
current findings and are likely to change in the future as the field progresses and the
characteristics of stem cells are determined more precisely, for example the definition
of pluripotency for human ESCs and so-called induced pluripotent stem cells (Smith
et al., 2009).
Table 1.1: Overview of stem cell sources by origin - Advantages and disadvantages
of ASCs, ESCs and induced pluripotent stem (iPS) cells under the aspect of usability for
applications
Adult Stem Cells Embryonic Stem Cells Induced Pluripotent Stem
Cells
Advantages Easily obtainable Golden standard for charac-
terisation
No ethical issues
No ethical issues Customised
Autologous transplantation
Disadvantages Short life in vitro compared
to ESCs
Expensive culture in vitro Little knowledge
Ethical issues No standard procedure for
derivation
Tumorgeneity Tumorgeneity
1.1.1 Adult stem cells
Adult stem cells (ASCs), also known as somatic stem cells, are found in tissues through-
out the body of juvenile and adult animals or humans. Their main function is to replace
apoptotic cells or to rejuvenate tissue in a specific location. Due to their tissue-specific
origin, ASCs are multipotent rather than pluripotent and thus restricted to a given tis-
sue family, having a degree of lineage commitment (see also table 1.2). However, recent
1Donor and recipient are the same individual (reg, 2009)
2Donor and recipient are different individuals (reg, 2009)
3Donor and recipient belong to different species (reg, 2009)
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studies suggest that tissue-specific stem cells still possess developmental capabilities.
This characteristic is known as transdifferentiation or plasticity (Wagers & Weissman,
2004).
ASCs offer the advantage that an immune response is less likely if an autologous cell
therapy can be used. Furthermore, ASCs can be relatively easily obtained from a donor
and undergo directed differentiation.
Therapeutic interest in ASCs has particularly focused on the adult stem cells from the
blood, the bone marrow, the brain, fat tissue and the umbilical cord blood (see table
1.2). Certain stem cells are limited to certain tissues, for example hematopoietic stem
cells (HSCs) can only be found in blood, the bone marrow and the umbilical cord blood.
Mesenchymal stem cells (MSCs) in particular gained fame for tissue engineering appli-
cations such as bone or cartilage formation (Caplan, 2010). MSCs have also been used
to treat brain injuries, as an example for ASC plasticity (Ross & Verfaillie, 2008).
More recently, it has been shown as proof of concept that chondrocytes differentiated
from donor-originated MSCs can be successfully transplanted into the donor by re-
placing the trachea without administering medication to suppress immune responses
(Macchiarini et al., 2008).
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Table 1.2: An overview of tissue sources for different adult stem cells and
their derived cells - Adult stem cells can be derived from various tissue sources and
differentiated into many types of clinically relevant cell.
Tissue Source Cell Type Derived Cells References
Blood Hemapoietic stem
cells (HSCs)
Blood cells Czechowicz & Weissman (2011)
Endothelial pro-
genitor cells
(EPCs)
Endothelial cells Torsney & Xu (2011); Zampetaki et al. (2008)
Bone Marrow Hemapoietic stem
cells (HSCs)
Hepatocytes
Blood
Thorgeirsson & Grisham (2006)
Endothelial pro-
genitor cells
(EPCs)
Endothelial cells
Mesenchymal
stem cells (MSCs)
Adipocytes Muruganandan et al. (2009)
Cardiomyocytes Trivedi et al. (2010)
Chondrocytes Khan et al. (2010)
Endothelial cells Oswald et al. (2004)
Neurons Joyce et al. (2010)
Brain Neural stem cells
(NSC)
Adipocyte, chon-
drocyte, myocite,
neural progenitor,
osteocyte
Reynolds & Weiss (1992)
Fat Processed
lipoaaspirate
(PLA)
Adipocyte, chon-
drocyte, myocite,
neural progenitor,
osteocyte
Gimble & Guilak (2003)
Umbilical Cord
Blood
Hemapoietic stem
cells (HSCs)
Blood cells McKenna & Brunstein (2011)
Mesenchymal
progenitor cells
(MPCs)
Adipocyte, en-
dothelial cell,
blood cells, os-
teoblast
Fan et al. (2011)
1.1.2 Embryonic stem cells
Embryonic stem cells (ESCs) are derived from the inner cell mass of a blastocyst, an
early-stage embryo (Kim et al., 2005). Unlike ASCs, ESCs are pluripotent and thus able
to differentiate into any of the three germ layers - ectoderm, mesoderm and endoderm.
Murine ESCs (mESCs) were first derived in 1981 by Evans & Kaufman (1981) and
Martin (1981). It took nearly 20 years before Thomson et al. (1998) derived the first
human ESCs.
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A human ESC has been defined as a cell that 1) is isolated from the inner cell mass of the
blastocyst, 2) proliferates extensively in vitro, and 3) retains the ability to differentiate
into cell types of all three germ layers (Hoffman & Carpenter, 2005).
The number of hESC lines is rapidly increasing and variation of genomic expression
of individual lines have been recognised (Rao et al., 2004). Efforts have been thus
undertaken to establish characterisation standards for human ESC research (Pal et al.,
2007).
Culture conditions for hESCs have been largely based on xenogeneic culture materials
and are still under investigation for long-term expansion and differentiation. hESC lines
have been cultured in media supplemented with animal sera and/or on immortalized
mouse fibroblast feeder layers (Draper et al., 2004; Reubinoff et al., 2000; Skottman
& Hovatta, 2006). However, the use of xenogeneic components raises a concern about
introducing animal pathogens in clinical therapies (Lei et al., 2007; Mallon et al., 2006).
To address this issue, efforts have been made to maintain hESCs on human feeder la-
yers (Amit et al., 2003; Choo et al., 2004; Hovatta et al., 2003; Richards et al., 2002)
or in feeder-free culture systems (Amit & Itskovitz-Eldor, 2006; Hernandez et al., 2011;
Rosler et al., 2004). A complete synthetic culture system without animal sera-based
medium supplements has been investigated, but has not been established as a standard
culture protocol due to the high cost of its components (Ludwig et al., 2006).
Although mouse ESCs share properties with hESCs and are frequently used as model
for hESC research, it has to be noticed that self-renewal is regulated differently (Gri-
goryan & Kruglyakov, 2009). mESCs are grown in media with leukemia inhibitor
factor (LIF) or on feeder cells such as immortalized fibroblasts (Tremml et al., 2008).
However, hESC may require feeder cells, serum, and bovine fibroblast growth factor
(bFGF) instead of LIF (Xu et al., 2005).
Differentiation can occur spontaneously or can be directed. In vitro, differentiation
can be initiated by culturing cells in suspension to form embryoid bodies (EBs) or in
monolayers. Differentiation protocols have been established to derive clinically relevant
cells such as neuronal cells (Reubinoff et al., 2001), myocardiocytes (Vidarsson et al.,
2010) and insulin producing hepatocytes (Kroon et al., 2008).
Expression of intracellular markers such as Oct-4 and Nanog combined with surface
markers such as Tra-1-60/Tra-1-81 and SSEA-3/-4 are an indication of pluripotency
presence in an ESC culture.
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1.1.3 Induced pluripotent stem (iPS) cells
An alternative source of stem cells, possessing the same properties as ESCs, would help
to dispel the ethical concerns surrounding embryonic stem cells and their therapeu-
tic risks (Condic & Rao, 2010; Wert & Mummery, 2003). A breakthrough has been
achieved in 2006, when mouse fibroblasts were reprogrammed with four pluripotency
genes (Oct-3/4, SOX2, c-Myc, and Klf4 ) also found in naturally-isolated pluripotent
stem cells, exhibiting a similar phenotype and properties as their embryonic counter-
part (Takahashi & Yamanaka, 2006). This type of cell is known today as induced
pluripotent stem (iPS) cells (Stadtfeld & Hochedlinger, 2010). In 2007, human iPS
cells were generated by reprogramming somatic stem cells (Yu et al., 2007) or adult
human dermal fibroblasts (Takahashi et al., 2007).
Current research aims to improve the reprogramming method and efficiency by using
other means than viral transfection of cells with genes. The use of an adenovirus (Stadt-
feld et al., 2008), plasmids (Okita et al., 2008), recombinant proteins (Zhou et al., 2009)
or mRNA (Plews et al., 2010) have all been investigated to address this issue.
Reprogramming fibroblasts into stem cells has also encouraged the efforts to repro-
gram mature cells directly into specialised, functional cells. For example, fibroblasts
were directly converted into functional neurons by only three factors, AScl1, Brn2 and
Myt1l. These induced neurons expressed multiple neuron-specific proteins, generated
action potentials and formed functional synapses (Braun & Jessberger, 2010; Vier-
buchen et al., 2010).
The derivation of iPS cells from cells of a patient itself makes them particularly at-
tractive for regenerative medicine with a reduced risk of an immune response, or for
drug discovery as a patient-specific disease model. As a safety measure, the absence
of oncogenic genes such as myc and tumor formation is also required by regulatory
bodies if iPS cells are to be used in regenerative medicine for patient safety (Carpenter
& Couture, 2010; Smith, 2010).
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1.2.1 Drug discovery
Drug discovery is the selection process of a target compound for a certain disease un-
der the criteria of toxicity, efficacy and bioavalability of the active moiety in humans
(Gad, 2005). Historically, drug discovery has been a heuristic approach, but has now
shifted to a systematic search using technologies such as proteomics, genomics and high
throughput screening of compound libraries (Drews, 2000). Nevertheless, drug disco-
very and development is an expensive and risky undertaking with increasing attrition
rates (Kola & Landis, 2004; Paul et al., 2010). For example, a recent study documents
that only a fraction (less than a third) of all target compounds are approved (DiMasi
et al., 2010). To improve R&D productivity and thus reduce costs, an early elimination
of non-active targets is desired (Paul et al., 2010).
At present, reporter systems in genetically modified rodent or immortalised human cells
are being used to indicate if a signalling pathway is activated by a target. However,
these cell models may not represent the response in humans accurately enough. For
example, an overexpression of a reporter gene at high levels may not reflect a physio-
logical normal condition or their phenotype may be unrelated to the phenotype of the
tissue of interest (Ebert & Svendsen, 2010; Pouton & Haynes, 2005). In vitro, primary
cells of an appropriate tissue often dedifferentiate rapidly in culture and can only be
propagated for a short time (Pouton & Haynes, 2005).
Progress in stem cell technology provides the opportunity to set up human models of
diseases to elucidate the underlying disease mechanisms (Chien, 2008). By genotyping
human pluripotent stem cells, it will be possible to measure the influence of genetic
variations in drug response for example (Pouton & Haynes, 2005).
Certain small molecules have been recognised to have a negative impact on stem cell dif-
ferentiation. Drug-like molecules have been identified, both in vitro and in vivo, which
drive specific stem cell differentiation (McNeish, 2007). Specific human cells derived
from pluripotent stem cells (PSCs) may therefore play a key role in target validation
and/or toxicity, for example for hepatotoxicity and cardiotoxicity, and differentiation
screens (Ame´en et al., 2008; Rubin, 2008).
More accurate disease models could be derived directly from a patient’s cells which
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have been reprogrammed to resemble embryonic stem cells. For example, disease-
specific ESC lines were derived from patients suffering genetic diseases like adenosine
deaminase deficiency-related severe combined immunodeficiency, Shwachman-Bodian-
Diamond syndrome, Gaucher disease type III, Duchene and Becker muscular dystrophy,
Parkinson disease, Huntington disease, juvenile-onset, type 1 diabetes mellitus and the
carrier state of Lesch-Nyhan syndrome (Park et al., 2008).
In theory, reprogrammed ESCs could then be differentiated into patient-specific, func-
tional cells for drug discovery, for example for personalised medicine. However, it
remains unclear to which degree of cell specialisation these ESCs have to be differenti-
ated to represent a sufficient accurate model (Rubin, 2008).
To take advantage of the properties of these ESC-derived, specialised cells, it is paramount
to understand the mechanisms which control the expansion and differentiation of ESCs.
This would then allow the efficient and economical mass production of specialised, func-
tional cells.
1.2.2 Regenerative medicine
The lack of organ donors, for example for heart or liver transplants (Aubrey et al.,
2008), the life-long medication and its effects on diabetes patients (Rubin & Peyrot,
2001) or the non-existence of effective treatments for spinal cord injuries are some ex-
amples of issues in modern healthcare that need to be addressed.
Inspired by the Greek myth of Prometheus’ liver regeneration which fed Zeus’ eagle
daily, the ideal treatment strategy would aim to repair the damaged tissue or organ to
restore its functionality, thereby removing the need for long-term care (Power & Rasko,
2008).
However, the concept of using cells to treat diseases or trauma and restore tissue func-
tion is not outlandish. For example, the transplantation of hematopoietic stem cells
derived from the donor bone marrow has been a successful treatment of myeloma and
leukemia patients for over 50 years (Appelbaum, 2007).
Under the umbrella terms regenerative medicine or tissue engineering, new opportu-
nities for stem cell based therapies and cures have subsequently arisen since then,
with progress in stem cell research combined with other disciplines such as biomaterial
science or bioengineering. The definition by Daar & Greenwood (2007) clarifies the
difference between regenerative medicine and tissue engineering:
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Regenerative medicine is an interdisciplinary field of research and clini-
cal applications focused on the repair, replacement or regeneration of cells,
tissues or organs to restore impaired function resulting from any cause, in-
cluding congenital defects, disease, trauma and ageing. It uses a combina-
tion of several converging technological approaches, both existing and newly
emerging, that moves it beyond traditional transplantation and replacement
therapies. The approaches often stimulate and support the body’s own self-
healing capacity. These approaches may include, but are not limited to, the
use of soluble molecules, gene therapy, stem and progenitor cell therapy,
tissue engineering and the reprogramming of cell and tissue types.
The range of potential applications for regenerative medicine is immense (see table 1.3)
and it has also sparked now a growing interest of the pharmaceutical industry (McK-
ernan et al., 2010). To reflect this trend, the FDA1 approved in 2009 the first Phase 1
trial with hESC-derived oligodendrocytes for spinal cord injuries (Alper, 2009). Very
recently, two new neural stem cell trials have been approved in the UK and Switzer-
land (Mack, 2011). Despite the promises and hopes of regenerative medicine, some
challenges and issues exist in translating laboratory findings into clinical procedures
(Bongso et al., 2008). First, the efficacy and safety of these therapies in patients needs
to be thoroughly tested to avoid secondary malignancies (Carpenter et al., 2009). For
this reason, robust and functional assays need to be developed which are able to pre-
dict the clinical safety and efficacy (Rayment & Williams, 2010). After injection of
cells or transplantation of cell-laden grafts into a patient, severe immune responses
or malignancies are undesired secondary effects. This is particularly relevant for ESC
based therapies where undifferentiated cells have been shown to trigger tumor forma-
tion (Anisimov et al., 2010).
The long-term safety of stem cell based therapies has to be thoroughly proofed that
side effect disorders are absent. In a recent study, it has been shown for example that
up to 30% of the patients receiving hematopoietic stem cell transplants may suffer from
diabetes mellitus after 2 years post-implantation (Griffith et al., 2010).
Besides the aforementioned biological issues, practical issues such as the cell numbers
required for a therapy are stalling the advancement of regenerative medicine. Mason &
1Food and Drug Administration
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Dunnill (2009) estimate required cell numbers in the range of 105 − 109 cells depend-
ing on the tissue to treat. It becomes a huge challenge to manufacture these cells as
currently no culture system and strategy is in place to cope with cell numbers of these
magnitudes (Oh & Choo, 2006).
This challenge could be addressed by more efficient expansion and differentiation pro-
tocols using novel bioreactor types which allow to control the microenviroment of stem
cells. However, at this stage, there is no bioprocess development tool available which
could assess the influence of different culture variables on cell numbers obtained in ex-
pansion or differentiation steps.
Table 1.3: Exemplary summary of potential future regenerative therapies -
A few examples of potential stem cell therapies for different, clinically relevant tissues.
Naturally, there are more applications for stem cell based therapies.
Clinical Application Injury/Disease Description Current Treatment Future Treatment References
Neural Spinal cord injury (SCI) Defect of the
spinal cord by in-
terrupting axonal
pathways. Loss
of nervous tissue
and consequently
of motor and
sensory ability.
Treatment in-
clude neuronal
protection and
preservation of
residual axons
and white matter.
Injection of stem
cells can lead to
functional bene-
fits.
Lindvall
& Kokaia
(2010); Rossi
& Keirstead
(2009); Sahni &
Kessler (2010);
Schwarz &
Schwarz (2010)
Alzheimers’s disease Disorder is char-
acterised by
neuronal and
synaptic loss
throughout the
brain. Memory
and cognitive
performance is
progressively
impaired
Acetylcholinesterase
inhibitors are ad-
ministered to
enhance choliner-
gic function.
Genetically mod-
ified stem cells
could be used for
delivery of factors
that can modify
the course of the
disease.
Go¨gel et al.
(2011); Kim &
de Vellis (2009)
Parkinson’s disease Gradual loss
of nigrostra-
tial dopamine-
containing neu-
rons. Symptoms
include rigidity,
poverty of move-
ments, tremor
and postural
instability.
Oral administra-
tion of L-dopa
and dopamine
receptor ago-
nists, deep brain
stimulation in
the subthalamic
nucleus.
Replacement
with dopamin-
ergic neurons
generated in
vitro.
Lindvall &
Kokaia, 2010;
Morizane et al.,
2007; Schwarz
& Schwarz,
2010
continued on the next page
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continued from the previous page
Clinical Application Injury/Disease Description Current Treatment Future Treatment References
Huntington’s disease Fatal, intractable
disorder that is
characterized by
excessive sponta-
neous movements
and progressive
dementia.
- Treatment is
in infancy, but
implanted NS
cells in rat brains
were found to
reduce motor
impairments in
experimental HD
through trophic
mechanisms.
Go¨gel et al.
(2011); Kim &
de Vellis (2009)
Cardiovascular Myocardial repair Mycardial in-
farcts lead
eventually to
congestive heart
failure
Heart transplan-
tation
Cardomyocytes
differentiated
from stem cells
could replace
damaged heart
tissue. Ideal
response includes
revascularisation
and electrical
synchroniza-
tion with host
myocardiocytes.
Braam et al.
(2009); Sui
et al. (2011);
Wong & Bern-
stein (2010)
Blood Vessel Substi-
tute
Vascular lesions
result in tissue
loss.
Xenogenic or
synthetic mate-
rials lack growth
potential and
pose a risk for
complications
Vascular grafts
using biodegrad-
able scaffolds and
autologous cells
allow better tis-
sue integration.
Atala (2009)
Orthopedic Articular Cartilage
Damage
Loss of lubrica-
tion functionality
leads to severe
pain. Causes are
trauma, but as
well arthritis.
Physiotherapy,
weight loss, pain
relief medication,
intraarticular
injections and
orthotic interven-
tions.
Cartilage de-
rived from stem
cells can be
transplanted.
Ahmed &
Hincke (2010)
Metabolic & Secre-
tory
Diabetes Type I & II Chronic disease
by a deficit of
β-cell mass and
failure of glucose
homeostasis
Rigorous and
invasive regi-
ment of repeated
testing of blood
sugar levels
and injections
of recombinant
insulin
Implantation of
ESC-derived β
cells
Gonez &
Knight (2010);
Wen et al.
(2011)
1.3 Stem cell bioprocessing
Stem cell bioprocessing is concerned with the manufacture of stem-cell derived products
using robust and reproducible culture conditions and processes (see figure 1.2). Unlike
traditional microbial up- and downstream bioprocessing, it has to be pointed out that
stem cell bioprocessing may also include further bioprocessing steps such as the delivery
of the final product to a patient for example (Mason & Hoare, 2007).
Three design principles are applied to stem cell bioprocessing: the process compo-
nents, the process requirements and the process functions (Placzek et al., 2009). Process
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Figure 1.2: Basic concept of stem cell bioprocessing - A simple and basic description
of stem cell bioprocessing. Stem cells are screened for and selected to meet specific process
criteria. Stem cells are expanded under process conditions EC1...ECn to the required cell
density and kept pluripotent. These cells undergo directed differentiation under process
conditions DC1...DCn into target cells.
components are the cell source and type, the signalling required for cell development
and the bioreactor design and implementation. Practical considerations of bioprocess-
ing are addressed by process requirements and includes aspects of good manufacturing
practice (GMP), bioprocess monitoring, control and automation and finally the deliv-
ery of the product. Both aspects - process components and process requirements - lead
to product functionality and integration to name a few examples of process functions.
The systematic and cost-effective production of specific, stem cell-derived cells is
required by both, drug discovery and regenerative medicine applications. The future
success of regenerative medicine will rely on the bioprocessing capabilities to clear
many of the current hurdles related to stem cells (see section 1.2.2). To address these
issues and concerns, Kirouac & Zandstra (2008) proposed four criteria for stem cell
bioprocess development and optimisation: 1) assessment of relevant cell properties, 2)
measurement and control of key parameters, 3) robust predictive strategies for key
parameters and 4) approaches to test the many different parameters that may affect
cell output in a high throughput and scale-relevant manner.
Proliferation and differentiation protocols for stem cells are developed in simple,
laboratory-scale open bioreactors such as Petri dishes or T-flasks. However, the transi-
tion of a biological, laboratory-scale problem (can cell A be turned into a cell B under
culture condition C ?) into a system (can A cells be turned into B cells per volume
and time unit under process conditions C1...Cn ?) requires engineering principles and
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practices to achieve control, reproducibility, automation, validation and safety (Polak
& Mantalaris, 2008).
To implement these criteria into an engineered system, the understanding of the
so-called stem cell niche is necessary, a model to explain the survival, self-renewal and
differentiation of stem cells. The niche is in vivo the microenvironment which consists
of key components such as growth factors, cell-cell and cell-matrix interactions (Becerra
et al., 2010; Discher et al., 2009). To resemble in vitro the complex and multi-factorial
in vivo niches and taking the sensitivity of stem cells to their culture environment into
account, the understanding of the microenvironment of stem cells and the interactions
with other cells and the extracellular matrix (ECM) are paramount (see also figure 1.3
A) (Peerani & Zandstra, 2010). The following subsections elucidate the importance of
the regulatory aspect of the stem cell niche - the cell interactions and the ECM - that
are necessary for successful outcomes of stem cell bioprocessing. Due to the complexity
of these interactions, this overview covers only two-dimensional culture systems, but
it is inevitable that culture systems using engineered three-dimensional scaffolds will
appear in the near future which mimic the in vivo niche more accurately. To resemble
stem cell niches, cell culture systems have been developed which, in case of a two-
dimensional culture, consists of a medium for expansion/differentiation with a cocktail
of soluble cues, an ECM and a bioreactor.
1.3.1 Stem cell regulation & cellular interactions
A number of different molecular signalling pathways control and regulate whether a
stem cell population proliferates or differentiates. For example, the TGF-β/activin,
Wnt and Nanog pathways control and regulate pluripotency (Angers & Moon, 2009;
Pera & Tam, 2010; Watabe & Miyazono, 2009), the TGF-β, Hedgehog and c-Myc
pathways have been identified to regulate proliferation (Jenkins, 2009; Murphy et al.,
2005; Singh & Dalton, 2009; Taipale & Beachy, 2001). Although important pathways
have been discovered and elucidated, a complete identification of all pathways and their
interactions is lacking (Darr & Benvenisty, 2006; Stewart et al., 2008).
To trigger these pathways in a controlled manner, it is necessary to understand the
signalling factors, which trigger a signalling cascade and eventually lead to the start of
a certain gene expression.
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Figure 1.3: The in vitro microenvironment of ESCs - ESCs are grown on an extra-
cellular matrix (ECM) and fed with media to either maintain their self-renewal capability
or differentiate into a target cell. Cells communicate with itself (autocrine) or with other
cells (paracrine) and interact with the ECM (A). In current culture protocols using T-
flasks for example, media is exchanged daily (B). Medium exchanges impose time- and
cell number dependent concentrations, which might not occur in a pseudo steady-state
microenvironment with continuous medium exchange (C).
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The mTor pathway has been identified as playing a major role in the cell cycle
and proliferation (Fingar & Blenis, 2004). The cell cycle of stem cells in turn plays
an important role in cellular fate decisions (White & Dalton, 2005). Whether a cell
continues to proliferate or starts to differentiate is mainly decided in the G1 phase
of the cell cycle by a number of checkpoints (Burdon et al., 2002; Neganova & Lako,
2008; Zhao & Xu, 2010). The cell cycle itself is regulated by pathways such as cyclin-
dependent kinases (CDK) and c-Myc (Singh & Dalton, 2009). The majority of a
mESC population for example is in the S phase of the cell cycle, where the DNA
is replicated (White & Dalton, 2005). Not all cells in a stem cell cluster/colony are
therefore at the same stage of the cell cycle either, so that different signalling cues are
only released by a fraction of the cells. The elimination or minimisation of the effects
of these concentration differences are likely to have a vast influence on the outcome of
the entire bioprocess.
In vivo, there is a complex interplay of different soluble extrinsic and intrinsic
signalling cues (Firestone & Chen, 2010; Kristensen et al., 2005; Li & Ding, 2010),
gap junctions1 (Wong et al., 2008) and the extracellular matrix (Tsang et al., 2010)
which control the fate of stem cells. Of particular interest for ESC bioprocesses are the
extrinsic factors such as soluble signalling and the ECM due to their ease of control.
For example, leukemia inhibitor factor (LIF), a cytokine secreted by fibroblasts,
regulates STAT3, Oct-3/4 and Sox-2, which are transcription regulators for pluripo-
tency (see section 1.1.2) (Okita & Yamanaka, 2006). The absence of LIF thus promotes
ESC differentiation. Immortalised fibroblasts are traditionally used as feeders to keep
ESCs pluripotent. However, murine ESCs remain pluripotent in the absence of feeder
cells, if medium is supplemented with bone marrow protein 4 (BMP-4) and LIF (Okita
& Yamanaka, 2006).
As discussed in the previous example, cells are capable of secreting signalling factors
which bind to specific cell receptors on the surface of another cell; this mechanism is
known as paracrine signalling (Baraniak & McDevitt, 2010). However, the receptor
can also be located on the same cell, which released the signalling factor and is known
then as autocrine cell signalling. For example, the transforming growth factor beta
1specialised intercellular connection which allows various molecules or ions to pass freely between
cells
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family TGF-β is a protein, which regulates pluripotency, and is secreted by ES cells
themselves.
The last category of signalling mechanisms includes intrinsic mechanisms such as
notch signalling, gap-junctions, and intercellular signalling such as endocrine signalling.
Although intrinsic cues may not play an immediate part in stem cell bioprocess con-
trol, inhibition or promotion of intrinsic signalling might help to integrate such cells
into an existing tissue. For example, gap junctions are important in myocardiac tis-
sue to synchronise the heart beat frequency. Transplanted myocardiac cells or tissue
have therefore to establish a connection with the existing tissue to synchronise the
contraction for a heart beat.
So far, only extrinsic and intrinsic biochemical cues have been discussed. Physico-
chemical and topographical cues due to their direct interaction with cells play an im-
portant part to promote directed differentiation of stem cells into specialised, functional
cells. For example, mesenchymal stem cells differentiate into osteochondrocytes under
cyclic mechanical stimulation (Maul et al., 2011). Hydrodynamic shear stress promotes
the differentiation of human embryonic stem cells into endothelial-like cells (Ahsan &
Nerem, 2010). Nano- and microstructured two-dimensional cell culture surfaces such
as linearly aligned gratings for instance have a positive effect on the directed differenti-
ation of a number of different types of stem cell (Mart´ınez et al., 2009). Valamehr et al.
(2008) have demonstrated that the hydrophobicity of the cell culture surface plays a
role in the embryoid body (EB) formation size and efficiency. The rigidity of cell culture
substrate itself has also an influence on stem cell morphology as demonstrated by Yang
et al. (2011). Chemical cues such as low oxygen tension levels may increase the differ-
entiation efficiency, for example of ESC-derived neuronal progenitor cells (Mohyeldin
et al., 2010; Simon & Keith, 2008).
It is evident that the cellular environment of a stem cell is a complex and dy-
namic interplay of different cues - soluble factors, cell-cell signalling, mechanical load
and the extracellular matrix. To precisely define a reproducible stem cell niche, engi-
neered cellular environments are needed (Burdick & Vunjak-Novakovic, 2008; Peerani
& Zandstra, 2010).
Static cultures, where medium is exchanged regularly, have a transient behaviour
of the soluble microenvironment (see figure 1.3 B). Considering two arbitrary sized
cell clusters/colonies in a static culture vessel for example, the larger sized cluster will
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produce more signalling factors and toxic metabolites over time and consume more
nutrients than the smaller cluster resulting in concentration gradients in the vessel.
However, a steady-state cellular environment is more likely to expose cell clusters
to constant, spatially invariant concentration levels of nutrients and signalling factors
(see figure 1.3 C). The choice of an appropriate bioreactor design and culture mode
will therefore be critical to achieve steady-state conditions and yield large quantities of
cells with specific properties.
1.3.2 The importance of the extracellular matrix
In vitro, some adherent cells require a biological glue, the extracellular matrix (ECM),
to attach to a cell culture surface (Frantz et al., 2010; Raymond et al., 2009). The
ECM is composed of different molecules such as collagens and other glycoproteins,
hyaluronic acid, proteoglycans, glycosaminoglycans and elastins. ECM molecules have
different functions: adhesive surfaces for cells, structure for cells, storage and mediation
of growth factors and the sensing and transduction of mechanical signals (Rozario &
DeSimone, 2010). The distribution of these molecules is not static, but rather changes
dynamically with the development of a tissue.
The ECM has not only a structural support role, but also an interaction with
receptors on the cell surface which transmit signals through the cell plasma into the
cytoplasm (Daley et al., 2008; Hynes, 2009). Stem cells communicate therefore not
only via soluble signalling factors, interaction with the ECM regulates and controls also
pluripotency/differentiation of stem cells via cell adhesion molecules signalling (Reilly &
Engler, 2010; Yamashita, 2010). Cell adhesion molecules such as integrins and cadherins
are proteins in the cytoskeletone which control cell-cell and cell-ECM communication.
For example, integrin adhesion affects stem cell function and maintenance (Ellis &
Tanentzapf, 2010; Lee et al., 2010; Prowse et al., 2011).
For embryonic stem cell expansion, different ECMs have been tested for culture of
hESCs while maintaining their pluripotency (see table 1.4). Synthetic materials due to
their cost and availability will become more important to deliver stem cell regulatory
signals to direct stem cell fates (Lutolf et al., 2009). Cell-generated physical forces and
the stiffness of the extracellular matrix are increasingly linked to differentiation (Engler
et al., 2006; Guilak et al., 2009; Reilly & Engler, 2010).
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For scalable hESC culture systems, fully defined culture surfaces are required to en-
sure bioprocess reproducibility. Well defined synthetic surface components have proved
that they are capable of maintaining long-term hESC pluripotency (Melkoumian et al.,
2010; Villa-Diaz et al., 2010). Rodin et al. (2010) have shown that long-term culture
of hESC on recombinant human laminin-511 while maintaining pluripotency is also
possible. A controlled and quantifiable deposition of extracellular matrix proteins on
a hyaluronic acid and chitosan surface has been demonstrated to promote culture of
hESCs and MSCs (Doran et al., 2010). These efforts are important steps towards
scalable culture systems and the elucidation of the fundamental biological processes of
expansion and differentiation.
Table 1.4: Summary of some different ECMs used for embryonic stem cells -
ECMs used for expansion and differentiation of hESCs and mESCs.
ECM Description Role/Effect References
Collagen Group of proteins found es-
pecially in connective tissues.
Of particular interest is colla-
gen IV, which forms bases of
the cell basement membrane
and is found in gelatine.
Maintains pluripotency of
stem cells. Greenlee et al. (2005); Jones
et al. (2010); Li et al. (2009)
Fibronectin Group of proteins which are
secreted by a number of cells.
They play a critical role in
wound healing and are neces-
sary for embryogenesis
Fibronectin consistently
supports hESC growth
with feeder cells, condi-
tioned medium and defined
medium.
Lu et al. (2006); Pankov &
Yamada (2002)
Laminin Group of proteins of the
ECM, structural components
of basement membranes.
Laminins play important
roles in tissue morphoegensis
and homeostasis by regu-
lating tissue architecture,
cell adhesion, migration and
matrix-mediated signalling.
Maintains pluripotency
of embryonic stem cells
combined with conditioned
medium. Only laminin 511
maintains pluripotency in
human and murine ESCs.
Domogatskaya et al. (2008);
Hamill et al. (2009); Rodin
et al. (2010)
Matrigel™ Protein mixture secreted
by Engelbreth-Holm-Swarm
mouse sarcoma cells contain-
ing structural proteins like
laminin and collagen. Exact
composition unknown.
Maintenance of pluripotency
over several days and passage
numbers.
Hughes et al. (2010); Klein-
man & Martin (2005); Row-
land et al. (2010); Xu et al.
(2001)
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1.3.3 Bioreactors for stem cell bioprocessing
Media composition and ECM are not the only variables that affect the outcome of a
stem cell bioprocess. The choice and operation mode of an appropriate bioreactor type
will play an equally important role in the efficient large-scale and long-term manufacture
of cells (King & Miller, 2007).
In general, a bioreactor is a device in which biological and/or biochemical processes
occur under a controlled environment and operating conditions (Martin et al., 2004).
For stem cell bioprocesses, the condition of the media such as pH, temperature, dis-
solved gas tensions, nutrients, metabolites and regulatory molecules can be controlled
by the bioreactor. Cues such as mechanical forces or signalling molecule concentrations
are generated, applied to cells by the bioreactor. Furthermore, bioreactor designs for
stem cell applications need to incorporate rigorous quality control (QC) and process
control (PC) measures to guarantee product safety (Kino-oka & Taya, 2009). For re-
generative medicine stem cell bioprocesses, a bioreactor will have more functions than
cell expansion or differentiation, for example the delivery of cells to the patient in a
clinical fashion.
Monitoring or even control over important culture parameters in bioreactors are
thus important to ensure GMP production of cells. In microbial bioprocesses, optical
density and dissolved oxygen are commonly monitored parameters to ensure product
consistency (Harms et al., 2002).
Although a real-time multi-channel systems to monitor pH, oxygen and carbon
dioxide tension and temperature has been developed for stem cell culture processes (Yue
et al., 2008), real-time monitoring of cell morphology or even cell functionality has been
rarely implemented as standard in bioreactor designs for stem cell bioprocesses. Due to
the complex biological mechanisms involved in stem cell expansion and differentiation,
sophisticated, non-invasive monitoring approaches are required (see figure 1.4).
However, non-invasive monitoring and controlling efforts are still at an early devel-
opment stage. Hagenmu¨ller et al. (2007) developed a bioreactor for the formation of
bone-like tissue using time-lapsed micro-computed tomography (µCT) to monitor bone
mineralisation in a scaffold over 44 days. The characterisation of the beating frequency
of ESC derived cardiomyocytes is another example for innovative bioprocess monitoring
and control. Digital video recording and analysis of pixel intensity were converted into
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Figure 1.4: Theoretical innovative feedback loop for controlling stem cell bio-
processes - A reference value is given, for example ideal cell morphology, and processed
by a controller by adjusting a number of parameters. System output such as phenotype or
functionality are monitored by a sensor such as an advanced image processing algorithm
which feeds back into the control chain.
time and frequency domains to characterise and categorise cardiomyocytes (Hossain
et al., 2010).
Microscope-based analysis is a simple and automated approach to monitor stem
cell expansion or differentiation (Rubin, 2008). Stem cell populations tend to be non-
homogenous and cells expressing relevant markers by means of a fluorescent protein or
antibody can even be detected at single-cell level. Advanced fluorescent cell labelling
methods are in development for labelling different locations in or on a cell, which allow
data-rich monitoring for stem cell bioprocesses. Although these techniques are in their
infancy, they will become necessary tools for stem cell bioprocess characterisation and
optimisation.
An overview of commonly used bioreactors for stem cell culture is given in the
following sections to highlight their advantages and disadvantages. Three-dimensional
bioreactors involving scaffolds are not covered in this overview.
1.3.3.1 Static bioreactors
Current methods available for the expansion or differentiation of stem cells are two-
dimensional bioreactors such as Petri dishes, T-flasks and roller bottles. These biore-
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actors are generally used for monolayer culture of adherent cells, and are marked by
ease of use, low cost and disposability. However, frequent subculturing is necessary to
maintain an undifferentiated state in stem cells. Subculturing requires manual interac-
tion such as dissecting ESC colonies or the use of collagenase or trypsin to remove cells
from the flask. To reduce cellular stress during subculturing, synthetic coatings have
been developed, which change their polymer chain length by a temperature decrease
thereby releasing cells gently.
Petri Dishes and T-flasks are most commonly employed in early stages of stem cell
bioprocess development and are available with surface areas between 20 and 175 cm2.
To achieve cell numbers required by regenerative medicine applications (see Section
1.2.2), in combination with a scale out approach, the growth areas of individual flasks
have been increased up to 1720 cm2 (Corning HYPERFlask) by parallel stacking of
growth surfaces.
Spatial and temporal variances in nutrient and cytokine concentrations are likely to
occur as described in Section 1.3.1. For example, Veraitch et al. (2008) have shown that
manual processing changes the culture conditions in flasks and wells dramatically. This
becomes even more critical when differentiation protocols require hypoxic conditions,
for example to efficiently derive neurons from ES cells (Mondragon-Teran et al., 2009).
It is thus difficult to maintain long-term culture conditions using manual interaction.
Efforts have been also made to automate hESC culture in T-flasks using pipette
robots (Terstegge et al., 2007) and laser-assisted dissection tools for passaging hESC
colonies to improve reproducibility (Terstegge et al., 2009).
1.3.3.2 Stirred bioreactors and microcarriers
Stirred bioreactors, with control over parameters such as oxygen mass transfer and pH
are well-established in the industry, and are suitable for large-scale culture processes
delivering high cell densities (Nienow, 2006). Initial work using stirred bioreactors
has been demonstrated for the expansion of different types of stem cell, for example
hematopoietic and murine ES cells (Andrade-Zald´ıvar et al., 2008; Fok & Zandstra,
2005). Krawetz et al. (2010) have demonstrated that a 25-fold expansion of hESC over
a period of 6 days in a stirred bioreactor can be achieved while retaining high levels of
pluripotency and maintaining a normal karyotype. Similar results have been presented
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for the culture of hESCs and iPS cells supplemented with full-length IL6RIL6 chimera
and bFGF over 20 passages (Amit et al., 2010).
Suspension culture bioreactors have been also used for differentiation of mESC and
hESC. Steiner et al. (2010) have demonstrated the expansion and differentiation of
free-floating hESC clusters by optimising the expansion medium. After 10 weeks of
expansion, hESC clusters were cultivated for 4 weeks in chemically defined medium to
initiate neural differentiation.
Microcarriers which offer cells the ability to attach to a surface have also been used
in stirred suspension bioreactors. Cylindrical, Matrigel coated cellulose microcarriers
for the long-term culture (6 months) of hESC have been used to demonstrate a 2- to
4-fold increase over two-dimensional plastic surfaces (Oh et al., 2009).
1.3.3.3 Continuous culture bioreactors
In continuous culture bioreactors, also known as perfusion bioreactors, cells are trapped
in a contained system to which fresh medium is added while spent medium is removed
at the same rate (Arathoon & Birch, 1986). Medium can be recirculated where fresh
medium is added for replenishment of growth factors and nutrients or non-recirculating.
Continuous culture bioreactors offer an immediate control over culture conditions such
as pH, minimise problems associated with medium depletion and rapidly dilute and
remove negative metabolic products. However, hydrodynamic shear stress on cells can
cause metabolic changes and needs to be taken into account (Kretzmer, 2000).
Different designs for continuous culture bioreactors have been proposed such as hol-
low fiber bioreactors, perfused cartridges, tubular bioreactors and rotating wall vessel
bioreactors. Continuous culture bioreactors are of particular interest for tissue en-
gineering applications where mass transfer of oxygen and nutrients to cells in a 3-D
scaffold would otherwise be limited.
An advantage of continuous culture for bioprocessing is the establishment of steady-
state conditions and therefore yielding probably higher cell numbers. For example,
continuous culture bioreactors employed for hematopoietic progenitor cell cultures have
shown that an 11-fold increase for granulocyte-macrophage colony forming units com-
pared to static cultures over 15 days can be achieved (Koller et al., 1992, 1993a,b).
Initial experiments with murine and human ESCs using a two stage perfusion bioreac-
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tor system indicate that within 2 weeks of culture time in a 1 L scale 100 billions ESCs
can be propagated (Ouyang & Yang, 2008).
Smaller bioreactor systems have been reported for hESC perfusion cultures where
the medium in a modified organ culture dish was exchanged every 12 h for various
pumping times increasing cell numbers by 70% in the best case compared to the static
controls over a period of 7 days (Fong et al., 2005). More recently, it has been shown
that a perfusion reactor in combination with oxygen control produces a 12-fold increase
in cell numbers of hESCs compared to static 2-D cultures (Serra et al., 2010).
1.4 Micro-scale culture for stem cell bioprocess develop-
ment
To speed up the delivery of products to market, the prediction of culture performance
and efficiency is an important bioprocess challenge. Micro-scale technologies can ad-
dress this challenge, which combine high-throughput screening with instrumentation
(Rees & Wise, 2008). For microbial and mammalian bioprocesses, micro-scale culture
vessels, predominantly microwell plates, have become a common and fast approach to
screen in parallel for two or more culture conditions (Micheletti & Lye, 2006). Par-
allelised, automated and multiplexed culture systems fitted with instrumentation for
data-rich bioprocess monitoring and control are important tools for bioprocess devel-
opment and optimisation (Scha¨pper et al., 2009).
For stem cell bioprocesses, dedicated and validated micro-scale culture systems for
bioprocess development and optimisation have not yet been established. Two different
systems are discussed in the following subsections - microwell plates and microfluidic
systems. A comparative summary of advantages and disadvantages of the two systems
is given in table 1.5.
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Table 1.5: Comparative summary of microfluidic cell culture systems and mi-
crowell plates
Microfluidic Systems Microwell plates
Advantages (+++) flexible in modes of operation
(static, intermittent, continuous)
(+++) highly parallel
(++) dynamic changes of the environment
spatially and temporally
(++) culture of cells adherent to the well
surface or on beads in a well
(++) parts or entire process steps on chip
in series
(++) different sizes of wells available
(+) parallelisation allows screening of dif-
ferent conditions
(+) well established technology
(+) implementation of optical and chemi-
cal monitoring (e.g. microscope or CCD-
chip)
(+) automated (with pipette robot)
Disadvantages (-) lack of large scale integration and par-
allelisation
(-) limited mode of operation
(-) materials used not necessarily compara-
ble with scale
(-) optical monitoring difficult to imple-
ment
(-) Usability
(+++) extremely favourable, (++) very favourable, (+) favourable, (-) disadvantageous
1.4.1 Microwell plates
A solution to minimise development and screening costs is to use well plates, because
they are widely accepted. Traditionally, well plates have been used for micro-scale
microbial and mammalian bioprocess studies offering parallel experimentation on a
small foot print (Barrett et al., 2010). They are available in various formats for cell
culture, for example 6-well to 96-well plates. Reproducible results are crucial for a
process and hence, manual interaction is undesired. Automated culture systems using
well plates have been used for maintenance of pluripotent hESCs (Terstegge et al.,
2007; Thomas et al., 2008).
A recent trend towards microfabricated microwells is observed to control EB size,
formation and differentiation. It has been demonstrated that a differently sized moulded
polyurethane microwell array coated with ECM influence the differentiation capability
of EBs from hESCs into cardiomyocytes (Mohr et al., 2010). A similar approach using
a concave microwell array to control the size of EBs from murine ESCs has shown that
cardiogenesis and neurogenesis is strongly regulated by the microwell size (Choi et al.,
2010). A comparative study of a microwell and a micropatterned chip for the prolifer-
ation and differentiation of EBs from murine ESCs indicates though that proliferation
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was lower and EB differentiation proceeded slowly forming only a small amount of the
endoderm (Sakai et al., 2011).
1.4.2 Microfluidic systems
Microfluidic systems or devices are defined by their small volumes, usually in the mi-
crolitre to nanolitre range. Other sources define microfluidics by the size of the channel
which are in the range of a few micrometer to a few hundred micrometers. These two
physical aspects have been combined in the following definition (Li, 2008a):
Microfluidic system manipulate or process tiny (10−9−10−18 L) volumes of
fluids in channels with dimensions of tens to hundreds of micrometers.
The origins of microfluidics are found in analytical chemistry applications where it
was desirable to use small sample volumes, to separate and detect reagents with high
resolution and sensitivity, and to have a small footprint and a low cost (Whitesides,
2006). Microfluidic systems are also often referred to as lab on a chip or micro total
analysis system (Manz et al., 1990).
For life sciences such as bioprocessing or systems biology, cell culture, high-throughput
cell assays, gradient devices or single cell analysis are microfluidic applications which
will benefit from the physical properties microfluidic systems offer (Andersson & van den
Berg, 2003; El-Ali et al., 2006; Feng et al., 2009).
Faster response times, smaller reagent volumes and the potential integration of
instrumentation are also important features. The unique characteristic of microfluidic
systems is the ability to manipulate small volumes of fluids and this offers therefore
an unmatched control over the cellular microenvironment (Young & Beebe, 2010). At
present, three flow manipulation modes for cell culture are used, static, intermittent
and continuous flow (see table 1.6).
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Table 1.6: Comparison of the different flow manipulation modes in microfluidic
systems - Flow modes of interest for micro-scale stem cell bioprocessing.
Static Intermittent Continuous
(+) studies of microenvironment
by diffusion
(+) hydrodynamic shear stress
lowered compared to continuous
culture
(++) continuously controlling the
soluble microenvironment
(+) comparable with large scale
perfusion bioreactors
(+) ability to run in all modes
(-) no relevant information for bio-
processes
(-) no advantage over microwells (-) hydrodynamic shear stress
(++) very favourable, (+) favourable, (-) disadvantageous
Microfluidic cell culture systems offer spatial and temporal control of soluble cues
on a micro-scale, which can not be captured in conventional static culture equipment.
For example, research for stem cell culture would greatly benefit from the study of cell-
cell and cell-ECM interactions using gradients of cues generated in microfluidic systems
(Gupta et al., 2010; van Noort et al., 2009).
Unlike a 96-well plate, microfluidic systems for cell culture offer the option of an
undisturbed optical observation. The meniscus of fluid formed in well plates and the
thickness of the well bottom distort the visualisation of cells by phase or fluorescence
imaging, but this problem can be solved in microfluidic systems. For example, Yin
et al. (2008) has demonstrated that the performance of a quantitive, on-chip calcium
flux assay is comparable and allows the possibility for faster screening protocols with
the potential ability for resolving sub-cellular information than in microtiter plate for-
mats. However, the influence of hydrodynamic shear stress above a threshold in the
microfluidic system has triggered responses in cells similar to chemical stimuli (Yin
et al., 2007).
In spite of the experimental advantages these microfluidic systems offer, they have
yet to find acceptance and general use among biologists (Andersson & van den Berg,
2006; Paguirigan & Beebe, 2008).
Firstly, the challenges associated with fabrication, use and reliability of microfluidic
devices are currently outweighing the potential experimental gain.
Secondly, existing cell analysis equipment such as plate readers, flow cytometry,
microscopes or laboratory tools such as pipettors will need to be integrated to facilitate
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the operation and the accessibility of microfluidic systems for cell culture. For example,
plate reader compatible microfluidic systems for cell culture culture have been presented
to analyse fluorescent labelled cells (Lee et al., 2007; Sung et al., 2009; Wen et al., 2010).
Andersson & van den Berg (2007) raised the question of whether to analyse single
cells or cell clusters in microfluidics. From a biological point of view both aspects are
required to understand the mechanisms which regulate self-renewal or differentiation
of stem cells. Microfluidic platforms have been developed to analyse the genetic profile
of single iPS cells in a high-throughput screen for example. This has an implication on
the dividing potential of individual cells and represents an opportunity to gain insight
for basic stem cell research (Spiller et al., 2010).
For translational research such as stem cell bioprocessing, microfluidic tools with
the required functionalities are rarely available. An overview of specifically designed
microfluidic culture systems for human and murine ESCs is given in table 1.7. All
devices, except Kim et al. (2006); Villa-Diaz et al. (2009), are used in static cultures
(medium is not replaced) or in periodic refeed cultures (medium is exchanged at discrete
points in time). These devices thus lack the ability to create a steady-state soluble
microenvironment over long periods of time.
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Table 1.7: Chronological summary of microfluidic culture systems for embry-
onic stem cells
Reference Cell type (line) Culture time Features
Khademhosseini et al. (2005) mESC (R1) N/A1 5 x 5,Orthogonal pattern-
ing and multiphenotype
culturing
Kim et al. (2006) mESC (ABJ1) 4d 4/12 chambers. Per-
fusion with concentration
and shear gradient
Abhyankar & Beebe (2007) hESC (N/A1) 48h Spatiotemporal patterning,
static culture
Torisawa et al. (2007) mESC (D3) 3d Controlled EB formation
on semi-porous membrane
Figallo et al. (2007) hESC (H9/H13) 4d 12 chambers with optional
inlet configuration, 3-D in
gel
Lii et al. (2008) mESC (R1) N/A1 16 chambers, 3D culture in
Matrigel, medium replace-
ment every 12h
Korin et al. (2009b) hESC (Rex1) 2d Single channel, periodic
refeed
Kamei et al. (2009) hESC (HSF1/HSF6/H9) max. 12d 6 parallel channels, semi-
automated colony control,
periodic refeed
Villa-Diaz et al. (2009) hESC (hESCBGN-01/H9) 48h Single channel/ delivery of
different reagents
Ellison et al. (2009) mESC (ESD3) N/A1 Modelling approach for au-
tocrine and paracrine sig-
nalling, verified with 6 mi-
crochannels and periodic
refeed
Fung et al. (2009) mESC (E14) 5d Exposure of one EB to two
different streams
Khoury et al. (2010) hESC (H9 & H1 Oct4-
EGFP) & mESC (Nestin-
GFP mESC)
6d Different sized microtraps
for EB culture, monitoring
of Oct4-GFP and Nestin-
GFP.
1 Information not available
Microfluidic devices designed for bioprocess development and screening must fol-
low a scaling law for meaningful and translatable results. For suspension cultures for
example, the design is based on either miniaturising existing bioreactors or the use of
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an engineering constant like kLa as design principle for scale down bioreactors. The
mass transfer coefficient kLa is a classical engineering constant used to describe mass
transfer in large-scale suspension bioreactors. A microfluidic suspension bioreactor for
E. coli with a similar kLa value to a shaker flask has been shown to match the growth
characteristics of bioreactors (Szita et al., 2005). Microfluidic bioreactors can thus be
used as accurate predictors for scale up in process development and optimisation.
Unlike suspension cultures with a scaling technology already in place, a straight-
forward definition of design rules for stem cell microfluidic bioreactors is difficult at
present (see section 1.3).
Firstly, basic research to understand the mechanisms of stem cell proliferation and
differentiation is still ongoing and thus, methods are likely to change in future. There-
fore, a predominant culture vessel technology has not been selected and adopted by
researchers and industry. Secondly, embryonic stem cells and reagents used, for exam-
ple media, are extremely costly, therefore process development and screening is limited.
However, the main advantage of microfluidic systems lies in manipulating very
small volumes of fluid. This ability can thus be used to probe the microenvironment
in transient and steady-steady state conditions with respect to cell numbers and pro-
cess efficiency, and translated to implications and assess the impact for macro-scale
bioprocesses (see figure 1.5).
Two important design principles for a microfluidic tool for stem cell bioprocessing
can thus be formulated :
1. The design of the microfluidic system is adaptive to allow the incorporation of
future changes in stem cell research and bioprocessing techniques
2. Culture outcomes are only affected by microfluidic operations and not by alter-
ations or modifications to current culture protocols
These two design principles and how they are implemented are discussed in more detail
in the following sections.
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Figure 1.5: Micro-scale stem cell bioprocessing and its potential implication
for macro-scale bioprocessing - The ability of microfluidic systems to manipulate vol-
umes of fluid - static, intermittent and continuous - offers new possibilities to probe the
microenvironment for stem cell expansion and differentiation. Scalability and comparabil-
ity of micro-scale experimental outcomes are critical for the translation into meaningful
implications for macro-scale bioprocesses.
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1.4.3 Concept of a microfabricated stem cell bioprocess development
platform
1.4.3.1 Requirements for a microfabricated stem cell bioprocess develop-
ment platform
To elucidate the influence of discrete or continuous medium exchange in a microfluidic
system on cell numbers, a complete microfluidic stem cell bioprocessing platform needs
to be designed with well-defined functionalities and requirements. Bioprocessing of stem
cells in static laboratory culture-ware involves generally a process of seeding, culture
and analysis (see also figure 1.6).
Figure 1.6: Comparison of macro-scale cell culture and microfluidic cell cul-
ture - Generally, a macro-scale cell culture experiment consists of three steps: seeding,
culture and analysis. The translation of these steps for microfluidic cell culture represents
a challenge in terms of dimensioning microfluidic devices properly and implementing the
necessary functionalities for each step. For reproducible experimental outcomes, seeding is
a critical step for a microfluidic stem cell bioprocessing platform. During culture, hydro-
dynamic shear stress needs to be under the critical threshold value. After culture, enough
cells need to be available for quantitative analysis off-chip.
A laboratory-scale, stem cell experiment starts usually with coating a pre-sterilised
tissue culture polystyrene (TC-PS) bioreactor with an ECM, usually 0.1% (w/v) gela-
tine, followed by incubation in a sterile environment. For pre-culturing cells, stem
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cells grown in a monolayer are trypsinized and quenched with medium, spun down and
re-suspended in fresh medium. To determine the correct seeding density, trypan blue
exclusion and manual counting under a microscope is a commonly used viability assay
in a separate experiment prior to any cell experiment. Cells are seeded by aspirating
the necessary volume from the cell suspension with a pipettor and transferring the
cell suspension to the new T-flask. Cell distribution is achieved by shaking the culture
vessels gently before attachment of cells to the growth surface starts. Seeding for mono-
layer differentiation experiments for example requires an accurate seeding density. The
density can be very low, in the range of thousands to ten-thousands cells per square
centimetre, for example, for differentiation of murine ESCs into neuroectodermal pre-
cursor cells (Ying et al., 2003). It has also been demonstrated that the plating density
of human bone marrow stromal cells regulates the vascular lineage commitment (Whyte
et al., 2011).
A culture system often used for human ESCs expansion consists of a feeder layer
and clusters of human ESCs (see section 1.1.2). The cluster size plays an important role
for hESC expansions and it has been demonstrated that clusters with less than 10 cells
often spontaneously differentiate (Reubinoff et al., 2000). Hydrodynamic shear stress
and the cross-sectional geometry in the loading channel will thus have a critical limit
to deliver cell clusters intactly to the culture area. Cell seeding is therefore a critical
step in any stem cell experiment/bioprocess, as it precisely defines the cell density or
excludes undesired cell cluster sizes.
After seeding, static bioreactors are kept in temperature-controlled incubators and
medium is usually exchanged daily by manual interactions using pipettors in a sterile
environment. Furthermore, the cell culture medium needs to be protected from UV-
exposure (> 1d) and stored in a fridge to prevent degradation of glutamine for example
during an experiment (Arii et al., 1999).
Analysis of cells is also critical for optimisation of an experiment or protocol. Stain-
ing is a commonly used technique for qualitative or quantitative visualisation of cell
properties via markers using flow cytometry. However, quantitative methods require a
minimum cell number (approximately 5000 cells) to be accurate, for example for flow
cytometry or trypan blue viability assays.
All aforementioned experimental steps in macro-scale cell culture need to be ade-
quately addressed in a microfluidic system. Furthermore, to exploit and use the advan-
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tages of a microfluidic system, three aspects in particular need to be considered when
designing a microfluidic bioprocessing platform for stem cells:
1. The ability to adapt and change designs rapidly
2. Scalability and comparison criteria
3. Innovative monitoring solutions
Firstly, the platform needs an inherent flexibility to implement changes to optimise the
microfluidic network, to design new microfluidic networks for future advanced assays
or culture protocols and to implement advanced functionalities (see section 1.3.1). For
example the implementation of a gradient generator for soluble cues or the integration
of sensors in the platform, such as oxygen or pH sensors, need to be straightforward
without redesigning the entire platform. Furthermore, the ability to implement future
trends in stem cell bioprocessing needs also to be addressed by the microfluidic platform.
Future stem cell bioprocessing trends may include for example cell reprogramming
protocols or even three-dimensional culture of stem cells in scaffolds.
Secondly, for a microfluidic stem cell bioprocessing platform, comparability and
scalability criteria are not currently developed, but these criteria can be adequately
addressed in methods, in materials and in process conditions (see figure 1.7).
Comparability in methods means that the same stem culture protocols can be used
in a microfluidic cell culture device as in a T-flask for example, but also the entire
handling of cells is similar, exposing the cells for example to similar levels of shear
stress during subculturing.
An important factor for expansion and differentiation of stem cells is the culture
surface where cells grow. The culture surface in T-flasks consists of a mechanically
stiff substrate, such as TC-PS, and an ECM coating such as gelatine, fibronectin or
Matrigel. Cell adhesion is a function of the surface properties of the substrate, such
as hydrophilicity (Carre´ & Lacarrie`, 2010). A recent study to compare cell adhesion of
mouse embryonic stem cells to various materials used for microfluidic culture systems
has shown that TC-PS is superior than PDMS or glass (Liu et al., 2010). Optimising
the surface properties, for example Zeonor surfaces, by plasma treatment has not shown
superior results in viability of HeLa cells compared to polystyrene surfaces (Beaulieu
et al., 2009). Optimised culture surfaces by mixing different ECMs for microfluidic
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Figure 1.7: Comparability criteria for scale down of stem cell culture protocols
and use in a microfluidic stem cell bioprocessing platform - Three areas to imple-
ment comparability have been identified which contribute to the scalability of microfluidic
stem cell bioprocessing.
culture devices may be used (Kamei et al., 2009). However comparison of a substrate
material with an optimised surface or ECM composition is not possible with a control or
a T-flask and thus, not applicable for stem cell bioprocessing. The impact of the prop-
erties of the culture surface on differentiation behaviour or pluripotency maintenance
is tremendous and therefore comparability in materials is a necessary requirement.
Finally, the microfluidic experimental outcomes for stem cells need to be translat-
able and therefore criteria such as seeding density, surface area to volume ratio and the
physicochemical environment need at least a similarity to the static controls prior to
microfluidic experimentation by modulating flow. These three scalability and compa-
rability criteria ensure that microfluidic operation will predominantly influence exper-
imental outcomes and minimise effects resulting from miniaturisation. A summary of
all requirements necessary for the microfluidic platform is given in table 1.8.
36
1.4 Micro-scale culture for stem cell bioprocess development
Table 1.8: Summary of requirements and functionalities for the microfluidic
stem cell bioprocessing platform
Requirement Quantification P1/S2 Description
1 Window for microscope Diameter of the micro-
scope stage: 10 cm
(Nikon)
P A time-lapse system is needed to get
an optical feedback and automation of
the culture
2 Pumping mechanism N/A3 P The pumping mechanism should be re-
liable over a long period of time, auto-
clavable and mobile.
3 Mixing gases N/A3 S For a dynamic cultivation it is required
to modulate the gas composition
4 Store medium 4-8℃ P Medium has to be kept cool and in
the dark to prevent glutamin degrada-
tion at room temperature, this requires
though a preheating of the medium
prior to use in the microfluidic chip
5 Medium modulation 2 bottles P To proliferate/differentiate hESC, dif-
ferent media are required. Further-
more, staining and washing steps could
be included and variations minimised
6 Thermal insulation N/A3 S To prevent thermal gradients, the in-
cubator platform has to be insulated
7 Oxygen measurement 0-21% oxygen S Oxygen seems to have a critical impact
on the culture of ESCs (Mohyeldin
et al., 2010)
8 pH measurement N/A3 S pH is another variable, which is inter-
esting to monitor
9 Temperature control 30-40℃ P Temperature seems to have an impact
on proliferation/differentiation (unre-
ported results)
10 Generation of gradients N/A3 S Chemical gradient on one chip and
possibly within one channel for rapid
screening
11 Cultivation area required 1 cm2 P A minimum cell culture surface is re-
quired for further cell analysis (e.g.
Guava)
12 Different flow regimes N/A3 P Steady, semi-steady and continuous
flow regimes under consideration of a
reasonable amount of shear stress
13 Comparability criteria N/A3 P Comparability in materials, in meth-
ods and in parameters
1 Primary requirement P: has to be incorporated in platform
2 Secondary requirement S: desirable implementation, but not necessary
3 Information not available
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1.4.3.2 Design considerations for a microfabricated stem cell bioprocess
development platform
To comply with the requirements defined in the previous section, a modular microflu-
idic platform design is proposed which addresses the flexibility to adapt changes and
functionalities for future bioprocessing steps or developments. The advantages of such
a modular design approach are compared to integrated microfluidic systems in table
1.9.
Table 1.9: Comparison of integrated versus modular microfluidic systems for
stem cell bioprocessing
Integrated Systems Modular Systems
(++) implementation of entire processes or sequences (+++) highly flexible for changes in design
(++) application specific (+++) parts/functionalities for different biopro-
cesses easily interchangeable
(+) small dead volume (++) cheap or easily reproducible parts are disposed
(- - -) entire system will be disposed (- -) reliable packaging and interconnection with off-
chip components
(-) increased complexity of a system (-) window of operation
(-) adaptions or changes can be difficult to implement (-) dead volume
(+++) extremely favourable, (++) very favourable, (+) favourable, (-) disadvantageous, (- -) very disad-
vantageous, (- - -) undesired
Integrated systems are defined here as a microfluidic system which has a culture
chamber, valves and pumps on-chip. Such microfluidic systems have been designed and
developed most notably by the Quake group (Melin & Quake, 2007; Thorsen et al.,
2002). The proposed modular approach restricts the functionality of the microfluidic
system to cell culture only and separates pumping and liquid storage from the microflu-
idic system.
By defining sub-assemblies, an independent development and later optimisation of
each sub-assembly and its modules is possible without re-designing the entire microflu-
idic platform. Besides the engineering advantages, it facilitates the exchange or disposal
of used or defect parts. Furthermore, such a modular platform allows to expand the
system with more functionalities to address future bioprocessing requirements.
For the microfluidic platform, two sub-assemblies have been defined. The first sub-
assembly is the modular microfabricated cell culture device and the second subassembly
includes functionalities such as the pumping mechanism, storage of media and the mi-
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croscope with a camera. The microfabricated cell culture device sub-assembly needs to
incorporate two important design features: 1) disposability of the microfluidic chip and
2) an inherit flexibility to easily implement various microfluidic layouts for different
assays, for example for shear stress studies (see figure 1.8). Seeding, culturing and
Figure 1.8: Packaging concept for a modular microfabricated cell culture device
- The mo dular microfabricated cell culture device design consists of three layers: A dis-
posable and customisable layer which includes the entire microfluidic network and sensors
and two re-usable layers which serve as packaging for the disposable layer and can be used
as mounting base for instrumentation such as optical fibres. The packaging concept allows
to test or experiment with disposable layers of the same design (Chip 1.1, 1.2...1.n) or of
a different microfluidic network layout (Chip 2.1) without affecting the re-usable layers.
harvesting the cell material for analysis are critical tasks in any stem cell experiment
or bioprocess as outlined in section 1.4.3.1, a mechanism for seeding and harvesting
has thus to be incorporated in the microfabricated cell culture device to facilitate these
operations.
1.5 Organisation of the thesis
The previous sections have provided a description of stem cell sources, applications and
stem cell bioprocessing to date. The need for the prediction of culture conditions has
been elucidated by understanding the complex interplay of cellular functions with the
microenvironment. The complexity of stem cell bioprocessing requires new bioprocess
development and optimisation tools alongside existing development and optimisation
tools for successful translation of laboratory findings into a large-scale production.
The aims of the thesis were to develop a microfabricated platform for stem cell
bioprocess development by a) implementing a modular system to explore the capa-
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bilities of culturing stem cells, b) developing a cell culture device which allows scaling
and comparison with existing small scale bioreactors and c) obtaining data-rich process
information.
The thesis covers in Chapter 2 the development of a modular packaging system for
microfluidic devices for stem cell bioprocess development. Chapter 3 introduces issues
associated with the seeding and continuous perfusion culture of embryonic stem cells
in microfluidic devices. First, an overview of seeding methods and the theory of flow
is given, followed by experiments with hESCs to prove the seeding method and the
microfluidic concept.
Chapter 4 is based on the findings of Chapter 2 and 3 and uses the modularity and
the seeding method for a microscope-based platform. Chapter 5 outlines the conclusion
of the presented work and Chapter 6 suggests directions for future work on the modular
microfabricated stem cell bioprocess development platform.
40
2Development of a modular
microfluidic cell culture device
with rapid prototyping capability
Long-term microfluidic cell culture devices require reliable packaging and interconnec-
tion to off-chip components. The research progress to elucidate the complexity of the
interactions between stem cells and the soluble microenvironment requires that unique
design features can be rapidly implemented in a microfluidic cell culture device. Vari-
ous features, for example the possible integration of a tissue-culture polystyrene slide,
have to be integrated that the results obtained with such a microfluidic cell culture
device are then more likely to be scalable.
The results in this chapter have also been presented as a conference proceeding at
the Microtechnologies in Medicine and Biology conference 2011 in Lucerne, Switzerland
(see Appendix G).
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2.1 State of the art fabrication and packaging methods
Microfluidic cell culture devices have a hierarchy of requirements, beginning with the
microfluidic chip function, then extending to fluidic connections, sensor and actuator
integration, and subsequent levels of packaging. The development of microfluidic cell
culture devices is usually an iterative process, outlined in figure 2.1, typically requiring
a series of improvements in performance, function, or reproducibility, before arriving
at a final design. Accordingly, an approach that allowed to concentrate the efforts
on making these improvements for the microfluidic chip, with minimal modification of
other system components, would streamline and accelerate the development process.
It would also enable a better integration of the prototyping in the laboratory with the
design and modelling stages, the so called ’virtual prototyping’, such as finite element
method (FEM) prototyping (Erickson, 2005). This would further allow the definition
of design rules, turning the device development process into a truly rapid prototyping
approach.
Figure 2.1: Microfluidic design & prototyping process - Design improvements can
be divided into expected (solid lines) and undesired iterations (dashed lines). The expected
iterations include a short phase of virtual prototyping, for example the use of design and
modelling software to check the performance of a design idea. This is ideally followed
by a rapid translation of the design to a reproducible number of working prototypes for
verification of performance and reliability and as few as possible iterations for improvement.
Undesired iterations, caused for example by deficiencies in the interconnect (IC) or by poor
bonding (B) delay this translation to working microfluidic prototypes.
To achieve this, three key elements are required: 1) rapid fabrication of large num-
bers of prototype test chips for performance evaluations (Easley et al., 2009; Nath
et al., 2010; Yuen & Goral, 2010); 2) reliable integration, via the packaging hierarchy,
with off-chip components (Crane et al., 2010; Whitesides, 2011); and 3) independent
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development of chip and packaging design. In contrast, complex or expensive fabrica-
tion techniques, and unreliable interconnections, can introduce delays and sources of
errors (Han & Frazier, 2005). To address this, the modular assembly of pre-fabricated
chip components has been previously presented as a solution for rapid development of
proof-of-concept devices (Rhee & Burns, 2008; Yuen, 2008). However, pre-fabricated
components reduce the ability to customise the channel network and to integrate sensors
and actuators which in turn limits the ability to tailor the microfluidic chip function.
2.1.1 Fabrication methods
The use of various inexpensive polymers to fabricate disposable test chips is widespread,
and they can be machined using a variety of fabrication methods (Becker & Ga¨rtner,
2008; Fiorini & Chiu, 2005) (see also table 2.1).
Table 2.1: Overview of transparent polymers and their fabrication technologies
for microfluidic devices
Material Fabrication Autoclavable2 Remarks References
technologies1
COC/COP
Injection moulding,
Hot embossing,
Milling
Yes3
Limited availability
of different sheet di-
mensions
Bundgaard et al.
(2006); Mair et al.
(2006)
PC
Milling, Hot emboss-
ing, Laser ablation
Yes
Tough material to
mill (Young’s modu-
lus: approximately 2
GPa)
Ogonczyk et al.
(2010); Qi et al.
(2009)
PDMS Soft lithography Yes
Non-cured polymer
chains may affect ex-
perimental outcomes
McDonald & White-
sides (2002)
PMMA
Laser ablation, Hot
embossing, Milling
No
Variations in sheet
thickness
Brown et al. (2006)
PS Injection moulding No
Not commercially
available as sheet
Young et al. (2011)
1 using commercially available materials
2 121℃ for 20 min
3 except Topas Series 8007
Direct writing methods, such as CO2 laser writing (Klank et al., 2002), are appeal-
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ing for rapid fabrication of new chip designs with feature sizes in the range of 100 µm
within minutes. However, writing a new microfluidic chip for each experiment can intro-
duce unnecessary variations in dimensional fidelity and back end processing (bonding
for example takes several hours in an oven). Injection moulding and hot embossing are
fabrication techniques for large-scale production of chips, but are economically ineffi-
cient for the fabrication of prototypes (the mould alone costs several 1000), and there is
a lack of flexibility for design changes. Direct writing, injection moulding and hot em-
bossing require rigid, polymeric materials such as poly(methylmethacrylate) (PMMA),
poly(carbonate) (PC), poly(styrene) (PS) or cyclo-oleofin copolymers (COC).
Soft polymers such as poly-dimethylsiloxane (PDMS) are frequently used materials
for fabrication of multiple prototype chips by casting and moulding from a master
(McDonald et al., 2000; Sia & Whitesides, 2003) allowing feature sizes between 5 and
200 µm. This greatly reduces dimensional variations and the preparation time of an
individual chip, yet the preparation of the master by photolithographic means can
itself be time-consuming (including delivery of mask up to 5 days), precluding rapid
implementation of changes to chip design. Silicones and in particular PDMS are well
characterised materials for biomedical applications, however there are concerns about
uncured polymer chains and their effects on cells.
Computer numerical controlled (CNC) micro-milling offers quick and simple direct
writing of master moulds or chips with feature sizes down to 25 µm if necessary, allow-
ing rapid fabrication of new chip designs and large numbers of high-fidelity replicas for
reproducibility and performance testing within one day (Jung et al., 2007; Mecomber
et al., 2006). Additionally, the versatility of micro-milling machines also allows fabri-
cation of the microfluidic packaging.
2.1.2 Packaging and interconnect solutions
A wide range of interconnects, such as those reviewed by Fredrickson & Fan (2004),
have been presented. These can be partitioned into two classes, permanent and non-
permanent.
Permanent connections typically rely on adhesives, often epoxy resins, to attach
tubing to the microfluidic chip either directly or via commercially available connection
ports such as the NanoPort™ assembly. This approach requires an operator to repeat the
interconnection attachment process for each test chip, and reproducibility may depend
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on their manual skill (Gray et al., 1999; Mair et al., 2006; Nittis et al., 2001). Adhesives
may block the microfluidic channels and connections or may not be compatible with
some applications or the solvents used (Sabourin et al., 2009). Glueless solutions have
also been presented using a press-fit to connect different microfluidic chips by a small
metal tubing. Biocompatibility and sufficient thermal resistance to withstand autoclave
sterilisation are particular concerns for a microfluidic cell culture device.
Non-permanent interconnect solutions have the advantage of being re-usable - an
important consideration if multiple prototypes need to be tested rapidly, as repetition
of interconnection attachment is avoided. Forming a reliable seal however requires a
more complex design of the interconnect than with permanent systems, and a number
of O-ring or custom gasket systems (Bhagat et al., 2007; Miserendino & Tai, 2008;
Perozziello et al., 2008; Snakenborg et al., 2007), press-fit designs (Dalton & Kaler,
2007; Li & Chen, 2003; Quaglio et al., 2008; Saarela et al., 2006), and even magnetic
clamps (Atencia et al., 2010) have been described. Non-permanent interconnects can
be integrated into chip fabrication (Mair et al., 2006) or can be decoupled entirely from
the chip (Sabourin et al., 2009). Decoupling may be preferred as it allows simplified
chip fabrication and reuse of the same interconnects for multiple experiments, therefore
reducing the variability of results.
2.2 Design of the modular packaging system
To address the need for an adaptive microfluidic bioreactor module that allows the
implementation of changes in the microfluidic network layout, or the incorporation
of new functionalities (see section 1.4.3.1), a simple fabrication and comprehensive
packaging route for a modular microfabricated cell culture device for stem cell bio-
process development is required. Currently, the casting of PDMS in moulds created
by photolithographic techniques is a commonly used fabrication method for dispos-
able microfluidic chips, offering the ability to fabricate highly customised microfluidic
network layouts. However, the need for special equipment such as a mask aligner for
photolithography and the lack of standardised world-to-chip interfaces solutions are
disadvantageous for rapid translations of design ideas. Functional microfluidic blocks
and units made from thermoplastics allow a simple and rapid assembly for microflu-
idic systems, but the customisation and optimisation of individual blocks is difficult to
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implement rapidly. A rapid prototyping approach which combined simple fabrication
of customisable microfluidic channel networks with standardised world-to-chip inter-
faces and packaging, would allow to design, build and optimise microfluidic systems
(see figure 2.2). A robust and versatile rapid prototyping process for fabricating all
device components, combined with a reliable and reusable interconnect design, could
fulfil all requirements for accelerating device development. Such an approach may fur-
ther open the field of microfluidics to non-engineers (Andersson & van den Berg, 2006;
Mukhopadhyay, 2009).
Figure 2.2: An ideal microfluidic rapid prototyping system for stem cell biopro-
cess development - Soft lithography and PDMS casting offer a high degree of microfluidic
network customisation when compared with prefabricated functional blocks. However, the
degree of standardisation of the prefabricated functional blocks allows short assembly times.
A microfluidic stem cell bioprocess development tool requires both aspects to find an op-
timal balance - a high degree of microfluidic network customisation and short assembly
times due to standardisation.
A key issue of microfluidic prototypes is the functional reliability across the proto-
types, for example avoiding leakage. Due to the nature of planar, multi-layer microflu-
idic devices, leakages are most likely to occur at the interfaces of the layers. Therefore
the number of layers is ideally reduced to a minimum, at the cost of a limited complex-
ity of the channel network design. Modular microfluidic systems using hard polymers
for the microfluidic layer require gaskets to seal the interface, thereby introducing a
new set of undesired layers.
Using a sandwich of hard and soft polymer layers, functionalities such as intercon-
nects for tubing or the microfluidic network can be separated. The hard polymer layers
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serve as packaging plates to attach interconnects for tubing while the soft polymer layer
contains the microfluidic network and uses its soft material properties to seal itself with
the interconnect in the hard polymer layer. Using standard connectors for tubing such
as Upchurch fittings facilitates development of microfluidic prototypes and increases
the reliability of the interconnect. Furthermore, this modular packaging approach may
also serve as an engineering basis for future add-on instrumentation modules such as
the integration with microscope platforms or oxygen sensing systems.
2.2.1 First generation modular packaging system
The first generation of a modular packaging system was based on deforming a plate on
the microfluidic chip to establish a fluidic connection. Two plates are clamped together
around a microfluidic chip, which is made from a silicone rubber and acts as a gasket
on the interconnect socket. While the the two plates are re-usable (interface plate and
frame), the microfluidic layer and the glass slide can be disposed after use. All parts of
the modular packaging assembly are depicted in figure 2.3.
The socket for the fitting itself was attached to a rigid interface plate with four
countersink screws. The socket had a boss with a centred throughhole to fluidically
link the microfluidic chip with tubing (see Appendix B.1 for dimensions). The boss
protrudes by a height H (80 µm) of the interface plate and a diameter D of 6 mm has
been chosen (see figure 2.4).
The microfluidic layer was made from PDMS and aligned with the interface plate
via pins to prevent misalignment with the inlet and outlet ports. The microfluidic
layer had a channel included which measured 1.5 mm in width, 36.5 mm in length and
125 µm in height (see Appendix B.4 for more dimensions). A microscope slide made
from either glass or TC-PS was inserted in the frame to seal the microfluidic layer. 16
screws were used to secure all layers. After securing all screws, the microfluidic layer
was compressed and formed a seal with the protruding boss of the interconnect socket
at the inlet and outlet ports.
2.2.2 Second generation modular packaging system
The overall concept of the first generation was maintained, for example the re-usable
packaging system with a disposable microfluidic chip. However, to implement microflu-
idic network layouts which would allow a larger cell culture area and multiple layers,
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Figure 2.3: Exploded view of the first generation microfluidic packaging system
- Basic microfluidic assembly with the reusable parts of the packaging system and the
disposable microfluidic chip consisting of a microfluidic layer and a microscope slide.
Figure 2.4: Working principle of the first generation interconnect and packaging
system - Schematic of the interconnect, outlining critical dimensions of the boss (D, H ).
To keep the microfluidic layer in place, the microfluidic layer has holes included which align
with the corresponding pin in the interface plate. The PDMS microfluidic layer forms a
seal with the protruding boss of the interconnect socket when clamped together. Figure is
not to scale and the interface plate and the microfluidic layer are shown in exploded view
to facilitate labelling of the dimensions.
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the microfluidic layer dimensions were altered to 18 mm width, 50 mm length and 1
mm thickness. Instead of using alignment pins and holes, the outer geometry of the
microfluidic layer was used to align it with a corresponding recess in the interface and
thus with the boss of the socket (see figure 2.5 A and Appendix B.7 for dimensions).
The microfluidic channel was 1.4 mm wide, 32 mm long and 200 µm high (see Appendix
B.9). The same interconnect socket was used as for the first generation (see Appendix
B.1 for dimensions), however smaller cylindrical versions or versions which use only
three attachment screws have also been designed and developed (see Appendix B.5 &
B.6). A basic assembly of the second generation is shown in figure 2.6 A to highlight all
components. To increase the mechanical stiffness of the frame, a support underneath
the fluidic interconnects was left in the frame (see also Appendix B.8 for dimensions).
Furthermore, the amount of screws to tighten the packaging was reduced from 14 screws
to 10 screws to simplify assembly.
Figure 2.5: Working principle of the second and third generation interconnect
and packaging system - Schematic representations of the working principle of the inter-
connect for the second (A) and third generation (B) are shown. Critical dimensions of the
boss (D, H) and recess (DR, HML) are outlined. The difference between the depth of the
recess DR and the height of the microfluidic layer HML limits the mechanical deformation
of the microfluidic chip using the microscope slide as a bed stop. For these prototypes, a
maximum mechanical deformation of approximately 50 µm for the second generation and
100 µm for the third generation has been allowed for the microfluidic chip. Therefore DR
has been set at 0.9 mm, HML at 1 mm. Figures are not to scale and the interface plate and
the microfluidic layer are shown in exploded view to facilitate labelling of the dimensions.
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Figure 2.6: Exploded view of the microfluidic assembly of the second and third
generation - Basic microfluidic assemblies of the second (A) and third generation (B)
are shown. The disposable microfluidic chip is the same for both generations. The second
and third generation differ in two areas: the socket design and structural improvements to
the packaging. The third generation for example has an integrated interconnect while the
second generation relies on a socket from the first generation. The third generation has
also a stiffer interface plate and frame compared to the second generation.
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2.2.3 Third generation modular packaging system
The third generation is based on the second generation, but includes an integrated
interconnect boss in the interface plate and a screw-on socket for fittings on the interface
plate (see figure 2.5 B). By separating the protruding boss from the socket, a thicker
interface plate can be used, thus increasing the stiffness of the interface plate which is
better for repeated use (see figure 2.6 B and Appendix B.11 for dimensions). For the
second generation, the thickness of the interface plate was 3 mm which was determined
by the height of the protruding boss of the aluminium sockets. For the third generation,
a 5 mm thick interface plate was chosen which increased stiffness approximately 4.5
times compared to a 3 mm thick plate without sacrificing short machining times. The
socket for the tubing fitting has been designed to be made from a 6 mm thick PMMA
sheet (see Appendix B.10 for dimensions). The socket has 3 holes, a centred hole (5
mm in diameter) to cut a M6 thread and two holes with a diameter of 3.1 mm, each
7 mm from the centre hole apart to attach the socket to the interface plate with M3
screws.
The frame has been redesigned for simpler milling operation and the material has
been changed to aluminium to increase stiffness of the frame (see Appendix B.12 for
dimensions). To observe the inlet/outlet ports when assembled, the frame had observa-
tion holes (8 mm in diameter) cut out. In comparison with the second generation, these
changes also allow the interconnect to be entirely manufactured using the micro-milling
machine.
2.3 Materials & methods
2.3.1 Fabrication and characterisation of the packaging system
For all generations, all machined parts were designed with a 3-D CAD program (Solid-
Works, Dassault Systems, France) and CNC-code was generated with a CAM program
(Mastercam X2, Mastercam, USA). A micro-milling machine (M3400E, Folken Indus-
tries, USA) with a standard length, 2 flute, 2 mm diameter end mill (Kyocera Micro
Tools, USA) was used to manufacture all parts of the packaging system and the mould.
For the third generation packaging, the interface plate and the socket for the fittings
were milled from 5 mm thick polymethylmetacrylate (PMMA) sheets, while for the first
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a 2 mm thick polycarbonate sheet and for the seond generation a 3 mm thick polycar-
bonate sheet was used. M3 and M6 threads were manually cut in the appropriate bores
for attachment of the sockets and the fittings. The frame and the mould were milled
from 3 mm thick aluminium sheets. M3 threads for the screws to hold the interface
plate in place were manually cut in the appropriate bores in the aluminium frame.
PDMS (Sylgard 184, Dow Corning, UK) was mixed according to the manufacturer’s
instructions, degassed in a vacuum desiccator and then poured into the mould (see
figure 2.7). The mould with the PDMS was subjected to vacuum again to ensure all
air bubbles were removed. The mould was closed with a 5 mm thick PMMA sheet or a
5 mm thick PC sheet and clamped between two rigid, 10 mm thick aluminium plates
as reported in a similar procedure (Jo et al., 2000). The thick aluminium plates were
secured with four screws and tightened with a torque screw driver at 250 Ncm. The
assembly was then placed in an oven at 85°C for at least one hour to cure the PDMS.
After curing, the clamp was dismantled and the PDMS microfluidic layer released with
tweezers. To seal the disposable microfluidic layer, a microscope glass slide was bonded
to the PDMS microfluidic layer by an air plasma. Both parts were thoroughly cleaned
with deionised water and ethanol and dried prior to bonding. To align the microfluidic
layer with the microscope glass slide, the glass slide was placed in the frame and the
microfluidic layer in the recess of the interface plate. The two surfaces to be bonded were
placed in a plasma chamber (90 s, 30 W, 500 mTorr, PDC-002, Harrick Plasma, USA).
The interface plate and frame were aligned and pressed together gently, ensuring that
the PDMS and glass components of the chip were correctly placed. The microfluidic
chip was then removed from the frame, and cured in an oven at 85°C for at least 2
hours.
The positive height of a microchannel feature in an aluminium mould, and the
negative depth of the corresponding channel in a PDMS cast, were measured at the
inlet, outlet and middle of the microchannel with a stylus profiler (Dektak 8, Veeco,
USA). A stylus profiler is a measurement tool where a needle tip is dragged in direct
contact over a surface. The deflection of the needle tip is measured and a 1-D plot
generated displaying the heights and valleys. For these experiments, the stylus force
was chosen to be 10 mg and the scan length was 2 mm. To measure the height of
the protruding boss, a standard micrometer vernier calliper was used. Both bosses
in an interface plate were measured six times and the mean and standard deviation
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Figure 2.7: Fabrication process of a mould and a microfluidic chip created
in the mould. - A 3 mm thick sheet of aluminium (1) was machined to a mould
with standard CNC milling techniques (2). The mould was filled with PDMS monomer,
degassed using vacuum and covered with a sheet of PMMA or PC and cured (85°C, 90min)
(3). After curing, the PDMS microfluidic chip was released from the mould (4). The
PDMS microfluidic chip and a microscope glass slide were exposed to an air plasma and
immediately bonded together (5). Figure is not to scale.
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calculated. A compact digital microscope (AM413T, Dino-Lite, USA) was used for
imaging the different bosses, and the diameters measured using image analysis software
(ImageJ, NIH, USA).
2.3.2 Setup for burst pressure measurement
To measure the effect of different boss geometries on the burst pressure of the inter-
connect, a syringe pump and tubing were connected to one of the fluidic ports of the
microfluidic chip and a pressure sensor (40PC100G, Honeywell, USA) was glued into a
fitting (P-207, Upchurch Scientific, USA) with an epoxy glue, and attached to the other
end with a Luer lock (see figure 2.8 A). To generate pressure, a syringe pump was used
to push air into the chip from a 5 ml syringe with a Luer lock connector. The force
applied to the interface plate was controlled by tightening the screws to torques ranging
from 2 Ncm to 5 Ncm using a torque screw driver. A LabView™ routine (LabView 8.2,
National Instruments, USA) was used to log the pressure readings from a data acquisi-
tion card (USB-6229BNC, National Instruments, USA). The burst pressure was taken
as the highest recorded applied pressure for a given experiment, and was measured six
times for each torque setting.
2.3.3 Setup for flow rate measurement
To measure the deformation of the microchannel by the clamping procedure, a pres-
surised reservoir of water was used to deliver a constant flow rate, which was monitored
by a flowmeter (see figure 2.8 B). The setup consists of a pressure regulator (ITV0011-
2BL-Q, SMC, UK), a fluid reservoir, the microfluidic chip and a flowmeter (SLG1430-
480, Sensirion, Switzerland). The fluid reservoir had two custom made ports built into
the lid to connect to the pressure regulator and to the microfluidic chip, respectively.
A Luer lock fitting was used to connect the reservoir with pneumatic tubing (SMC,
UK) to the pressure regulator, which was connected to a compressed air supply. The
other port had an M6 thread to accommodate a threaded flat bottom fitting. A fit-
ting was attached to a 15 cm long PTFE tubing (ID: 0.8 mm, OD: 1.6 mm)(S1810-10,
Bola, Germany) with the same fitting at the other end to connect to the microfluidic
chip. The microfluidic chip was fitted on the other fluidic port with a male Luer lock
adapter. A 5 cm long PTFE tubing was fitted on one end with an M6 fitting and a
female Luer lock adapter to connect to the microfluidic chip and on the other end with
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an adapter to connect to the flow meter. The adapter was fitted with a 300 µm inner
diameter capillary, which was cut to a length of 5 cm. Flow rates for the minimum
and maximum compression of the microchannel were recorded over 15 minutes, and
the mean and standard deviation calculated.
2.3.4 Parametric simulation of microfluidic layer and microchannel
dimensions
To study the influence of important dimensions, a simple two-dimensional model of a
cross-section of the interface plate and the microfluidic layer (see figure 2.12 A) was
analysed with a parametric model using a finite element software package (COMSOL
4.1, COMSOL AB, Sweden). The material properties of PMMA for the interface plate
were taken from the material library of the software package. PDMS (microfluidic
layer) was modelled as incompressible (Poisson number 0.499) with a Youngs modulus
of 1 MPa (Gervais et al., 2006).
Four critical parameters were defined: the width of the microfluidic layer Pw, the
height of the microfluidic layer Ph, the width of the channel Cw and the height of
the channel Ch. Pw was varied between 5 mm, 10 mm and 20 mm and Ph, between
1 mm, 1.5 mm and 2 mm. Values for Ch have been varied between 10 µm, 50 µm
and 250 µm and for Cw, between 100 µm, 500 µm and 1.5 mm. The glass slide
sealing the PDMS microchannel was assumed to be rigid, therefore imposing a zero-
displacement boundary condition at the interface microfluidic layer/microscope glass
slide. The torque applied to a screw results in an axial force on the interface plate,
and point loads at the edges of the plate were used to represent this force generated by
the screws. Friction losses between screw head and interface plate were neglected. The
strain of the channel was calculated for the middle of the channel roof by dividing the
displacement at this point by the nominal height.
2.4 Results & discussion
2.4.1 Design
A reusable, modular packaging system has been designed and developed, based on an
adhesive-free connection of a reusable and mechanically stiff polymeric interface plate
with a disposable, soft polymeric microfluidic chip under compression (see figure 2.9
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Figure 2.8: Schematic of the testing setup for burst pressure and flow rate -
(A) Setup to measure the burst pressure of the interconnect. A syringe pump was used
to generate pressure with air as medium. The exit of the microfluidic chip was blocked
by a pressure sensor. The pressure sensor was read out and data logged on a PC. (B)
Setup to measure the flow rate. The pressure in the reservoir was controlled and used to
pump water at a constant flow rate through the microfluidic chip. A flow sensor was used
to monitor the flow rate at the outlet of the microfluidic outlet for different compression
forces of the interface plate. Figure is not to scale.
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A, B). The packaging system enables the simple insertion and alignment of disposable
poly(dimethylsiloxane) (PDMS)/glass chips or any other material. To attach and con-
nect with standard and commercially available fittings, a socket is fixed with screws to
the interface plate, and is easily aligned with the inlet and outlet bores in the interface
plate. Self-alignment of the fluidic ports of the microfluidic chip with the corresponding
bores in the interface plate is achieved by a recess in the interface plate. In the latest
generation, the protruding boss to seal the microfluidic chip has been machined into
the recess, and forms a tight seal with the microfluidic chip.
In the system presented here, the implementation of a standard microscope slide
format (3 x 1 inches) for the rigid part of the microfluidic chip also allows the use of
different commercially available materials, such as tissue culture polystyrene (TC-PS).
This compatibility with this standard slide format also facilitates the integration of mi-
crofluidic chips with routine endpoint-analyses. For observation during the experiment,
the centre opening in the bottom frame allows the objective of an inverted microscope
to be placed in close proximity to the slide. It is thus possible to use the same mi-
croscope settings as employed with microscope slides to monitor the experiment in the
microfluidic chip.
Further observation windows under the sockets enable visual verification that the
fluidic connection is indeed leak-tight. Tubing is reliably connected to the interface
plate with a commercially available flat-bottom fitting in the designated socket. The
simple connection of tubing renders the preparation and set-up of a microfluidic exper-
iment straightforward and without difficulties. Additionally, unlike other interconnect
solutions, where only tubing can be connected, this socket can be used with different
fitting types, for example Luer lock adapters (see figure 2.9 B), or can be modified for
custom-made interconnects if required. In the past, such sockets for screw type fittings
have been used in combination with injection moulded cyclooleofin copolymer (COC)
microfluidic devices (Mair et al., 2006), but this fabrication method is not suitable for
rapid prototyping.
The force to compress the microfluidic chip is generated by screwing the interface
plate with the microfluidic chip to a frame and can be varied by applying a different
torque to the screws. It is thus important to properly characterise the effect of this
force and the interconnect dimensions on the static burst pressure and on the flow rate.
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To characterise the third generation interconnect, the dimensions of the boss have
been varied for the diameter D between 3 mm and 5.5 mm and for the height H
between 75 µm and 125 µm. These dimensions were tested in combination with a
microfluidic chip consisting of a microfluidic layer and a standard microscope glass
slide. The microfluidic layer had a single microchannel (nominal values: 200 µm in
height, 1.25 mm in width and 36 mm in length) and two fluidic ports. Microfluidic
layers with microchannel heights of 50, respectively 100 µm have been also designed
and fabricated for the characterisation of the fabrication process.
Figure 2.9: Modular microfluidic packaging - Filling test with the first generation
of the modular microfluidic packaging system with water blue dye (5 g L−1) (A) and an
assembled microfluidic system of the third generation with different options for connectors
such as a screw type fittings or Luer lock fittings (B).
2.4.2 Fabrication
The entire modular interconnect and packaging system and the mould for the mi-
crofluidic layer were fabricated with a CNC micro-milling machine. All materials are
readily available at low cost. Feature sizes as small as 50 µm could be achieved by
this technique. Allowing 3 - 4 hours for milling, and 2 hours for each curing step, the
fabrication process takes less than two days. Surface modification for de-moulding is
not required and moulds can be used repeatedly. The boss heights of the interconnect
of the third generation have been measured with a micrometer calliper (see table 2.2)
and the diameter has been measured using digital imaging (see table 2.3). The max-
imum difference between the nominal and measured heights was 10.7%. For all boss
diameters, the maximum difference between nominal and measured diameter was 2.9%.
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Nominal height (µm) Measured height +/− std dev (µm) Deviation from nominal height (%)
75 67 +/− 3 10.7
100 100 +/− 9 0
125 118 +/− 3 5.6
Table 2.2: Measurement of boss heights - Boss heights of the third generation.
Boss heights were measured with a vernier calliper. Every boss in the interface plate was
measured six times and the average, the standard deviation and the deviation of the average
from the nominal boss height calculated (n=6).
Nominal diameter (mm) Measured diameter +/− std dev (mm) Deviation from nominal diameter (%)
3 3.02 +/− 0.04 0.6
4 3.94 +/− 0.02 1.5
5.5 5.66 +/− 0.03 2.9
Table 2.3: Measurement of boss diameters in the interface plate - Boss diameters
of the third generation. Boss diameters were measure with a vernier calliper. Every boss
in the interface plate was measured six times and the average, the standard deviation and
the deviation of the average from the nominal boss diameter calculated (n=6).
To fabricate and rapidly test microfluidic chip designs, microfluidic layers were cast
in an aluminium mould from PDMS. The mould contains the structures for the mi-
crochannel and the fluidic ports and defines the outer dimensions of the microfluidic
layer. The negative microchannel height in the mould and the positive microchan-
nel depth in the PDMS microfluidic layer were measured at three locations along the
microchannel for nominal microchannel heights of 50 µm, 100 µm and 200 µm using
contact profilometry (see figure 2.10 A–H). Table 2.4 shows the nominal and measured
average values including standard deviation and deviation from the nominal height for
different microchannel heights. To compare the dimensional fidelity of microchannel
features in the PDMS microfluidic layers with the features in the moulds, microchannel
depths of different PDMS microfluidic layers have also been measured (see table 2.5).
Comparing the microchannel depths of PDMS microfluidic layers with the correspond-
ing microchannel moulds shows either a difference which is within the measurement
error margins (50 µm and 200 µm) or is less than 10 % of the average microchannel
height of the mould (100 µm).
At the edges of the microchannels in the mould, bumps or spikes are observed (see
figure 2.10 C, E, G). The height of these bumps is increasing with decreasing nominal
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microchannel height in the mould. However, these bumps are less predominant in the
PDMS microfluidic layer (see figure 2.10 D, F, H).
Milling generates generally burrs and burr generation is dependent on a few variables
such as feed rate parameters, coolant and tool wear. The bumps observed for all
microchannel heights are thus most likely burrs. To avoid burr generation, the number
of moulds or parts milled with the same end mill has to be restricted.
Nominal height (µm) Average height in mould +/− std dev (µm) Deviation from nominal height (%)
50 32.9 +/− 2.2 34.2
100 88.9 +/− 2.1 11.1
200 185 +/− 2.3 7.5
Table 2.4: Profilometer measurements of microchannel heights in moulds -
Every microchannel in the mould was measured three times at different locations along
the microchannel and the average, the standard deviation and the deviation of the average
from the nominal height calculated (n=3).
Nominal depth (µm) Average depth in PDMS +/− std dev (µm) Deviation from nominal value (%)
50 32.5 +/− 3.2 35.1
100 86.8 +/− 1.38 13.1
200 184.6 +/− 2.5 7.7
Table 2.5: Profilometer measurements of microchannel depths in PDMS mi-
crofluidic layer - Every microchannel in the PDMS microfluidic layer was measured three
times at different locations along the microchannel and the average, the standard deviation
and the deviation of the average from the nominal height calculated (n=3).
The variation in deviation of the nominal microchannel heights for decreasing mi-
crochannel heights may be a result of two causes - either due to the backlash in the
Z-axis spindle drive of the micro-milling machine used for the fabrication of the moulds
or due to an error by manually levelling the end mill on the work sheet.
Backlash is usually a clearance between two mating parts. In micro-milling ma-
chines, backlash occurs most likely in the bearing of the spindle drive. To level the
end mill and define a machine origin on the work piece or the material to mill, a mi-
croscope is used to verify the contact of the end mill with the work piece surface. All
moulds for the different microchannel heights were fabricated on the same aluminium
sheet with a 2 mm end mill. The CNC program sequence is set to mill first the pocket
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Figure 2.10: Characterisation of milling moulds with different channel heights
and their cast PDMS parts - (A) Schematic of the microfluidic layer and the indicated
scan locations. (B) Assembled microfluidic layer on a microscope slide. (C - H) Height
and depth profiles of the microfluidic layer in the mould and the PDMS microfluidic layer
for nominal values of 50 µm (C, D), 100 µm (E, F) and 200 µm (G, H).
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defining the microfluidic layer dimensions and the inlet and outlet holes down to the
features of the microchannel. The second milling step of the CNC program sequence
defines the microchannel height and uses the same end mill level settings as for the first
step. An end mill levelling error would therefore only lead to a decreased or increased
overall microfluidic layer thickness, but not affect the height of the microchannel. It
can therefore be assumed that the deviation from the nominal value occurs due to the
backlash of the Z-axis spindle drive.
The accuracy of feature heights in the mould is thus limited by the micro-milling
machine, in particular for features below 100 µm. However, a significant difference in
height of the transferred features of the mould to a PDMS microfluidic layer has not
been measured.
Before casting and curing, no surface treatment of the mould was required to pre-
vent adhesion in the mould, and PDMS microfluidic layers from all mould geometries
presented were de-moulded without difficulty. The subsequent plasma-assisted bonding
of the PDMS microfluidic layer to a glass microscope slide was performed without any
additional processing steps for the microfluidic layer (see figure 2.10 B), demonstrat-
ing that the mould fabrication method creates very smooth surfaces. Unlike silicon-
photoresist masters, the monolithic aluminium mould is not prone to delamination of
microfluidic structures. It is also more rapidly fabricated than other monolithic masters
such as micro-machined silicon masters or plastic masters made from silicone (Desai
et al., 2009). Furthermore, micro-milling also allows to fabricate moulds with circular
microchannel shapes as (Wilson et al., 2011) has recently demonstrated. Milling moulds
for the creation of microfluidic chips has a further advantage over directly milled parts.
For directly milled parts, the end mill diameter defines the smallest feature possible.
For moulds, the feature size is limited only by the accuracy of the micro-milling ma-
chine, and the robustness of the material being milled. However, these variations are
considered to have a minimal effect on cells.
2.4.3 Burst pressure
The static burst pressure for all interface plate dimensions of the third generation was
measured using the same microfluidic chip, indicating that the integrity of the PDMS
bond to the glass slide was maintained, and that the eventual failure occurred between
the microfluidic chip and the tubing interconnect. For the interface plates with varying
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boss heights, the mean burst pressure ranges from 5.62×105 Pa to 6.89×105 Pa (see
figure 2.11 A). For the applied screw torques (2 Ncm to 5 Ncm), no significant change
in burst pressure values were observed. For the interface place where the boss diameters
have been varied, the mean burst pressure ranges from 5.62×105 Pa to 7.26×105 Pa
(see figure 2.11 B).
The measured values imply that the burst pressure can be considered virtually
independent from the boss geometry for a 5 mm thick interface plate. The protruding
boss is therefore a reliable approach to obtain leak-tight sealing, and it can compensate
for manufacturing tolerances and small differences in the applied screw torque.
Figure 2.11: Burst pressure measurements using air - (A) Shows the mean burst
pressures for varying boss heights (75 µm, 100 µm, 125 µm) with a constant diameter (5.5
mm) under different torques (2-5 Ncm). (B) shows the mean burst pressures for varying
boss diameters (3 mm, 4 mm, 5.5 mm) with a constant height (H = 125 µm). n = 6.
2.4.4 Flow rate
To assess the effect of the compression on the flow rate, the flow rate of water through
the microfluidic chip for a given pressure applied to the water reservoir has been mea-
sured at the lowest and highest torque (see figure 2.8). The decrease in flow rate for
the highest applied torque is approximately 12% of the flow rate for the lowest torque
(see Table 2.6). As expected a lower torque results in a less deformed microchannel and
therefore, a higher flow rate is expected. However, the flow rates are highly reproducible
at defined compressions of the microfluidic chip. For 2 Ncm for example, a coefficient of
variation (i.e. the standard deviation over the mean) smaller than 1% from a total of 6
experiments was obtained. It has to be noted however, that the variation in flow rates
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due to different torque settings is unlikely to affect cells within such a micro channel.
These experiments were conducted independently, i.e. the system was re-assembled for
each flow rate measurement. The measured variation is likely to be within the toler-
ance of the pressure-based pumping mechanism. Therefore, by precisely controlling the
torque (which is straightforward when using a torque screw driver), it is possible to
perform highly repeatable experiments. Finally, given that working pressures for most
microfluidic applications are below 2.5 bar (Eddings et al., 2008; Lee & Ram, 2009), it
is recommend working at the lowest torque setting, minimising the mechanical stress
on the entire microfluidic device.
Table 2.6: Difference in flow rate due to compression - (n=6)
Torque per screw (Ncm) Flow rate (µl min−1) +/− std dev (µl min−1)
2 39.27 +/− 0.31
5 34.5 +/− 1.3
2.4.5 Design rules for a modular microfluidic packaging system
Due to the packaging, a compression of the microfluidic layer occurs which affects the
dimensions of the microfluidic structures. To study this effect, a simple two-dimensional
model of a cross-section of the interface plate with a microfluidic layer consisting of a
single channel has been analysed (Calculations for translating screw torque into an
axial force can be found in Appendix A). To formulate design rules, a number of finite
element calculations were performed for different geometries. The width Pw and height
Ph of the microfluidic layer, and the channel height, Ch, and width, Cw, were varied
in a wide range (see figure 2.12 A). To plot the results, the different geometries were
normalised against the channel height Ch. The figure 2.12 B, C show the impact on
the strain at mid-width of the channel roof for Ph = 1 mm, for 2 Ncm and 5 Ncm
torque, respectively. These are also the two torque settings which were subsequently
used for the burst pressure (section 2.4.3) and flow rate analysis (section 2.4.4).
In general, for any given Cw/Ch ratio, the maximum strain occurs for low Pw/Ch
ratios. A microfluidic layer which is significantly wider than the microfluidic structures
thus reduces the strain. This effect was observed for all values of Ph. For Cw/Ch ratios
below 10, strain in the channel is negligibly small for any torque setting. Cw/Ch ratios
above 10 exhibit strains up to 1% for 2 Ncm torque, and up to 2.1% strain for 5 Ncm,
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respectively (see figure 2.12 B, C). Increasing the height Ph decreases the strain on the
microchannel. A Ph of 1 mm however is a good compromise which allows machining
of the moulds in a reasonable time while keeping microchannel strain below 1 %.
2.4.6 Potential of the fabrication and packaging system
In order to demonstrate that the rapid prototyping method can easily be extended
to more complex structures, a number of microfluidic demonstrators were prepared.
A three-dimensional channel network (see figure 2.13 A - D), where coloured liquid
streams (blue and yellow food dyes in water) pass over and under each other before
being combined, was fabricated by using two layers of PDMS and a system of through
holes. The moulds were machined with a single 2 mm end mill tool, using PMMA rather
than aluminium, demonstrating also the versatility of the mould fabrication technique.
The alignment of the PDMS layers before bonding was easily achieved, thanks to the
standardisation of the outer dimensions. Feature sizes ranged from 125-1000 µm, much
smaller than the 2 mm end mill tool used to mill the mould. A functioning leak-free
prototype was successfully fabricated and tested within 24 hours of the final design
being approved.
Similarly, a staggered herringbone mixer with grooves approx. 35 µm wide (50 µm
spaced grooves under a 45°a˜ngle) was prepared (using a 2 flute end mill with a 0.001
in. diameter), where negative mould was machined from brass stock (see figure 2.14).
Various Y-channel mixing devices were also fabricated to demonstrate integration of
multiple interconnect ports in the packaging system (see figure 2.15 A). Finally, a
multiplexed microfluidic demonstrator has also been design and fabricated (see figure
2.15 B).
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Figure 2.12: Model and compression under two different forces - (A) Schematic
of the two-dimensional model to assess the influence of microfluidic layer (Ph, Pw) and
microchannel dimensions (Ch, Cw) on strain experienced by the microfluidic layer. (B)
Ch strain dependence on Pw/Ch ratios at different Cw/Ch ratios for Ph = 1 mm and a
torque = 2 Ncm. (C) Ch strain dependence on Pw/Ch ratios at different Cw/Ch ratios
for Ph = 1 mm and a torque = 5 Ncm. For (B) and (C) the blue, grey and black lines
represent the values for Ch = 10 µm, Ch = 50 µm, Ch = 250 µm, respectively.
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Figure 2.13: Fabrication and testing of a 3-D microfluidic demonstrator with
two PDMS layers - Both microfluidic layers can be cast at the same time in the mould
(A). The well-defined outer dimensions of the PDMS layers help to align the two layers for
bonding (B). The assembled 3-D demonstrator has two inlets (A+B) for different fluids
and a common outlet (C). The demonstrator was tested with yellow and blue food dyes
(D). The entire microfluidic chip - from the design idea to a working prototype - has been
realised in two days. For more details, see please Appendix B.13 & B.14.
Figure 2.14: Brass mould and PDMS cast of a staggered herringbone mixer
- Features as small as 35 µm can be fabricated, for example a mould with channel and
a staggered herringbone mixer (Mixer structures are 20 µm deep, and 50 µm wide at a
45° angle to the channel wall. Dimensions of the microchannel: 200 µm (w)×100 µm (h)).
See also Appendix B.15 for more details.
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Figure 2.15: Multiple port and parallel chip packaging - Multiple ports can be
realised, for example for mixer chips with different mixing lengths i)-iii) (A). These pro-
totypes have been jointly developed with Dr. Brian O’Sullivan. To multiplex microfluidic
chips, a packaging system for two microfluidic chips has been developed (B). Such a mul-
tiplexed system could be used for example to compare culture conditions, i.e. static versus
perfusion culture.
2.5 Summary of findings
An integrated rapid prototyping approach has been developed and characterised, which
offers a simple but comprehensive route to large numbers of ready-to-use microfluidic
cell culture devices. The system consists of a casting method to deliver microfluidic
prototype chips within two days, and a modular, robust, and adhesive-free interconnect
and packaging system to rapidly test microfluidic chips for cell culture. This approach
separates packaging and microfluidic chip, thus facilitating the rapid testing of mi-
crofluidic design concepts. The microfluidic devices are easy to fabricate and assemble,
and do not require expert fabrication knowledge or specialised environments such as
cleanrooms. Therefore it is also suitable for users with non-engineering backgrounds.
Micro-milling represents a cost-effective, rapid fabrication method for microfluidic
prototypes. With the same machine, parts such as the interconnects and the packaging
system can be fabricated directly, and moulds to cast soft microfluidic chips machined
more quickly than with photolithography. All materials are widely available and at low
cost. The packaging and fabrication method presented in this chapter will also serve
as the basis for improved and optimised microfluidic cell culture chips.
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3Seeding and continuous culture
of human embryonic stem cells in
a microfabricated cell culture
device
In the previous chapter, a packaging and fabrication approach to rapidly implement
changes in the design of the microfluidic chip has been developed and tested using
various configurations demonstrating the potential of the rapid prototyping approach.
Critical aspects for a microfluidic tool for stem cell bioprocess development are cell
seeding and the ability to culture cells in continuous perfusion, which are pivotal for
successful experimentation. Besides these aspects, the culture chamber needs to be
designed large enough to obtain a significant number of cells that off-chip analysis is
feasible using flow cytometry for example.
The results in this chapter have also been presented as a conference proceeding at
the Micro Total Analysis Systems conference 2009 in Jeju, Korea (see Appendix G).
3.1 Issues of adherent cell culture in microfluidic devices
Microfluidic devices for cell culture offer great advantages over current bioreactors (see
also section 1.4.2) in terms of resources used and the data-rich experimental sets made
possible by the parallel nature of the microfluidic devices. To take advantage of mi-
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crofluidic cell culture devices, two particular requirements are of great importance -
efficient and accurate cell seeding and low hydrodynamic shear stress microfluidic de-
signs. A concise overview of the design of microfluidic cell culture devices for adherent
cells is given by Kim et al. (2007). However, the requirements for a microfluidic stem
cell bioprocess development and optimisation tool demand scalable and comparable
methods as outlined in section 1.4.3.1.
3.1.1 First issue: Cell seeding
Every cell culture experiment is started with the seeding of cells into a bioreactor. Prior
to seeding, an appropriate cell seeding density is calculated based on a cell viability
count, which determines the amount of cell suspension to be added to a T-flask for
example. It has to be pointed out that the seeding density plays an important role to
control stem cell expansion or differentiation. For example, the differentiation of mESCs
into neuronal precursor cells has been optimised for a low seeding density showing the
importance (Ying et al., 2003). The seeding process thus affects all subsequent process
or experimental steps, and is therefore a critical element for successful and repeatable
experimental outcomes.
Compared to off-the-shelf, ready-to-use T-flasks for example, traditional microfab-
ricated cell culture devices for hESCs are cumbersome to operate (see figure 3.1).
Firstly, sterilisation procedures usually require a sequence of washing steps of the
microfluidic channel network with ethanol and subsequent washings with phosphate
buffer solution (PBS) or the exposure to a UV light source. However, both sterilisation
methods are ineffective for long-term culture (>3 days), because these methods do not
follow an approved standard sterilisation protocol.
Secondly, it would be desirable to follow the same seeding procedures of a macro-
scale hESC experiment in a microfluidic device to facilitate scalable experimental re-
sults. However, traditional microfluidic cell seeding procedures differ from macro-scale
cell culture by using volume units rather than area units.
These process steps prior to microfluidic cell culture may add a source of error
which can affect device reliability during cell culture or the cell culture outcome it-
self. Common errors which may occur during microfluidic cell seeding are for example
contamination by bacteria, incorrect seeding density or mechanical disruption of cells.
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Figure 3.1: Comparison of seeding procedure - Comparison of seeding procedure in
current small-scale cell culture methods (e.g. T-flasks) and a traditional microfluidic cell
culture device for human ESCs on a feeder layer.
3.1.1.1 Flow-based seeding methods
The majority of microfluidic systems use flow-based seeding methods, where cells are
seeded into a reservoir separate from the culture chamber and subsequently flowed
to the culture chamber via fluidic connections (Kim et al., 2007). This method has
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also been applied to seed hESCs on human foreskin fibroblasts and on growth-arrested
murine embryonic fibroblasts (mEFs) (Kamei et al., 2009). Kamei et al. (2009) have
reported a microfluidic selection port where only hESC clusters of a defined size were
admitted into the downstream culture chambers.
While these methods offer a straightforward experimental procedure and allow the
use of relatively simple microfluidic devices, they lack two important aspects for mi-
crofluidic cell culture. Firstly, flowing through ECM components results in coating the
walls of the entire microfluidic channel network and therefore promoting cell adhesion
throughout the entire microfluidic device. This can affect cells in the downstream cul-
ture area by exposing these cells with signalling cues secreted from cells in the upstream
section. The definition of a dedicated cell growth area, and thus a precisely defined cell
culture chamber within the microfluidic device, is difficult.
Secondly, loading a microfluidic chip with a cell suspension solution in long mi-
crochannels may result in cell settling due to gravity. A low flow rate during cell
seeding has to be chosen to prevent hydrodynamic shear induced cell damage. How-
ever, low flow rates may also result in cell settling due to gravity before reaching a
dedicated cell culture compartment. It is therefore difficult to find an appropriate flow
rate, and such flow rate will also vary with different microfluidic chip designs and cell
types.
Different solutions have been presented to address these flow-related effects during
seeding. For example, Kim et al. (2006) have developed a microfluidic hydrodynamic
shear stress gradient device with four chambers for mESC culture. Each chamber can
be loaded over a seeding channel to ensure equal seeding densities across all chambers
by manipulating valves. Gomez-Sjoberg et al. (2007) achieved an automatic seeding
of MSCs by using a microscope and an image analysis algorithm to determine seeding
density refilling the culture chamber accordingly with cell solution until the required
seeding density was reached. To prevent cell adhesion outside the culture chamber, the
microchannels were coated with Pluronic® F-68, a cell-repellent reagent.
Both examples demonstrate that the complexity of the microfluidic network design
or experimental procedure in microfluidic devices increases with more advanced, flow-
based solutions for cell seeding, which may reduce device reliability.
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3.1.1.2 Alternative seeding methods
To simplify cell seeding and avoid the challenges described previously (see section
3.1.1.1), microfluidic networks which can be detached from a cell culture substrate
allow a simple route to efficient cell seeding. Instead of waiting until cells are confluent
in a microfluidic channel, cells are grown in a Petri Dish or on a microscope slide until
cells are confluent or ready for experimentation and then closed with a microfluidic
network. Various solutions to seal the microfluidic chip with the cell laden substrate
have been presented using vacuum, magnets or clamps (Chung et al., 2007; Tamanaha
et al., 2009; Tkachenko et al., 2009). Tilles et al. (2001) have developed a method, in
which a microscope glass slide was seeded, either with hepatocytes only or with fibrob-
lasts and hepatocytes as a random co-culture, in a Petri dish. Once the glass slide was
confluent, it could then be mounted in the bioreactor. However, these methods require
special care when assembling the microfluidic device to avoid contamination.
3.2 Second issue: Hydrodynamic shear stress
Hydrodynamic shear stress caused by continuous culture can be a reason why cells de-
tach from a substrate (Gutierrez et al., 2008; Lu et al., 2004), change their morphology
(Metallo et al., 2008) and, in the case of ESCs for example, may lose their pluripotency.
Microfluidic devices for the culture and manipulation of hESCs have been presented
(Abhyankar & Beebe, 2007; Figallo et al., 2007; Korin et al., 2009b), but the continuous
culture of hESCs remains a challenge. In case of a feeder culture system, hESC colonies
must be attached to the feeder layer, before continuous culture can be started. However,
hESCs in particular seem to be prone to wash out under continuous hydrodynamic shear
stress (Korin et al., 2009a).
Several examples of flow-stop modes or cell re-feeding schedules with long periods of
static incubation have been reported, where cells remained pluripotent (Kamei et al.,
2009; Korin et al., 2009a). However, for continuous culture culture the reports in
literature are inconclusive. Wash-out of hESCs within a few hours was reported for a
straight microchannel with a syringe-pump actuated flow rate of 0.05 ml h−1 (Korin
et al., 2006). To minimise hydrodynamic shear stress on cells, gentle pump methods
such as gravitational flow have been proposed for handling of cells (Boettcher et al.,
2008).
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In a Y-channel design and using gravitational flow up to 1.5 ml h−1, for example
an approximately ten-fold increase in hydrodynamic shear, viable cells did not wash
out and in fact retained their undifferentiated state over 96 hours of culture (Villa-Diaz
et al., 2009). The latter study also used the gravitational flow to obtain a gentle seeding
procedure. This indicates that the seeding method and the proper attachment to the
cell growth surface are in fact critical for the success of continuous culture of hESC in
microfluidic devices and may as well depend on the used cell line.
Other designs have been proposed, where cells are not directly exposed to hydro-
dynamic shear (Liu et al., 2008; Toh et al., 2007) or the shear stress distribution in
the culture chamber has been adjusted with flow restrictors to a more uniform velocity
profile (Petronis et al., 2006).
3.2.1 Theoretical considerations for continuous culture in microfluidic
devices
Shear stress at the wall in a rectangular channel can be expressed as a function of flow
rate Q and channel dimensions h and w (the derivation of the equation can be found
in the Appendix C):
τwall = 6 · µ · Q
h2 · w (3.1)
Another important characteristic number represents the media residence time (MRT).
This becomes an important characteristic when studying steady-state versus transient
microenvironments of stem cells described in section 1.3.
A bioreactor might not be ideally designed and stagnant zones in the bioreactor
might falsify concentration predictions. The residence time distribution unveils such
non-ideal bioreactor performance. The mean media residence time can be predicted
with a simple equation:
tMRT =
VCC
Q
(3.2)
where tMRT is the mean media residence time, VCC the volume of the culture chamber
and Q the volumetric flow rate.
For a straight microchannel (W: 1.5 mm, L: 30 mm, H: 125 µm) shear stress levels
can be as high as 0.2 dyne cm−2 at the cell culture plane and the MRT ranges from 40
s to 6 min (see figure 3.2).
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Figure 3.2: Shear Stress and MRT in a microchannel - Schematic of the microchan-
nel and flow direction (A). Hydrodynamic shear stress and medium residence time in a
microchannel can be calculated as a function of Q and the geometrical dimensions (W: 1.5
mm, L: 30 mm, H: 125 µm) of the microchannel section (B).
By analysing equation 3.1, hydrodynamic shear stress can be reduced by either
lowering the flowrate Q and/or increasing the cross-sectional dimensions h and w.
Medium residence time (MRT) is an important measure how long a molecule remains
in a bioreactor chamber. As shear stress scales linearly with width and squared with
height, a larger culture chamber design is advantageous. If compared with a straight
microchannel, a large chamber design allows MRT to be changed/varied while the shear
stress remains almost constant.
The calculations so far were based on average velocities across the entire microchan-
nel section and do not represent the real physics. It has to be noted that flow in a tube
or microchannel is generally known as Hagen-Poiseuille flow. The characteristics for
Hagen-Poiseuille flow are that the maximum velocity is reached at the centre of the
channel and equals zero at the walls.
3.3 Design of the microfabricated cell culture device
To address the issues associated with microfluidic continuous culture of adherent cells
described in the section 3.1, a microfluidic continuous culture bioreactor is presented
with a simple, yet reliable seeding method and a low hydrodynamic shear stress mi-
crofluidic network. The modular design of the microfluidic devices described in chapter
2 serve as basis for the microfluidic continuous culture bioreactor.
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To streamline the seeding procedure in the microfabricated cell culture device with
standard, laboratory scale cell culture techniques, a static seeding method with direct
access to the microfluidic culture chamber using a standard laboratory pipette is pro-
posed. In the open configuration, the microfluidic chip and the interface plate form a
well with a depth DW (see figure 3.3 A). The depth DW can be adjusted by varying the
thickness of the interface plate and the microfluidic chip to match the liquid film height
in a standard T-flask for example (3 mm in a T25 flask with 5 ml working volume). By
matching the surface-to-volume ratios in the microfabricated cell culture device during
seeding, similar gaseous tension levels at the cell culture substrate can be expected.
Figure 3.3: Cross-sectional schematic of the microfabricated cell culture device
concept and its two modes - (A) shows a cross-sectional schematic of the modular
bioreactor in the open configuration used for coating with ECM and seeding of cells. DW
defines the depth of the well during static incubation of ECM and cells. In continuous
culture mode, a lid is used to form a microfluidic channel with a height HC (B). Figure is
not to scale.
Once cell seeding in the microfabricated cell culture device is completed and cells
have attached to the culture substrate, a T-shaped lid made from PC seals the mi-
crochannel network in the microfabricated cell culture device (see figure 3.3 B). The
horizontal bar of T-shape lid acts as bedstop and defines therefore the height HC of
the microchannel. The height HC can be adjusted by altering the length of the vertical
bar of the T-shape lid.
To prevent a wash out of viable cells during continuous culture, hydrodynamic shear
stress due to flow has to be minimised. Three engineering parameters can be identified
by analysing equation 3.1: flow rate Q, microchannel width w and microchannel height
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h. To lower hydrodynamic shear stress level below the indicated maximum for hESCs
(see figure 3.5), flow rate Q can be reduced, but this will also affect the medium
residence time. Ideally, hydrodynamic shear stress should be engineered independently
from MRT.
The modularity of the packaging system described in chapter 2 allows us to engineer
hydrodynamic shear stress by adjusting the geometry parameters h and w. The design
of the T-shape lid, for example, enables quick adjustments of hydrodynamic shear stress
by altering the length of the vertical bar which defines the microchannel height HC . By
widening the microchannel width and increasing microchannel height in the cell culture
chamber (in comparison with a straight microchannel, see figure 3.4), hydrodynamic
shear stress can be lowered below the critical hydrodynamic shear stress causing a
wash out of hESCs and remains almost constant for a wide range of different MRTs
(see figure 3.5).
Figure 3.4: Schematic of an approach to lower hydrodynamic shear stress - (A)
shows a schematic of a straight microfluidic channel and the velocity profile. To lower
hydrodynamic shear stress, widening of the channel lowers the velocity field and therefore
the shear tensor for the same volumetric flow rate Q (B). Conservation of mass imposes
that v2 = v1 ·A1 ·A−12 . Figure is not to scale.
3.4 Materials & methods
3.4.1 Modelling of critical parameters
The Navier-Stokes equations were solved using the finite element method (FEM) soft-
ware package Comsol Multiphysics 3.5a/4.1 (Comsol, Cambridge, UK) for a set of
parameters (see table 3.1). To solve the problem, it was assumed that a) the three-
dimensional model is in steady-state, b) the flow is fully developed, c) no slip at the
boundaries occurs, d) an incompressible fluid is used and e) the influence of cells at the
77
3.4 Materials & methods
Figure 3.5: Hydrodynamic shear stress as a function of average medium resi-
dence time - Analytical equations were used to calculate hydrodynamic shear stress and
average medium residence time for a straight channel (red solid line) (W: 1.5 mm, L: 30
mm, H: 125 µm) and a wide channel (black dashed line) (W: 12 mm, L: 4 mm, H: 450
µm). Korin et al. (2009a) indicated a maximum hydrodynamic shear stress of 0.1 dyne
cm−2 at which a wash out of viable hESC colonies occured.
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bottom of the channel can be neglected. Water at 37°C was used as working fluid and
assumed to be sufficiently comparable with cell culture media. For all models simu-
lated, the boundary conditions were set at the inlet to an average velocity (calculated
from the flow rate), at the outlet to zero pressure and at the channel walls to non-slip.
Due to the longitudinal symmetry of the microfabricated cell culture device lay-
out, only one half of the microfluidic chip was incorporated in the model to minimise
computational time. For comparison, a straight channel (L: 30 mm, W : 1 mm, H:
125 µm) was incorporated as an entire model. The three dimensional domain of the
microfabricated cell culture device and the straight channel were meshed using tetra-
hedral elements. For the microfluidic chip, the mesh size was varied between 2.5 to 7.5
µm, resulting in 527539 elements. The straight channel had a uniform mesh size of 5
µm, resulting in 54300 elements. Both models were solved with a built-in linear system
solver UMFPACK. For both the microfluidic and the straight channel, hydrodynamic
shear stress was calculated from simulated velocity profiles with the following equation:
τh = µ · γ˙ (3.3)
where τh is the shear stress at a height h from the surface, µ the dynamic viscosity and
the γ˙ shear rate. To verify and compare the calculated shear stress from the models,
the analytical solution of the equation to determine the shear stress at the wall was
used:
τwall = 6 · µ · Q
h2 · w (3.4)
where τw is the shear stress at the wall, h the height of the microchannel, w the width
of the microchannel, µ the dynamic viscosity and Q the volumetric flow rate.
Table 3.1: Parameters used for finite element models - Water has been considered
a valid approximation for cell culture media as a fluid.
Parameters Value Unit Reference
Density H2O 993.249 kg m−3 Interpolated from Lemon (2009)
Dynamic viscosity H2O 6.96× 10−4 Pa s Interpolated from Lemon (2009)
Volumetric flow rate 300 µl h−1 Design specification
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3.4.2 Fabrication of the cell culture device
The modular microfabricated cell culture device consisted of reusable and disposable
parts based on the second generation packaging described in section 2.2.2. Reusable
parts included a lid made from poly(carbonate) (PC) and a modified interface plate
(PC). A gasket and a microfluidic chip made from poly(dimethylsiloxane) (PDMS),
and a TC-PS slide (16004, Nunc, Denmark) were the disposable parts (see figure 3.6).
Figure 3.6: Exploded view showing all parts of the modular microfabricated
cell culture device - The reusable world-to-chip interface was made from polycarbonate
and aluminium and the disposable parts from poly(dimethylsiloxane) (PDMS). The tissue
culture polystyrene (TC-PS) microscope slide and the microfluidic chip are compression-
sealed between the top plate and the bottom frame. The opening in the microfluidic chip
and the TC-PS slide then define the culture chamber body and the cell growth surface,
respectively. To seal the chamber, the lid forms a press fit with the corresponding gasket.
For cell culture imaging, an opening in the frame provides optical access to the TC-PS
slide for the objective of an inverted fluorescence microscope.
The interface plate included an opening to hold the lid. The position of the opening
matched the footprint of the culture chamber of the microfluidic PDMS chip. The inter-
face plate also had two recesses included. The first positioned the microfluidic PDMS
chip with respect to the interface plate, and the second deeper recess, accommodated
the gasket. A set of bores in the interface plate enabled the two interconnects to be
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mounted. A more detailed drawing of the interface plate can be found in Appendix
B.16.
The frame had the same outer dimensions as the interface plate and its recess was
of the dimensions of a microscope slide to hold the TC-PS slide (see Appendix B.8
for dimensions). The opening in the centre was designed to bring objectives from an
inverted fluorescence microscope into close proximity with the TC-PS slide for cell
culture imaging.
The lid was T-shaped with the upper horizontal bar acting as a bed stop when the
lower vertical bar was pushed into the opening of the top plate. This defined the height
of the culture chamber below (450 µm). The vertical bar formed a press-fit with the
gasket to seal the chamber.
The microfluidic chip was made from two PDMS layers. The first layer included
nineteen flow restrictors (200 µm × 1000 µm) on each side of the cell culture chamber
(4 mm × 13 mm) (see figure 3.7, and for more dimensions, Appendix B.19).
Figure 3.7: Schematic of the microfluidic continuous culture chip - (A) shows a
schematic of the channel arrangement of the microfluidic chip with an inlet/outlet port,
flow diffuser, flow equalisation barriers and a cell culture chamber body allowing access
to the cell culture slide for cell seeding, which had an area of 4 mm × 13 mm (dashed
rectangular). The dashed circles around the inlet and outlet ports depict the sealing areas
of the cylinders of the protruding bosses of the fluidic connectors. (B) shows a section in
the middle of the microfluidic chip. The height between the lower solid line and the dashed
line depicts the membrane that elevates the flow restrictors, whereas the upper solid line
approximately depicts the culture chamber height when the microfabricated cell culture
device is in continuous culture configuration. Figure is to scale.
The apertures between the restrictors had rectangular cross-sections (400 µm × 200
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µm). The inlet and outlet ports were connected with the chamber by three dividing
channels on each side.
The second layer (spacer) elevated the first layer above the cell culture plane by 120
µm. For ease of seeding with a pipette, the dimensions of the cell culture area were
chosen 4 mm wide and 13 mm long, resulting in a cell growth area of 52 mm2.
A gasket made from PDMS was designed to fit into the recess in the top plate to
ensure a leak-free operation both during seeding and continuous culture (see Appendix
B.18 for dimensions).
The mould for the microfluidic manifold layer followed a similar procedure as de-
scribed in section 2.3.1. The mould for the microfluidic manifold layer was milled
(8,000-16,000 rpm, 104 mm min−1) in Dural with 2 mm, 1 mm and 200 µm diame-
ter end mills (2 flute standard length, Kyocera Micro Tools, USA). 2 mm and 1 mm
diameter end mills were used to create the microfluidic manifolds or channels. A 200
µm diameter end mill was used to machine the flow restrictors. Poly(dimethylsiloxane)
(PDMS) (Sylgard 184, Dow Corning, USA) was mixed in a ratio of 10:1, base to curing
agent, and degassed under vacuum for approximately 15 minutes. The PDMS monomer
was cast into the negative Dural mould and thoroughly degassed again until no air bub-
bles were visible. A 3 mm thick PC sheet was then placed on top of the mould and the
stack clamped between two aluminium plates. Care was taken to prevent inclusion of
air bubbles (see figure 3.8, 1-3).
The clamped stack was placed in an oven at 85°C for 1 hour to cure the PDMS. After
removing the aluminium plates, the enclosed mould was left to cool. The microfluidic
manifold layer was then released from the mould with tweezers (see figure 3.8, 4).
Excess PDMS of the culture chamber body of the microfluidic manifold layer was cut
out with a scalpel under a microscope.
A membrane at the bottom of the microfluidic chip determined the elevation of the
flow restrictors with respect to the cell culture chamber bottom.
To fabricate the membrane, a 4 inch silicon wafer (Prolog Semicor, Ukraine) was
silanised to prevent subsequent sticking of the PDMS. 200 µl of the trichloro(1H,1H,2H,-
2H-perfluorooctyl)silane (448931, Sigma-Aldrich, UK) was dispensed into a vial and
placed with the silicon wafer in a desiccator under vacuum for 1 hour. 5 ml of degassed
PDMS was spun with a spin coater (P6708D, Specialty Coating Systems, USA) on the
silanised wafer at 500 revolutions per minute for 50 seconds to obtain a thickness of
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approximately 120 µm and placed in an oven at 85°C for 1 hour to cure (see figure 3.8,
3).
To bond the thin PDMS membrane with the PDMS microfluidic manifold layer,
an air plasma was used. Before bonding, the PDMS-coated wafer and the microfluidic
manifold layer were rinsed with ethanol and subsequently dried. Both PDMS layers
were then exposed to air plasma for 90 seconds at 30 W and 500 mTorr (PDC-002,
Harrick Plasma, USA). The microfluidic manifold layer and the membrane on the wafer
were then immediately brought into contact for bonding (see figure 3.8, 5). To further
strengthen the bond, the microfluidic chip was placed in an oven at 80°C for at least 2
hours.
The parts of the PDMS membrane which covered the cell culture chamber body
of the microfluidic chip were cut away with a scalpel to provide free access to the cell
culture slide underneath (see figure 3.8, 6). The dimensions of the mould and the mi-
crofluidic chip were measured with a stylus profilometer (Dektak 8, Veeco Instruments
Company, USA) and the quality of the mould was inspected with a SEM (XB1540
Cross-Beam, Carl Zeiss AG, Germany).
To cast the gasket, a negative mould was milled into a 5 mm thick poly(methyl-
methacrylate) (PMMA) (20070, Nordisk Plast, Denmark) using a 1 mm diameter end
mill (2 flute standard length, Kyocera Micro Tools, USA). The gasket was cast in a
similar manner as the microfluidic chip.
3.4.3 Cell culture
The Shef-3 hESC line (< passage 70) was obtained from the UK Stem Cell Bank and
used for all experiments. Primary mouse embryonic fibroblasts (MEFs) (< passage 5),
used as a feeder layer, were maintained in Dulbecco’s Modified Eagle Medium (DMEM)
(41965, Invitrogen, USA) supplemented with 10 % (v/v) heat inactivated foetal bovine
serum (FBS) (10270, Invitrogen, USA) and 1 % (v/v) Modified Eagle Medium Non-
Essential Amino Acids (MEM NEAA) (11140, Invitrogen, USA), passaged every 3 days
into T25-flasks (159910, Nunc, Denmark) and cultivated in a humidified incubator at
37°C and 5% CO2.
To inactivate the MEFs the growth medium was replaced with 5-7 ml of normal
MEF growth medium supplemented with 1 mg ml−1 of mitomycin C (M4287, Sigma-
Aldrich, UK), and incubated for 2 hours at 37°C. After inactivation cells were washed
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Figure 3.8: Fabrication process of a mould and a microfluidic chip created
in the mould - (1) A sheet of dural was machined with a micro-milling machine to a
mould (2). (3) PDMS was casted into the mould and then vacuum degassed. A PC sheet
was placed on top of the mould and clamped together. Concurrently, a silanised silicon
wafer was spin coated with PDMS to form a membrane. The PDMS-coated wafer and
the clamped mould were then cured for 1 hour at 85°C in an oven. (4) The microfluidic
manifold layer was released from the mould and the culture chamber body was cut out. (5)
The microfluidic manifold layer and the PDMS membrane were exposed to an air plasma
and immediately brought into contact for bonding. (6) The membrane at the bottom of
the culture chamber body was cut out and the microfluidic chip was cut to shape and
released from the wafer. Figure is not to scale.
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three times with Dulbecco’s phosphate buffer solution (DPBS) (D1408, Sigma-Aldrich,
UK) detached with a trypsin:EDTA solution (T4049, Sigma-Aldrich, UK) for 3 minutes,
quenched with normal MEF medium, centrifuged and re-suspended in MEF media
before being seeded at a density of 15,000 cells cm−2 into T25-flasks which had been
pre-coated with a 0.1 % (w/v) in DPBS gelatine solution (G1890, Sigma-Aldrich, UK)
for 10 minutes at room temperature.
hESCs were cultivated in KnockOut DMEM (10829, Invitrogen, USA) supple-
mented with 20 % KnockOut Serum Replacement (10828, Invitrogen, USA), supple-
mented with 1 % MEM NEAA (11140, Invitrogen, USA), 2 mM L-Glutamine (21051,
Invitrogen, USA), 0.1 mM β-mercaptoethanol (M3148, Sigma-Aldrich, UK) and 4 ng
ml−1 FGF2 (4114-TC, RD Systems, USA). For passaging, flasks were incubated with
1.5 ml of 0.025 mg ml−1 collagenase solution (17104, Invitrogen, USA) for 5 minutes,
before being replaced with fresh hESC medium. hESC colonies were then dissected
into medium-sized colonies using pasteur pipettes and transferred into a new flask con-
taining feeder cells prepared as outlined above.
3.4.4 Experimental procedure
Before every cell culture experiment, all parts of the microfabricated cell culture device
and all tubing and tools required for assembly were autoclaved. The microfabricated
cell culture device was then assembled with a sterile TC-PS slide in a laminar flow
hood. For substrate coating and cell seeding, the lid was removed (open configura-
tion, Figure 3.9 A). Laboratory pipettes with 200 µl pipette tips were employed for all
steps. The TC-PS surface of the culture chamber and three single-well dishes (353653,
BD Biosciences, USA) were coated with 0.1 % (w/v) gelatine in DPBS solution, and
left to incubate at room temperature for 15 min. Then, each dish was seeded with
40,000 inactivated MEFs (seeding density of 13,800 cells cm−2). The microfabricated
cell culture device was seeded with 20,000 inactivated MEFs (40,000 cells cm−2) in a
suspension of 200 µl culture medium (Figure 3.9 A) (A higher cell density was chosen
for the microfabricated cell culture device to ensure confluency.) The dish and mi-
crofabricated cell culture device were transferred to incubator (37°C, 5% CO2). For
transfer between laminar flow hood and incubator, the microfabricated cell culture de-
vice was placed in a large sterile glass Petri Dish (2175553, Schott, USA) (Figure 3.9
C). 1 day later, 6-8 dissected hESC colonies ( 250 µm to 1 mm in diameter) were
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seeded in the microfabricated cell culture device, 10-12 dissected hESC colonies in the
dishes, and incubated (37°C, 5% CO2) for 1 day (Figure 3.9 B & C). Before perfusing
the cell culture in the microfabricated cell culture device, the medium in the culture
chamber was aspirated and the microfabricated cell culture device closed with the lid
(closed configuration, Figure 3.9 D). The microfabricated cell culture device was manu-
ally primed with culture medium using a syringe. Two tubings, an autoclavable tubing
(R1230, Upchurch Scientific, USA) with Upchurch fittings (P207, Upchurch Scientific,
USA) and a gas-permeable silastic tubing (R3607, Tygon, USA), connected the syringe
with the microfabricated cell culture device (see figure 3.10). The two tubings were
attached to each other via Luer adapters (F331 and P659, Upchurch Scientific, USA).
After priming of the microfabricated cell culture device, the syringe was placed on the
syringe drive (Model100, KD Scientific, USA) and the cell culture in the microfabri-
cated cell culture device perfused for 2 days with culture medium at a flow rate of 300
µl h−1. Medium in the control dishes was exchanged every day.
3.4.5 Immunocytochemistry
For immunocytochemistry, the lid of the microfabricated cell culture device was re-
moved and all operations carried out with a standard laboratory pipette (see figure 3.9
E). hESC colonies were fixed with 4 % (v/v) paraformaldehyde (PFA) in phosphate
buffered saline (PBS) for 20 minutes and washed three times in PBS supplemented
with 10% (v/v) FBS to block non specific binding. Primary monoclonal antibodies
Oct-4 (SC-5279, Santa Cruz, USA), Tra-1-81 (MAB4381, Chemicon, UK) and SSEA-3
(MAB4303, Chemicon, UK) were used at a dilution of 1:200, incubating them with the
cells for one hour at 37°C. The fixed cells were washed with PBS three times and incu-
bated with secondary antibodies that had an excitation wavelength of 488 nm (A21212,
Invitrogen, USA) and 555 nm (A21426, Invitrogen, USA) for an hour at room tempera-
ture. Finally, the cells were stained with 4’,6-diamidino-2-phenylindole (DAPI) (D1306,
Invitrogen, Carlsbad, CA, USA). DAPI at a dilution of 1:200 was incubated with cells
at room temperature for 10 minutes. Daily cell culture inspections and end-point assay
imaging were performed with an inverted microscope (Eclipse TE2000-U, microscope
camera DS-Fi1, Nikon, Japan).
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Figure 3.9: Seeding procedure - Schematic of the procedure for the microfabricated
cell culture device in seeding and continuous culture configurations. (A) The TC-PS in
the microfabricated cell culture device was coated with 0.1% gelatine with a pipette prior
to seeding of the feeder cells. Inactivated MEFs were seeded subsequently with a pipette
directly into the cell culture chamber of the microfabricated cell culture device and left
overnight in an incubator to attach to the surface. A Petri dish fitted with spacers for
gas exchange was used to accommodate a microfabricated cell culture device and kept in
an incubator at 37°C and 5% CO2 (C). hESC colonies were added into the culture area
with a pipette (B), the Petri dish subsequently closed and the microfabricated cell culture
device placed back into an incubator (C). Prior to changing to the perfusion configuration,
medium was aspirated and the culture chamber closed with a lid. Tubing was connected
to the microfabricated cell culture device and perfusion started using a syringe pump for
48 hours in an incubator (D). On the last day of experiment, medium was aspirated, cells
fixed and stained with pluripotency markers to assess the effect of seeding and perfusion
of hESC in a microfabricated cell culture device (E). Figure is not to scale.
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Figure 3.10: Schematic representation of the continuous culture setup - A syringe
pump is used to pump media through gas-permeable tubing to adjust gaseous tension levels
before entering the microfabricated cell culture device. A waste container is used to collect
media from the outlet of the microfabricated cell culture device. The entire setup is placed
in an incubator to maintain the culture temperature.
3.5 Results & discussion
The objectives of this chapter were to establish a microfabricated cell culture device
which i) can be configured with cell growth surfaces typically employed in current rou-
tine hESC maintenance, ii) is compatible with standard laboratory procedures, and iii)
maintains viable hESCs in continuous culture in order to fully harness the advantages
of microfluidics for the probing of hESC behaviour and the implications for stem cell
bioprocessing.
3.5.1 Design of the microfabricated cell culture device
To this end, a microfabricated cell culture device has been developed, where each part
fulfils a specific function. The modularity of the packaging system allowed the optimisa-
tion of each part individually, i.e. without having to re-design the entire microfabricated
cell culture device. To further facilitate the rapid re-design of the microfabricated cell
culture device, the microfluidic chip was fabricated using the rapid prototyping tech-
nique described in chapter 2 (see also Appendix E.1 for additional characterisation using
stylus profilometry and scanning electron microscopy). Additionally, the reusable parts
of the microfabricated cell culture device (lid, interface plate, bottom frame, sockets)
form a world-to-chip interface that can accommodate any microfluidic chip re-design
as long as the inlet/outlet ports remain at the same position on the chip. Furthermore,
88
3.5 Results & discussion
to ensure sterile long-term cultivations, all parts are fabricated from autoclavable ma-
terials such as poly(carbonate).
The interface plate and the frame provide the scaffold for the modular design. They
align and reversibly seal all parts to each other and therefore offer an easy assembly
of the microfabricated cell culture device. The frame of the microfabricated cell cul-
ture device holds a TC-PS slide or any slide of that size. Integration of TC-PS with
microfluidic devices would normally be difficult, since TC-PS is not compatible with
conventional bonding techniques. With this microfabricated cell culture device, slides
of different material can easily be integrated.
The PDMS microfluidic chip controls the distribution of cell culture medium in the
microfabricated cell culture device (see figure 3.7). The top layer contains a rectangular
culture chamber body and flow restrictors on its sides. The flow restrictors promote a
homogeneous velocity field during continuous culture. The efficacy of such restrictors
to create uniform flow velocity fields was previously demonstrated with slightly larger
apertures (Petronis et al., 2006), and with smaller rectangular apertures (Hung et al.,
2005). The perfusion barriers were implemented to minimise non-uniform cell growth
patterns which can arise from variations in velocity fields and thus, difficult to interpret
(Aunins et al., 2003).
The bottom PDMS spacer layer elevates the main plane of medium flow above the
cell growth surface. This elevation reduces the hydrodynamic shear stress on the cells
and therefore minimises the risk of cell dislodgement during medium perfusion.
Since the thickness of the layer is determined by spin-coating parameters, the ele-
vation can easily be changed, for example to optimise shear stress levels versus mass
transport conditions in the culture chamber or to conduct shear stress assays. Physical
separation of medium flow plane and cell growth surface has been shown previously, but
either required a large minimum separation distance to allow needle insertion for cell
seeding (Stangegaard et al., 2006) or was not combined with flow restrictors (Figallo
et al., 2007).
In this configuration, the separation distance can be freely chosen and is independent
of the restrictor geometry that controls the flow. The re-sealable lid provides a simple
means to open and close the culture chamber. To close the chamber the lid is inserted
into the corresponding opening of the interface plate and forms a press fit with the
compressible PDMS of the gasket. Due to the T-shape of the lid, i.e. due to the
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horizontal bar acting as a bed stop, the same chamber height is attained in every
experiment. Additionally, the hard material of the lid does not deform during medium
perfusion ensuring reproducible fluid flow patterns from experiment to experiment.
PDMS has been reported to absorb small hydrophobic molecules such as proteins
on the walls of microfluidic networks or to leach uncured oligomers (Regehr et al., 2009;
Toepke & Beebe, 2006).
However, alternatives have to be found to avoid negative effects caused by PDMS
on experimental outcomes. Surface modifications of the PDMS microchannels may
address these concerns (Wong & Ho, 2009). For example, it has been shown that
the microchannels are rendered more hydrophilic by adding Pluronic®to the PDMS
mixture before casting (Wu & Hjort, 2009). Such an approach could also be used to
prevent for example protein adsorption on the walls of the microfluidic network. How-
ever the high diffusivity of oxygen in PDMS may represent an issue for oxygen sensitive
applications such as differentiation of ESCs under hypoxic conditions in intermittent
flow.
Materials such as medical grade silicones or polyurethanes have been investigated
in preliminary experiments to offer an alternative to PDMS (James, 2007; Thompson,
2009). In contrast to PDMS, the fabrication methods for these materials are though
immature at present for use in microfluidic devices.
For example the higher viscosity of medical grade silicones requires longer vacuum
desiccation times to remove air bubbles than PDMS and casting of microfluidic layers
becomes problematic to prevent air bubble inclusion in the mould.
The fabrication of polyurethane microfluidic devices is a lengthy process requiring
a PDMS mould and a solvent to dissolve polyurethane granulates. It allowed thus only
a layer by layer deposition to prevent bubble formation when evaporating the solvent.
Using the second generation packaging system has also facilitated rapid set-up of the
cell culture experiment and achieved leak-free long-term operation, an easy and robust
interconnection with the macro-world. In this reactor, the protruding structures of
the interconnects press on the inlet/outlet ports of the PDMS microfluidic chip, which
provides a leak-tight seal upon device assembly. Additionally, the interconnects accept
standard Upchurch fittings and therefore permit simple connection with tubing for
manipulation of medium.
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Finally, to analyse and quantify the cell culture outcome, for example for real-time
monitoring of molecular markers, the microfabricated cell culture device fits onto an
inverted fluorescence microscope stage and the bottom frame has an opening to bring
objectives into close proximity with the cell culture.
3.5.2 FEM analysis of the microfluidic chip
The Navier-Stokes equations for three dimensional models of the microfluidic chip of
the microfabricated cell culture device and, for comparison, a straight channel have
been solved by using a FEM software package. Previous reports indicated that shear
stress is a critical parameter (Korin et al., 2009b), which were confirmed in preliminary
experiments (see Appendix D).
To evaluate the performance of our design, we compared it with a straight mi-
crochannel and analysed the velocity fields and shear stress for both configurations.
The uniformity of the flow velocity in the microfabricated cell culture device field
has been confirmed at various heights above the culture plane. In comparison with
the straight channel microfabricated cell culture device (for details, Appendix D.1) the
velocity field at half the height of the inlet channel is one order of magnitude lower
than in the straight channel with the same flow rate of 300 µl h−1 (see figure 3.11 A,
D). 15 µm above the cell culture plane, the velocity field is approximately two orders of
magnitude lower than in the straight channel (see figure 3.11 B, E). The flow restriction
barriers produce an evenly distributed flow velocity field across the culture chamber
(see figure 3.11 C), similar to the straight channel (see figure 3.11 D). An increased
velocity at the boundaries of the microfabricated cell culture device can be observed
due to the larger gap between flow restrictor and the boundary (see figure 3.11 C).
Air bubbles included during closing or filling are likely to be removed through this gap
when the bioreactor is positioned vertically.
Hydrodynamic shear stress was calculated 15 µm above the cell culture plane with
a flow rate of 300 µl h−1 in both the microfabricated cell culture device and the straight
channel. For the microfabricated cell culture device, an average of 1.1×10−3 dyne cm−2
and a standard deviation of 0.14×10−3 dyne cm−2 was obtained from the model. In con-
trast, the straight channel had an average hydrodynamic shear stress of approximately
0.16 dyne cm−2. The calculated value of 1.3×10−3 dyne cm−2 using the analytical
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solution for shear stress in the microfabricated cell culture device supports the result
obtained through finite element modelling.
Figure 3.11: Modelling of flow conditions in the microfluidic chip and a straight
channel - (A-C) relate to the microfluidic chip, and (D-F) to a straight channel. (A)
and (D) represent the velocity field at half the height of the inlet channel. (B) and (E)
represent the velocity field 15 µm above the culture plane (ACP). (C) and (F) show velocity
profiles at x0 along the Z-axis.
A conservative calculation of hydrodynamic shear stress has been applied for the
design of a microfluidic culture device for murine embryonic stem cells (Kim et al.,
2006). The lowest values achieved in the reported microfluidic design are comparable
with the range in which the microfabricated cell culture device is operated. It is there-
fore assumed that wash-out of viable cells is unlikely, as hydrodynamic shear stress is
below the critical value of 1 mPa (1 × 10−2 dyne cm−2 ) previously reported (Korin
et al., 2009a).
To verify the influence of the height in the culture chamber of the microfabricated
cell culture device on hydrodynamic shear stress, three different configurations of the
microfluidic chip have been analysed (see figure 3.12). The first model to analyse was a
basic configuration of the microfluidic chip with a channel height of 200 µm (Figure 3.12
A). The second model contained the basic configuration of the first, but a a recessed
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culture plane was added resulting in a channel height of 320 µm (Figure 3.12 B). The
third model had the configuration which was used for all experiments and had a channel
height of 450 µm (Figure 3.12 C).
By adding a recessed culture plane to the basic microfluidic model, a reduction
of approximately 50% in hydrodynamic shear stress across the culture chamber was
achieved (see figure 3.12 B, D). Hydrodynamic shear stress levels have been further
reduced by adding a recessed culture plane and lid compared to the basic configuration
shown in figure 3.12 A) resulted in a reduction of approximately 80% in hydrodynamic
shear stress (see figure 3.12 F).
These quantitative measurements confirm that the height of the cell culture chamber
in the microfabricated cell culture device plays an important role, showing also the
flexibility of the design.
3.5.3 Integration with current laboratory procedures
To perform hESC cultures, the microfabricated cell culture device can be operated in
an open configuration without the lid, and a closed configuration with the lid attached.
In the open configuration, the culture chamber is directly accessible with laboratory
pipettes. This makes it easy to apply the cell transfer methods typically employed in
routine hESC maintenance at laboratory scale. Additionally, the exposure to hydro-
dynamic shear stress occurring with the flow-based dynamic seeding methods (Kim
et al., 2007) in closed microfluidic perfusion devices is avoided. Minimising exposure
to hydrodynamic shear is particularly crucial for the handling of embryonic stem cells,
since shear stress can affect the phenotype (Veraitch et al., 2008).
Also, flow-based seeding could potentially even dissociate the multi-cellular hESC
colonies before attachment to the feeder layers. Furthermore, in the open configuration,
the depth of the culture fluid overlay in the microfluidic culture chamber is similar to the
overlay in T25-flasks or in standard control dishes. During cell settling and attachment,
the cells should thus experience a similar microenvironment as in traditional culture
systems.
To test this concept, the microfabricated cell culture device was seeded with cells
according to the protocol employed in our regenerative medicine laboratory (see Ma-
terials and Methods for more details). All parts of the microfabricated cell culture
device were autoclaved, assembled to the open configuration with a TC-PS slide, and
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Figure 3.12: Influence of channel height on hydrodynamic shear stress in
the microfabricated cell culture device - To gauge the influence of different chan-
nel heights, the microfluidic continuous chip was analysed in a basic configuration (A,
B), the basic design and a recessed cell culture plane (C, D) and the basic design with a
recessed cell culture plane and lid (E, F). A flow rate of 300 µl h−1 has been used for all
models. Due to symmetry, only one half of the chip was simulated.
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the culture chamber area coated with a 0.1 % (w/v) gelatine solution. To compare the
outcome with traditional culture vessels, we seeded three single-well dishes in parallel
to the microfabricated cell culture device.
In the microfabricated cell culture device and the control dishes, the inactivated
mouse embryonic fibroblasts (iMEF) started to attach within 2 hours. After one day,
the cells had attached and uniformly spread to attain their characteristic morphol-
ogy in both systems (see figure 3.13 A, E). Furthermore, the cells did not grow into
the apertures of the flow restrictors, demonstrating that the gelatine-coating step spa-
tially defined the growth area for the cells in the microfabricated cell culture device.
hESC colonies seeded to the uniform iMEF layer attached within 1 day. All colonies
maintained an undifferentiated morphology and were comparable to the colonies in the
control dishes (see figure 3.13 B, F).
Figure 3.13: Comparison of morphology in control dishes and microfabricated
cell culture device - Representative phase contrast images of iMEF feeder cells and hESC
colonies cultured in the microfabricated cell culture device (A -D) and in the control dishes
(E -H). All images were taken with 4× magnification, scale bar is 500 µm. Feeder cells
attained their characteristic morphology in both systems 1 day after seeding (A, E). 1 day
later, hESC colonies (highlighted with dashed lines) had attached to the feeder cells (B,
F). After one day of culture, hESC colonies in the continuously perfused microfabricated
cell culture device retained the characteristic morphology of undifferentiated hESCs and
were of similar size to the colonies in the control dishes (C, G). After two days of culture,
the hESC colonies continued to retain their undifferentiated morphology and were still of
comparable size to the colonies in the control dishes (D, H)
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3.5.4 hESC morphology & pluripotency after microfluidic continuous
culture
After seeding, the microfabricated cell culture device was closed and the hESC culture
was continuously perfused with a flow rate of 300 µl h−1 which resulted in a low
medium residence time of approximately 5 min. In the control dishes, the medium was
replaced once a day in line with standard manual cell culture practice. After 1 day,
the colony sizes in the continuously perfused microfluidic chamber were comparable to
the colonies in the control dishes (see figure 3.13 C, G). Additionally, the cells within
the colonies were small and tightly packed together - a characteristic morphology of
undifferentiated hESCs. A similar outcome was observed after a total of 2 days of
continuous continuous culture: the hESCs were proliferating at a similar rate and
maintained an undifferentiated morphology in both the microfabricated cell culture
device (see figure 3.13 D) and in the control dishes (see figure 3.13 H). Furthermore,
wash-out of viable colonies was not observed.
Immunocytochemistry for several pluripotency markers was carried out in the micro
fabricated cell culture device after continuous culture. The cells from the first culture
experiment were stained for Oct-4 (and co-stained with DAPI), and the cells from
the second and third experiment were stained for Tra-1-81 and SSEA-3 (and co-stained
with DAPI). The immunostaining sequences of antibody incubation and washing buffers
were directly performed in the open configuration and according to typical immunos-
taining protocols. As can be seen in figure 3.14, the hESC colonies stained positively
for Oct-4, Tra-1-81 and SSEA-3. The positive staining results confirmed the morphol-
ogy observation that the hESC colonies maintained their undifferentiated state during
seeding and continuous culture.
Continuous culture of feeder-attached hESC colonies in a microfabricated cell cul-
ture device without wash-out of viable colonies has thus successfully demonstrated.
Additionally, the hESC colonies maintained the expression of the pluripotency markers
after 2 days of constant medium perfusion. While these results must be further verified
with feeder cell densities that match more closely the densities from the control dishes,
the results indicate that in microfluidic devices the maintenance of pluripotent hESCs is
not constrained to specific cell re-feeding schedules. It will therefore be possible to use
the precise spatio-temporal control of the soluble microenvironment that microfluidics
offer to probe the behaviour of hESCs. Additionally, by using the open access facility
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of this MMB, the impact of a wide range of combinations of ECM components can be
evaluated. Given the high costs of stem cell culture media, such a microfabricated cell
culture device would be ideal to perform these investigations in a cost-effective manner.
Figure 3.14: Representative images of the feeder-attached hESC colonies after
2 days of continuous culture perfusion in the microfabricated cell culture device
- All images 4× magnification, scale bar is 250 µm. Each row shows the phase contrast
images (A1, B1, C1) of the feeder-attached hESC colonies (highlighted with dashed lines)
and the corresponding results from DAPI (A2, B2, C2) and pluripotency marker staining
(A3, B3, C3). The phase contrast images (B1, C1) show the culture chamber area and the
adjacent flow restrictors. Comparison with the corresponding DAPI images demonstrates
that the feeder cells stayed in the culture chamber and did not outgrow into the flow
restrictors. Viable colonies did not wash out and stained positively for Oct-4 (A3), Tra-
1-81 (B3) and SSEA-3 (C3) confirming that the hESCs retained their undifferentiated
state.
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3.6 Summary of findings
A versatile and robust microfabricated cell culture device has been developed that can
be autoclaved. The microfabricated cell culture device can easily be assembled and in-
cludes an interface which reversibly seals a disposable microfluidic chip with any culture
substrate of microscope slide format. A lid offers direct access to the culture cham-
ber which facilitates surface coating and cell seeding. The microfabricated cell culture
device can therefore be configured with different cell growth surfaces. Additionally, a
deep media overlay in the open configuration permits long incubation times during cell
seeding, enabling the complete attachment of slowly and weakly adhering cells.
In FEM simulations, it was shown that the shear stress generated in the micro-
fabricated cell culture device is two orders of magnitude lower than in a straight mi-
crochannel. Furthermore, changing the thickness of the spacer layer of the microfluidic
chip enables to vary the hydrodynamic shear over the cells. It is therefore possible to
rapidly test different microfluidic designs and fully exploit the versatility and the flow
control offered by microfluidic perfusion devices.
In the open configuration, feeder-attached hESC colonies were seeded on a gelatine-
coated TC-PS substrate in static conditions and according to current laboratory pro-
cedures. The feeder cells spread uniformly and attained their characteristic morphol-
ogy in the same time as in the control dishes. The hESC colonies remained intact
and retained their undifferentiated morphology. With the culture chamber closed, the
feeder-attached hESC colonies were cultured in the continuous culture mode. Viable
colonies did not wash out of the chamber. Furthermore, after 2 days of continuous
perfusion, the hESC colonies stained positively for a set of typically used pluripotency
markers.
These efforts address so far two important aspects of a microfluidic cell culture
tool for stem cell bioprocess development. The flexibility to change and adapt the
microfluidic chip has been shown by switching from the straight microchannel chip to a
more complex low hydrodynamic shear stress microfluidic chip design. To address the
scalability of results obtained with this cell culture device, three comparability criteria
have been considered. Firstly, the use of TC-PS meets the requirement that the same
materials are used as in small scale cell culture devices (e.g. T-flask). Secondly, the
direct access to the cell culture chamber allows the use of seeding density units used in
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small scale cell culture devices. Finally, the positive continuous perfusion experiments
with delicate cells such as hESC on feeder cells encourage the efforts made to study the
soluble microenvironment of stem cells.
However, to achieve throughput, a multiplexed system is required, which at least
offers an experimental triplicate. Furthermore, to be of utility as a tool for stem cell
bioprocess development or optimisation, an innovative monitoring solution to track the
phenotypes needs to be incorporated into such a multiplexed system.
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platform with time-lapse imaging
The integrated rapid prototyping approach for microfabricated cell culture devices pre-
sented in chapter 2 has addressed the need for an adaptable and flexible packaging and
fabrication methodology to take account of the rapid progress in stem cell research. In
the previous chapter, a seeding method closely mimicking bench-scale seeding proce-
dures has been developed using a lid to reseal a culture chamber within the microfab-
ricated device. To prevent a wash out of viable cells, a low hydrodynamic shear stress
microfluidic chip has been designed and both, seeding method and the low hydrody-
namic shear stress microfluidic chip, successfully tested using hESC colonies. However,
to serve as an automated and data-rich microscale stem cell bioprocess development and
optimisation tool, a monitoring system is missing to link stem cell phenotypes to solu-
ble cues in the microenvironment. This chapter addresses the last of the three aspect
required for a microfluidic tool for stem cell bioprocess development and optimisation.
The results in this chapter have been presented in conference proceedings at the
Micro Total Analysis Systems conference 2010 in Groningen, The Netherlands and at
the Microtechnologies in Medicine and Biology conference 2011 in Lucerne, Switzerland
(see Appendix G).
100
4.1 Integrating image-based monitoring techniques
4.1 Integrating image-based monitoring techniques
Since the beginning of the nineteenth century, light microscopy has enabled biologists
to describe the morphology of different cells, but the underlying functionalities and
fundamentals of cellular processes remained largely undiscovered. Responses of living
systems to cues were described, but the underlying molecular details required for a
thorough understanding were not available.
Fluorescent antibody labelling techniques for proteins or DNA have enhanced the
experimental capabilities to elucidate the underlying complex cellular pathways which
control proliferation, differentiation or apoptosis, albeit only by sacrificing or fixing
cells. However, the ’when and where’ of cellular events in living cells can not be exactly
pinpointed and fast cellular processes can not be tracked with these techniques.
The discovery of the green fluorescent protein (GFP) and other visible fluorescent
probes has enabled to target specific gene expressions and therefore to monitor their
expression over time without sacrificing cells (Chalfie, 2009; Tsien, 1998).
Light microscopy and visible fluorescence offer therefore a simple non-invasive route
to monitor stem cell fates (Fu et al., 2009). A few applications to characterise cells or
entire organisms use already an imaging approach, for example to monitor the devel-
opment of fish embryos (Clarke, 2009), cellular metabolites and ions using genetically
encoded biosensors (Okumoto, 2010), or to characterise bona fide iPS cells (Chan et al.,
2009).
An automated microfluidic system with a time-lapse imaging system would there-
fore greatly benefit from the combination of phase contrast and fluorescence microscopy
and thus enable automated analysis of experimental outcomes (see figure 4.1). In com-
parison to microfluidic tools for microbial bioprocesses where the cells are monitored for
example using oxygen and pH sensors, this non-invasive imaging approach would also
allow the direct monitoring of phenotypes in situ in real-time, if necessary, to obtain
data-rich experimental sets. Furthermore, such an imaging approach would allow the
study of phenotype variations under different culture parameters such as flow modes,
hydrodynamic shear stress or oxygen tension levels and the measurement of prolifer-
ation kinetics or pluripotency in situ using advanced image processing algorithms for
example.
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Figure 4.1: Feedback loop of the microfluidic platform for stem cell biopro-
cess development - A reference input to the system controls process parameters such as
temperature, flow mode and flow rate during the culture on the microscope. A feedback
loop automatically takes readings of all temperatures and images. Analysis of images and
metabolites can be done in a semi-automated fashion. Traditional bioprocess parameters
such as dissolved oxygen or pH can be added to the feedback loop for data-rich monitoring
and control.
However, integration of real-time optical monitoring with microfluidic culture de-
vices remains challenging, particularly for long-term culture (Charvin et al., 2010), for
example to maintain to sterility and gaseous tension levels in the media. Plate reader
compatible, microfluidic culture systems have been recently reported to measure fluo-
rescent tags as outlined in section 1.4.2. However, the analysis of cell morphology, a
daily routine task in cell culture, still has to be carried out manually on an inverted
microscope. Therefore, returning to a microscope and tracking of a specific area within
such a microfluidic device may be difficult.
A charged-coupled device (CCD) has been directly mounted to a microfluidic cell
culture device to count cells, but this solution may not be suitable for high resolution
imaging of cell morphology or fluorescent labels (Ozcan & Demirci, 2008).
An inverted microscope is used when high quality images of cells are required for
image analysis of phenotype or for determining cell numbers. A microfluidic culture
chamber on an inverted microscope has been previously implemented with a transparent
heater to monitor the proliferation of HeLa cells and to maintain culture temperature
for the duration of inspection on the microscope (Petronis et al., 2006). Albrecht et al.
(2010) have presented a microfluidic platform with time-lapse imaging in a 96-well
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format for mouse embryonic stem cells for the duration of 5 days.
All are examples for the experimental advantages microfluidic platforms with time-
lapse imaging offer. However, the results obtained with these systems focus mainly
on the handling of cells and the manipulation of medium in the microfluidic system.
The time-dependent properties of medium are not taken into account, which arise from
storage of medium at room temperature and its effects on various relevant culture
conditions, for example pH. The interpretation and translation of the results obtained
with these platforms, and therefore their relevance for scale, are thus difficult under
such uncontrolled conditions.
4.2 Design of the microfluidic platform
The design of the platform follows the design requirements and considerations described
in section 1.4.3.2. All functionalities of an incubator and a microfabricated cell culture
device have to be integrated and combined to enable long term proliferation or differ-
entiation of stem cells on an inverted microscope. This will serve as the basis towards
the implementation of a feedback loop to link phenotype with culture conditions )(see
also figure 4.1) By defining different sub-assemblies, an independent development and
optimisation of modules and their functionalities can be achieved. Two sub-assemblies
have been thus defined for the microfluidic platform - the microscope module and the
media handling module (see figure 4.2). Both sub-assemblies are designed to be mo-
bile that the platform can be used in different settings, for example during seeding or
end-point analysis, or even in another cell-specific laboratory (for example our hESC
laboratory).
4.2.1 Media handling module
The media handling module contains functionalities such as cooled storage and pumping
of medium to the microscope module. Two autoclavable reservoirs provide medium for
up to ten days of culture and can be selected by a set of valves. Each reservoir has a
sparger for medium aeration, an exhaust port for pressure relief when not in use and
a medium port for transporting medium to the microscope module. The set of valves
controls which reservoir is pressurised with cell culture gas to move medium. Flow rates
are controlled by the pressure in the reservoir using a computer controlled regulator.
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Figure 4.2: Schematic of the microfluidic platform - The microfluidic platform
consists of two modules - the microscope module and the media handling module. The
media handling module provides cooled storage of media and a set of valves and pressure
regulators to pump media. In the microscope module, medium is heated up before it enters
a bubble-trap and is split up to feed three parallel cell culture devices. A LabView™ routine
is used to control all important culture parameters such as temperatures, media selection
and flow rate.
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Using pressure-based pumps allows a nearly instantaneous control of flow rates and
thus preventing further dilution or transport of signalling factors into the cell culture
chamber.
The media reservoirs are stored in a dark cabinet and cooled to prevent degradation
of medium.
4.2.2 Microscope module
The microscope module consists of a preheat element, a bubble trap, a manifold, three
microfabricated cell culture devices and waste containers.
The preheat element is designed to prevent a temperature shock to the cells in the
microfabricated cell culture devices when medium is pumped from the cooled reservoir.
Medium then passes through a bubble trap. A perpendicular bore is aligned and
connected with the horizontal bore. When an air bubble enters the horizontal bore, it
will rise in the perpendicular bore and therefore be removed from the medium entering
the microfabricated cell culture devices (more details and dimensions can be found in
Appendix B.27).
The modular microfabricated cell culture device is based on the third generation
packaging described in chapter 2 and uses the seeding method described in chapter 3.
For the platform, the microfabricated cell culture device has been modified to maintain
the culture temperature for stem cells for the entire duration of an experiment. For
that reason, a transparent resistive glass microscope slide is used instead of TC-PS
as a heating element in the microfabricated cell culture device. Temperature on the
cell growth surface is measured with a thermistor and controlled with a software-based
PID1 controller. The first generation microfluidic chip introduced in chapter 3 has been
optimised to facilitate priming with medium.
A software-controlled microscope camera is used for phase contrast and fluorescent
imaging. Spent medium is collected in waste bottles for each microfabricated cell
culture device.
1PID stands for proportional-integral-derivative and is a widely used feedback controller
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4.3 Materials & methods
4.3.1 Cell culture device
The third generation packaging system and the microfabricated cell culture device
described in the sections 2.2.3 & 3.4.2 have been adapted and modified for use on an
inverted microscope (see figure 4.3). A 5 mm thick poly(carbonate) plate was chosen
to increase the stiffness of the interface plate. The interface plate has been fitted with
four bores (3.15 mm in diameter) for M3 screws to keep the microfabricated cell culture
device in place when mounted on the microscope. A pocket has been milled into the
interface plate to fit a thermocouple for the temperature feedback loop. The pocket
had a width and depth of 1.6 mm and a length of 22.8 mm. A M3 thread was made
in the pocket to secure and hold the thermistor in position (see Appendix B.20 for
dimensions). Two M3 threads for M3 × 30 mm standard brass screws (Clerkenwell
Screws, UK) were manually cut on the other side of the interface plate to electrically
connect an indium tin oxide (ITO) microscope glass slide (576352, Sigma-Aldrich, UK).
The frame was altered to minimise the contact area with the ITO microscope slide.
The frame had one large opening (49.5 mm long, 26 mm wide), which made observation
of the entire microfluidic chip possible (see Appendix B.21 for dimensions). The bearing
area for the microscope slide had a raised middle part to separate the electrical contacts
from the rest. The bearing area was covered with Kapton® tape (5413 (3/4”), 3M,
USA) to electrically insulate it from the ITO microscope slide (see figure 4.3).
Both sockets at the inlet and outlet were fitted with Luer lock adapters (P-686,
Upchurch, USA) to quickly connect tubing. At the inlet of the microfabricated cell
culture device, an autoclavable 3-way valve (PMMM-700-156W, Fisher Scientific, UK)
was attached to the Luer lock adapter.
The microfluidic layer manifold described in section 3.4.2 has been optimised to
simplify priming by omitting the split channels into three microchannels (see Appendix
B.25 for dimensions). A second microfluidic layer has been designed with a split cell
culture chamber to culture two different cell lines in the same microfabricated cell
culture device (see Appendix B.26 for dimensions). The lid to close the cell culture
chamber of the microfabricated cell culture device has been simplified and adapted to
the thickness of the interface plate (see Appendix B.22 for the single chamber version
and Appendix B.23 for the split chamber version).
106
4.3 Materials & methods
Figure 4.3: Exploded view of the cell culture device for the platform - Exploded
view of the microfabricated cell culture device with the reusable parts of the packaging
system and the disposable microfluidic chip consisting of a microfluidic layer, gasket and
a resistive indium tin oxide (ITO) microscope slide. The frame has been improved for use
on an inverted microscope and has been electrically insulated with Kapton® tape. The
packaging system is based on the third generation described in section 2.2.3 and uses the
the seeding method and a modified microfluidic layer described in section 3.4.4.
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For the split cell culture chamber microfluidic layer, a seeding lid has been designed
to avoid mixture of the different cell solutions (see Appendix B.24). All parts and
moulds were fabricated using the rapid prototyping method described in section 3.4.2.
However, all PDMS parts (gasket for lid, microfluidic layer and spacer) were first bonded
and then the bonded PDMS microfluidic chip to the ITO microscope slide using the
same plasma bonding technique described in section 3.4.2.
4.3.2 Pump
The pump consists of two 125 ml, autoclavable media reservoirs (2116-0125, Nalgene,
USA). Each reservoir is fitted with three ports.
The inlet port is made from a stainless steel M6 hex screw. The hex cap has been
machined into a round plate and a centred bore has been machined into the screw with
a lathe. A stainless steel pipe was fitted into the centred bore by a press fit. An O-ring
was placed at the former screw cap and the port was hold in the lid by a nut. The
threaded end was fitted with a Luer lock adapter (P-660, Upchurch, USA) for a filter.
The second port was used as an exhaust port and was made in a similar fashion,
except that the pipe has not been included. To fit two syringe filters as close as possible
next to each other, a shorter thread was chosen for this port.
The third port was used as a fluid outlet. An M10 stainless steel screw was used
as the basis for this port. The hex cap has been converted into a disc with a lathe. A
centred bore was machined into the screw to provide a fluidical link. On the threaded
end, a M6 thread has been machined in to accommodate a flat bottom fitting. A
stainless steel pipe was also fitted into the centred bore by a press fit. An O-ring was
placed at the former screw cap and the port was hold in the lid by a nut. The threaded
end was fitted with a Luer lock adapter (P-660, Upchurch, USA).
A set of four 3-way valves was used to switch between the two media reservoirs. One
valve (S070B-6CC, SMC, UK) was linked with the pressure regulator (ITV0011- 2BL-
Q, SMC, UK) and controlled which medium reservoir was pressurised. Each valve was
connected to the inlet port which has been fitted with a sterile filter (Minisart 16596,
Sartorius Stedim, Germany). Medium was pumped by controlling the pressure in the
reservoir. Each reservoir had an exhaust valve (S070B-6CC, SMC, UK) connected to
the exhaust port (fitted with a sterile filter (Minisart 16596, Sartorius Stedim, Ger-
many)) to release the pressure in the medium reservoir when not in use. The fluid
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outlet of both reservoirs were linked to another switching valve (LHDA243115H, Lee
Corporation, USA) (switching at the same time as the valve for the reservoir selection)
which was connected to microscope module.
Medium was pumped from the reservoir through the preheat element (described in
section 4.3.3) and a bubble trap in polytetrafluorethylene tubing (ID: 0.8 mm) (S1810-
10, Bola, Germany) which was fitted with standard nut fittings (P-207, Upchurch,
USA) and Luer lock adapters (P-657, Upchurch, USA).
The bubble trap had a T-shaped arrangement of bores. Fluid entered the trap
in the horizontal bore (1 mm in diameter), while the bore perpendicular and vertical
(5 mm in diameter) to the flow direction was fitted with a Luer lock adapter (P-686,
Upchurch, USA) and a manual valve (W2-30600–2, Cole Parmer, UK) (see Appendix
B.27 for dimensions).
Medium was distributed to three microfabricated cell culture devices using a man-
ifold (P-150, Upchurch, USA) and 12 cm long capillary tubing (ID: 500 µm) (1532,
Upchurch, USA) was attached to each port used of the manifold.
The three valves in the media handling module were driven with a custom-built
electrical circuit (see Appendix B.31). The valve which fluidically linked the media
reservoirs with the microfabricated cell culture devices was controlled by a fast switch-
ing relay (DMO063, Crydom, USA). The entire set of valves was controlled by a Lab-
Viewroutine.
The pump was characterised with a flow rate sensor (SLG1430-480, Sensirion,
Switzerland) in a similar set up described in section 2.3.3 at the the flow splitter,
when switching reservoirs and at the outlet of each microfabricated cell culture device.
Flow rates were measured for three pressure regulator settings (300 mV, 400 mV, 500
mV).
4.3.3 Temperature feedback loop
The media reservoirs were stored in a cooled water bath to prevent media decomposition
due to thermal exposure. The water bath consisted of an aluminium box with two
holes (80 mm in diameter) in the lid (1590D, Hammond, Canada) and a converted
Peltier cooling element (AA-60-12-00-00, Supercool, Sweden). A negative temperature
coefficient (NTC) thermistor (B57703M103G, Epcos, Germany) was mounted on the
inside wall of the aluminium box. The thermistor output was read with a custom made
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circuit over the analog input port of a data acquisition (DAQ) card (USB-6221, National
Instruments, USA) (see Appendix B.30). A LabView™ routine converted the read out
voltage into a temperature reading. Temperature was controlled by a software-based
PID feedback loop algorithm and pulse width modulation (PWM) (see figure 4.4). The
PWM has been realised with a LabView routine (LabView 8.2, National Instruments,
USA) using the digital outputs of the DAQ card.
Figure 4.4: Schematic of the temperature control loop - Temperature control loop
consists of a software PID algorithm and a sensor mounted on the microfluidic chip. The
resistive heater is controlled by a relay which is actuated with the PWM using the digital
output ports of the data acquisition (DAQ) card. Temperature is monitored with a negative
temperature coefficient (NTC) thermistor and fed back to the DAQ card using the analog
input ports. The PID algorithm processes the temperature reading and defines the pulse
width.
The same PID control algorithm with pulse width modulation (PWM) was also
used to control the temperature on the cell growth surface of each microfabricated cell
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culture device (see figure 4.4). The routine controlled a solid state relay (CMX60D10,
Crydom, USA) to switch the current of the power supply on or off. A NTC thermistor
(B57861S103F40, Epcos, Germany) was used to measure the temperature on the cell
growing surface of an ITO microscope slide. The custom-built circuit was also used to
deliver a constant current for the thermistor and was read out using the analog input
ports of the DAQ card (USB-6221, National Instruments, USA).
A 12 cm long conductive tape strip (1181 (1/4”), 3M, USA) was applied on the
resistive side of the ITO microscope slide.. The tape was placed that on each side of
the ITO microscope slide an excess of approximately 20 mm was made available. The
excess was wrapped around to the non-conductive side of the microscope slide and cut
off with a scalpel at the edge of the microfluidic chip.
The preheat element consisted of 4 parts and used the PID temperature controller
described above. A resistive heating foil (HK5160R157L12B, Minco, USA) was con-
trolled by the feedback loop algorithm using a fast switching relay (DMO063, Crydom,
USA) and a NTC thermistor (B57045K103K, Epcos, Germany). The thermistor was
screwed into part B of the housing (see Appendix B.29) and was facing towards the
surface of the heating foil which was placed in part A of the housing (see Appendix
B.28). Tubing was centred in a milled channel (1.6 mm × 1.6 mm) in part B of the
housing. When the preheat element was assembled, the tubing in part B was facing
the heating foil in part A.
4.3.4 Platform setup
For each module, a box was used to house all parts of the pump and temperature control.
The microscope module consisted of a two modified boxes. The first box (PCM 175/150
G, Fibox, UK) housed on a mounting plate (MIV 175, Fibox, UK) all electrical circuits
to control the temperature on the ITO microscope slides of the microfabricated cell
culture devices, and the preheat element and the relay to control the switching valve
between the two media reservoirs. The second box (6011324, Fibox, UK) was attached
to first box and modified to accommodate three microfabricated cell culture devices
and on a custom-made poly-carbonate mounting plate, the manifold, the bubble trap
and the preheat element. The entire microscope module was attached using standard
M3 screws to the manual stage of an inverted microscope (Eclipse TE2000-U, Nikon,
Japan) with a camera (Scout scA1400, Basler Vision Technologies, Germany).
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The media handling module was housed in a modified box with a hinged lid (CAB
PC 303018 G, Fibox, UK) and was fitted with two 25 mm thick, 10 cm high and wide,
custom made PMMA stands. The box contained the pressure regulator, the 3 valves,
the cooling plate with the two media reservoirs and the circuits to control the valves
and the temperature of the cooling plate.
Two power supplies (IPS 2303, Iso-Tech, UK) were used for the three microfabri-
cated cell culture devices (12V, max. 1 A) and the cooling plate (24 V, 3 A). The fan
of the cooling plate was powered by an unregulated power adapter at 5 V (UG01B,
Maplin, UK).
An unregulated power adapter (L48BQ, Maplin, UK) at 12 V was used to power
the circuits for the valves in the media handling module. The pressure regulator was
powered using a 12 V power source (EP-920, Eagle Technologies, South Africa). The
preheat element (24 V, 1 A) and the valve used for fluidic switching (24 V) were powered
by a fourth power supply (LT30-2, Farnell Instruments, UK).
All relevant parameters of the platform were controlled and recorded by a Lab-
View™ routine. LabView™ routines have also been programmed to tune the PID set-
tings of all heaters (microfabricated cell culture device, preheat element and cooling
plate) and to calibrate all thermistors.
4.3.5 Cell culture
Mouse embryonic stem cells (mESCs) with an Oct-4-GiP reporter (named Oct4-GFP
hereafter) and 46Cs (mESC with a Sox-2 GFP reporter) were obtained from Stem Cell
Sciences, Edinburgh, UK.
mESCs (all below p40) were routinely cultured on 0.1 % (w/v) filtered water porcine
gelatin (G1890, Sigma, UK) coated T25 flasks (136196, Nunc, Denmark) in a humidi-
fied, 5% CO2 controlled incubator. Medium in flasks was exchanged daily with 6 ml,
fresh and warm medium. Medium consisted of Glasgow Minimal Essential Medium
(GMEM) (G5154, Sigma, UK) and was supplemented with 10 % (v/v) fetal bovine
serum (FBS) (EU-000-F, Sera Laboratories International, UK), 1 % (v/v) glutamax
(35050-038, Invitrogen, USA), 1 % (v/v) sodium pyruvate (11360-039, Invitrogen, USA)
, 0.2 % (v/v) of 2-β-mercaptoethanol (31350, Invitrogen, USA) and 1 % (v/v) ml of
antibiotic-antimytotic solution (15240-062, Invitrogen, USA). After filter sterilisation,
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500 µl leukemia inhibitor factor (LIF) (ESG1107, Millipore, UK) was added to the
medium.
Cells were passaged every two days into new T25 flasks. New flasks were incubated
each with 3 ml of 0.1 % (w/v) filtered water porcine gelatin solution at least 10 min
prior to passaging in a laminar flow hood at room temperature. Cells were washed first
with approximately 3 ml of Dulbecco’s phosphate buffered saline (DPBS). DPBS was
aspirated and 500 µl of trypsin added to the cells in the flask and incubated at 37°C for
3 min. To quench trypsin, approximately 4.5 ml of complete medium was added to a
flask. The cell suspension was aspirated and added to a 50 ml centrifuge tube (210 261,
CellStar Tubes, Greiner Bio-One). Cells were spun in a centrifuge (Centrifuge 5810R,
Eppendorf, Germany) at 1200 revolutions per minute for 3 min at room temperature.
The supernatant was aspirated and the pellet re-suspended in warm, fresh complete
media. Cells were usually split in ratios of 1 to 8 or 10.
4.3.6 Experimental procedure
Prior to seeding, all microfabricated cell culture devices were placed in a glass Petri
Dish and both sterilised using an autoclave. A standard laboratory pipette (Pipettor
20-200µl, Eppendorf, Germany) with an autoclaved tip (Ultratip 739295, Greiner Bio-
One, Germany) a was used to coat the cell growth surface in the microfabricated cell
culture device with 200 µl of 0.1 % (w/v) filtered water porcine gelatin solution. The
microfabricated cell culture device was incubated for at least 1 h at room temperature
in a laminar flow hood.
Cells were counted with a cell counter (CASY TTC, Roche Diagnostics, Switzer-
land) to determine the seeding density for both configurations, the improved microflu-
idic layer and the split microfluidic layer. 46C and Oct4-GFPs were processed as
followed: Media in a T25 flask was aspirated. The cells were washed with 3 ml of
DPBS (autoclaved) using a 5 ml pipette (86.1253.001, Sarstedt, Germany). 500 µl of
trypsin were added with a 2 ml pipette (40502, Bibby Sterilin, UK). The T25 flasks
were then incubated at 37°C and 5% CO2 for 3 min (MCO-18M, Sanyo, UK). Trypsin
was quenched with 4.5 ml of warm media using a 5 ml pipette (86.1253.001, Sarst-
edt, Germany) and pipette (Matrix, Thermo Scientific, UK). Cells were aspirated and
transferred into a 50 ml tube. Tubes were spun at 1200 revolutions per minute for 3
min in a centrifuge (Centrifuge 5810R, Eppendorf, Germany). The supernatant was
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aspirated with a 5 ml pipette and the remaining pellet broken off by taping the tube
three times with a finger. The pellet for each cell line was re-suspended in 7 ml of fresh
and warm media.
9.95 ml of filtered CasyTon were dispensed in the CasyTubes with an Anachem
(25ml, Anachem, Germany). 50 µl of cell suspension were three times gently titurated
and then added to the 9.95 ml of CasyTon (dilution factor 200). The tube was then
turned three times to ensure mixing and immediately measured.
The Casy TTC was set to take a sample of 400 µl 5 times from the cell suspension
to be counted. Between each sample, a count deviation tolerance of 20 % was allowed.
A target cell concentration of 260,000 cells ml−1 was achieved by taking 1 ml of the
cell suspension, which has been used for the first measurement, and dilute to the correct
concentration and measure again with the Casy TTC as described above. The gelatine
solution was removed first from the cell culture chamber in the microfabricated cell
culture device. The cell culture chamber has then been washed with 200 µl of media
and 100 µl of cell suspension (corresponds to a seeding density of 10,000 cells cm−1) have
been added to each compartment (Oct-4: compartment 1, 46C compartment 2). 75 µl
of medium has been used to top up each culture chamber. If the single culture chamber
microfluidic chip was used, 200 µl of cell suspension using Oct-4 GFPs (corresponds to
a seeding density of 10,000 cells cm−1) has been added to the cell culture chamber, but
no medium has been added as top up.
To prevent evaporation of medium in the microfabricated cell culture device, a cap
of a 50 ml tube filled with 3 ml of sterile DPBS has been placed at the bottom of the
Petri dish. Approximately 30 min later, media levels in the microfabricated cell culture
devices were controlled.
Both complete media reservoirs, lids to close the microfabricated cell culture device
and screws were autoclaved and subsequently dried before moving the platform onto
the inverted microscope. The following day after cell seeding, all microfabricated cell
culture devices were closed and primed as described in section 3.4.4.
Tubing which has been in contact with medium has been sterilised using the follow-
ing procedure. One end of the tubing which connects to the fluid outlet of the media
reservoirs and the other end which connects with the microfabricated cell culture de-
vices have been fitted with pre-sterilised filters. All tubing was filled then with ethanol
or isopropanol using a syringe and left in the tubing for at least 30 min. The tubing
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was rinsed after at least two times with sterile DPBS, followed by applying a vacuum
to remove residual fluid. During the entire sterilisation procedure, the filters were not
removed from the tubing.
The microscope module was moved into a laminar flow hood, all three microfabri-
cated cell culture devices inserted and secured in the box of the module. The filters on
the tubing were removed and tubing attached to the manual valve at the inlet of the
microfabricated cell culture devices and the fluid outlet ports of both media reservoirs
(each filled with 50 ml of media). Each microfabricated cell culture device was elec-
trically connected to the microscope module by fixing the spade crimps to the brass
screws on the microfabricated cell culture device and the resistance of each heater in
the microfabricated cell culture device quickly tested with a multimeter.
The entire microscope module was transferred then to the inverted microscope.
The microscope module was connected to the PC and power supplies and the media
reservoirs stored in the media handling platform and connected with the gas inlet port.
The manual valve attached to the bubble trap was fitted with a sterile a filter and
opened while the pressure regulator was set at 1500 mV for each medium reservoir.
Once the tubing for each reservoir was primed and medium reached the bubble trap, the
manual valve was closed. Each microfabricated cell culture device was also fitted with a
manual 3-way valve. Each valve was opened sequentially to prime the capillary tubing
which connected the microfluidic cell culture device with the flow splitter. Once each
microfabricated cell culture device was primed, the valve was closed to start continuous
culture in the microfabricated cell culture devices and the pressure regulator set to 1200
mV.
Phase contrast images were taken automatically every 15 min, fluorescent images
were daily taken manually using the LabView routine.
4.4 Results & discussion
4.4.1 Microfluidic platform
A microfluidic platform has been developed to monitor cells in microfabricated cell cul-
ture devices using time-lapse imaging. The platform presented consists of two modules
- a microscope module and a media handling module (see figure 4.5).
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The microscope module was designed to accommodate three cell culture devices in
parallel to obtain experimental triplicates. Furthermore, a preheat element, a bubble
trap and a manifold were also integrated into this module. Compared to integrated
microfluidic systems, the modularity of the microscope assembly allowed independent
development and optimisation of each component, most notably the microfabricated
cell culture device.
The media handling module contained a set of valves, a pressure regulator, a cooled
bath and two media reservoirs. Two functionalities, cooled storage of media and pump-
ing, were integrated into this module.
Practical laboratory cell culture usually consists of more than just the periodic
replacement of medium, or the manipulations required by an experiment. The proper
storage of media in a cold and dark environment, the heating up of media in a water
bath to 37°C before adding to cells and the frequent microscope inspection of cells
for cell morphology or checking for contamination, play an equally important role in
guaranteeing the success of an experiment. These functionalities need also be considered
for microfluidic cell culture systems. Sophisticated, multiplexed microfluidic platforms
for long-term culture, most with integrated pumps and valves, have been presented for
various applications, for example for the three-dimensional perfusion culture of liver
cells in scaffolds in a 12-well plate (Domansky et al., 2010) or more recently, the culture
of murine ESCs in a microfluidic cell culture array (Albrecht et al., 2010). However,
the influence of the proper storage and handling of medium in microfluidic cell culture
systems on experimental outcomes has not been discussed yet in the literature.
The microfluidic platform presented combined with analytical methods such as
metabolite analysers allows therefore the study of the relevance of temperature-dependent
effects affecting the media quality on microfluidic experimental results.
The second functionality of the platform is a pumping mechanism that allows to
switch between two different media reservoirs. Generally, two types of pumps for mi-
crofluidic devices can be distinguished, on-chip pumps and off-chip pumps. The ad-
vantages of on-chip pumps such as small dead volumes are offset by the limitations
they impose on the microfluidic channel design, for example when a braille display or a
series of pneumatically actuated valves is used to move liquid within a microfluidic net-
work (Gu et al., 2004; Melin & Quake, 2007). In this thesis, an off-chip pump solution
has been chosen to maintain the flexibility of the microfluidic platform as there are no
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geometrical constraints on the microfluidic network design of the microfabricated cell
culture device.
A LabView™ routine has been developed to control and record all relevant param-
eters (Li, 2008b). The routine allows the user to either run an experiment manually
or fully automatically using a file which contains all setpoints for the experiment. The
routine worked stably over a week of experimentation.
4.4.2 Cell culture device for the platform
The microfabricated cell culture device developed in chapter 3 has been adapted for
use in the microscope module using the third generation packaging system (see section
2.2.3). The modularity of the packaging system has allowed to integrate a heating
element controlled by a feedback loop while other parts have either not been altered
(gasket) or the alterations have not affected the packaging system (microfluidic layer).
The heating element consisted of a transparent resistive ITO microscope slide and a
thermistor for the feedback loop control. The area bearing the resistive heater with the
aluminium frame was electrically insulated with Kapton® tape to avoid an electrical
short circuit. The electrical connection between the resistive microscope slide and the
platform was made using brass screws which protruded by approximately 75 µm from
the interface plate. The protruding screws were pressed against a copper strip wrapped
around the ITO microscope glass slide. The brass screws acted as attachment points
for the electrical wires. Spade crimps at the end of the electrical wires were secured to
the brass screws with nuts.
The thermistor was placed in a pocket in the interface plate, which was secured
with a screw, and was in direct contact with the cell growth surface plane of the ITO
microscope slide. The temperature uniformity of the ITO microscope slides reported
by Lin et al. (2010) (see also Appendix E.2) allowed the positioning of the thermistor
next to the PDMS microfluidic chip.
The possibility of using ITO heaters to precisely control temperature dependent
processes has already been demonstrated in various microfluidic devices used for DNA
amplification (Zhang & Ozdemir, 2009). For microfluidic cell culture devices, solutions
using ITO foil heaters or resistive wire heating have been presented (Alam et al., 2010;
Petronis et al., 2006). Resistive wire heating is simple to integrate and embed into a
microfluidic device when optical access for a microscope is not required, for example
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Figure 4.5: Microfluidic platform - The microfluidic platform consists of two modules
- the microscope module (A) and the media handling module (B). A LabView™ routine
is used to control parameters such as temperatures, media selection, flow rate and image
capture frequency.
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for suspension culture of cells in microbioreactors. However, this type of heater is not
suitable for the optical monitoring and imaging of of adherent cells such as stem cells.
For microscope based cell culture devices, an ITO foil heater has been compressed
into the layers of a PMMA microfluidic device for the culture of HeLa cells (Petronis
et al., 2006). An automated microfluidic cell platform using a bespoke ITO heater
and platinum thermistor has been demonstrated for the culture of bronchioloalveolar
carcinoma cells (Huang & Lee, 2007). The ITO heater presented in this work uses
off-the-shelf components, required minimal work to attach the microfluidic chip and
therefore the microfabricated cell culture device assembly and the electrical connection
to the temperature controller are straightforward, also in comparison with the ITO
heaters described above.
Figure 4.6: Cell culture device for use in the microscope module - The cell culture
device used for the platform had two configurations - an open configuration used for seeding
and a closed configuration used for culture. A split culture chamber in the microfluidic
chip accommodated two compartments.
A simplified, second generation microfluidic layer has been developed and fabricated
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by reducing the inlet and outlet manifold to one single channel. Two configurations of
the second generation microfluidic layer have been tested: one configuration had one
single culture chamber and the other configuration had a cell culture chamber equally
split in two halves allowing the culture of two different cell lines, in this case, the
Oct4-GFP and the 46Cs. Hydrodynamic shear stress levels were characterised using
the same FEM parameters used in section 3.4.1 for both versions of the microfluidic
layer. Changes in hydrodynamic shear stress compared to the first generation were not
expected, this has been confirmed in the FEM analysis (see Appendix E.3). For the
split microfluidic chip, a seeding lid has been designed to avoid mixing of the different
cell types.
4.4.3 Temperature characterisation
A temperature control system with a feedback loop has been developed for the micro-
fabricated cell culture device, the cooled storage and the preheat element. The feedback
loop uses a thermistor, a software based PID algorithm and pulse width modulation
to control the temperature. A tuning routine has been developed to easily adjust PID
settings and calibrate thermistors (Li, 2008b). Changes in temperature ranging from
35 to 37°C in 1°C steps have been measured to characterise the heaters in the three
bioreactors (see figure 4.7). Generally, the accuracy and reproducibility of the temper-
ature on the cell growth surface is well controlled over long time periods (over 24 h)
(see figure 4.7 A, C). Higher temperatures than the setpoint were recorded for only
one heater due to poor PID settings (see figure 4.7 B).
The temperature setpoints for the preheat element and the cooling plate were not
reached (see figure 4.8 A, B). For both the preheat element and the cooling plate,
the determination of proper PID settings is difficult due to their thermal mass. The
cooling element is also restricted by its power supply which is only capable of delivering
3 A. Using a higher rated power supply could rectify However, the temperature of the
cooling element is below the storage temperature of 10°C recommended by the media
manufacturer and therefore, thermal degradation of media can be excluded for long
time experiments.
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Figure 4.7: Temperature control in each of the three cell culture devices - The
temperature of each cell culture device has been varied between 35°C to 37°C in 1°C steps
and maintained for 1 h. Reproducible and accurate temperature readings which closely
match the setpoint can be achieved when the PID settings are properly adjusted (A, C).
In case of poor PID settings, temperature readings are at least reproducible (B).
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Figure 4.8: Temperature control in the preheat and cooling element - Tempera-
ture control in the preheat (A) and in the cooling element (B). In case of the cooling plate,
the power supply is limiting its maximum output current to 3 A and thus, the performance
of the cooling element.
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4.4.4 Pumping characterisation
A pump with short response times has been developed to generate different flow modes
(continuous, intermittent). Furthermore, a valve system has been developed as part of
the pumping system to switch between the two media reservoirs. A LabView routine
is used to control the flow rate and the medium reservoir to be pumped (Li, 2008b).
Flow rates have been characterised with a flow rate sensor, at three different lo-
cations in the fluid delivery chain. Typical for all flow rate measurements was the
periodical ’sawtooth’ flow rate curve (see figure 4.9). This effect is typical for this type
of pressure regulator and was predominant at low flow rates and decreased with higher
flow rates. Pressure is controlled with a series of solenoids and a pressure sensor in
the regulator. The output pressure is fed back to a control circuit which actuates the
solenoids until the pressure becomes proportional to the input signal. The actuation of
these solenoids causes therefore the periodical flow rate curve. However, the pressure
regulator is a low cost one and a more sophisticated replacement may be able to reduce
this effect.
Apart from this effect, the response time of the pump is superior than for example
that of a syringe pump (see Appendix E.4 for comparison).
Firstly, the flow rates at each port of the manifold have been measured for three
different pressure regulator settings and over 30 min (see figure 4.9, A). The average
and the standard deviation for each port and pressure setting have been calculated and
are summarised in table 4.1. The standard deviations of the flow rate differ only by 2
% to 5.5 % from the average of the flow rate. It can therefore be assumed that each
port delivers the same flow rate.
Secondly, the flow rate at the same fluidic port was measured when switching be-
tween media reservoir 1 to media reservoir 2 and then back to the first media reservoir
(see figure 4.9, B). The average and the standard deviation for each port and pressure
setting have been calculated and are summarised in table 4.2. For all three pressure
settings, the first switch increased the flow rate, while in the second switch flow rates
decreased as table 4.3. The difference in flow rates during switching may be a result
of an increased fluidic resistance for the flow path of media reservoir 1. Currently,
tubing can move freely from each media reservoir which may cause the increased fluidic
resistance. By fixing the position of the tubing, the effects of the tubing position on
123
4.4 Results & discussion
the flow rate could be eliminated. Compared to table 4.1, the flow rates are within an
acceptable range even after switching between the two media reservoirs.
Pressure regulator setting (mV) Port 1 Port 2 Port 3
300 9.17 +/− 0.27 8.68 +/− 0.36 8.15 +/− 0.45
400 15.09 +/− 0.51 16.13 +/− 0.34 15.89 +/− 0.58
500 20.64 +/− 1.11 23.24 +/− 0.46 21.49 +/− 0.53
Table 4.1: Flow rates for each port used at the manifold - Flow rate was measured
at each port of the manifold used for a microfabricated cell culture device. During a
measurement, the other ports of the manifold were closed. The average and the standard
deviation for the flow rate at each port were then calculated (n=3). Units for the flow rate
at each port are µl min−1.
Pressure regulator setting (mV) Media Reservoir 1 Media Reservoir 2 Media Reservoir 1
300 8.86 +/− 0.25 9.32 +/− 0.29 8.02 +/− 0.26
400 14.63 +/− 1.41 15.85 +/− 0.92 14.23 +/− 0.27
500 21.02 +/− 1.96 24.19 +/− 0.44 20.27 +/− 1.34
Table 4.2: Flow rates measured at the same port during media reservoir switch-
ing - Flow rate was measured at the same while switching between media reservoir 1 and 2.
The average and the standard deviation for the flow rate at each port were then calculated
(n=3). Units for the flow rate at each port are µl min−1.
Pressure regulator setting (mV) Switch 1 Switch 2
300 4.17 % - 9.41 %
400 8.32 % - 2.71 %
500 15.07 % - 3.56 %
Table 4.3: Increase/decrease in flow rate after switching - The increase or decrease
in flow rate was calculated by using the average flow rate achieved in media reservoir 1 as
the basis. Switch 1 referrs to switching from media reservoir 1 to media reservoir 2, while
switch 2 referrs to switching from media reservoir 2 back to media reservoir 1.
Finally, the flow rate after each microfabricated cell culture device has been mea-
sured using the same pressure settings and port as in the switching test. (see figure
4.10). The average and the standard deviation for each microfabricated cell culture
device and pressure setting have been calculated and are summarised in table 4.4. For
the lowest pressure setting, the flow rates achieved were not consistent for all micro-
fabricated cell culture devices. Most likely the inclusion of an air bubble caused the
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Figure 4.9: Flow rate measurements at the manifold using water - Flow rates
have been measured using water for three pressure regulator settings (300 mV, 400 mV and
500 mV) at all three ports used for the microfabricated cell culture devices (A). Air bubble
inclusion in the flow rate sensor is characterised by sharp spikes (port 2) or noise-like curves
(port 1), here occuring at the highest flow rate. Using the same pressure settings, the flow
rates have been measured when switching from media reservoir 1 to media reservoir 2 and
then back to the first media reservoir (B).
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variation across all three microfabricated cell culture devices. However, for the two
other pressure settings the flow rates were comparable to the flow rates obtained at
each port used at the splitter (compare with table 4.1). Furthermore, the flow rates
measured after the microfabricated cell culture device remain almost the same com-
pared to the flow rates measured at the splitter. It can be safely assumed that the
fluidic resistance of the microfabricated cell culture device can be neglected and its in-
fluence thus minimal on the overall pumping system. The length of the capillary tubing
at the inlet or at the outlet of the microfabricated cell culture device can therefore be
used to fine tune the flow rates.
Figure 4.10: Flow rate measurements for each microfabricated cell culture
device at three different pressure settings - Three pressure regulator settings (300
mV, 400 mV, 500 mV) were applied to each of the three microfabricated cell culture devices.
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Pressure regulator setting (mV) MB 1 MB 2 MB 3
300 9.94 +/− 0.29 1.17 +/− 0.09 3.46 +/− 0.676
400 16.35 +/− 0.41 15.10 +/− 0.43 13.28 +/− 1.24
500 23.58 +/− 0.40 22.57 +/− 0.29 20.33 +/− 1.06
Table 4.4: Flow rates after each cell culture device at the same port - Flow rate
was measured at the same port of the manifold for all three microfabricated cell culture
devices. The average and the standard deviation for the flow rate at each port were then
calculated (n=3). Unit for the flow rate at each port is µl min−1.
A flow rate chart has been compiled from the results of the flow rate measurements
after the manifold, after the microfabricated cell culture device and switching of the
media reservoirs by using the average of three measurements (see figure 4.11). A fitted
curve for these average flow rates after the manifold shows the expected linear correla-
tion between applied voltage to the pressure regulator and flow rate. The average flow
rates obtained in each microfabricated cell culture device and for both media reservoirs
for the three pressure regulator settings have also been plotted in the same figure. A
deviation in flow rate from the fitted curve can be interpreted as a change in fluidic
resistance along the flow path.
A media transport system has been developed to pump reproducibly medium through
the cell culture devices. Compared to syringe pumps, it offers storage capabilities for
enough medium for prolonged experiments (up to 7 days with a flow rate of 1.2 ml h−1)
and can easily be expanded if necessary. Currently, a ’sawtooth’ effect in the flow rate
curve is observed due to the pressure regulator used. However, such effects can also be
observed in miniaturised peristaltic pumps with flow rate changes of up to 0.2 µl min−1
(Skafte-Pedersen et al., 2009). In the system presented flow rate fluctuations of up to
1.1 µl min−1 were observed. These were minimised when multiple microfabricated cell
culture device are operated, possibly because the bubble trap in the flow path may act
as a capacitor, damping the flow rate fluctuations.
4.4.5 Experimental procedure & time lapse imaging
Finally, the microfluidic platform has been tested using mESC cell lines. Cells were
seeded using the method described in chapter 3. After 1 day of incubation at 37°C,
the culture chamber of each microfabricated cell culture device was closed and the
microfluidic chip primed with medium. After priming, the microfabricated cell culture
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Figure 4.11: Flow rate chart for a given pressure setting - The average flow rates
measured after the manifold for each port, after each cell culture device and for both
media reservoirs for the three pressure regulator settings (300 mV, 400 mV and 500 mV)
have been plotted. A linear curve fit of the flow rates measured after the manifold (R2 =
0.99826) can be used to predict the flow rate due to the linear correlation of pressure and
flow rate.
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devices were inserted into the microscope module in a laminar flow hood and then
continuously cultured on an inverted microscope for up to 4 days (see figure 4.12).
Cells were seeded according the seeding method described in chapter 3. mESC
attached within 24 h to the cell growth surface within the microfabricated cell culture
device and the culture chamber was subsequently sealed with the lid. Under continuous
flow, cell proliferation and movement have been recorded by the time-lapse system (see
figure 4.12 A, B). Changes in proliferation has been recorded in a time period of over
5 h (see figure 4.12 C). The GFP expression system allowed to monitor pluripotency
over time. To avoid damage to cells by exposure to UV light, pluripotency was assessed
every 24 h (see figure 4.12 A, B).
Whether cell proliferation or pluripotency were affected by flow, the light illumi-
nation or the properties of the cell growth surface (combination of 0.1% (v/v) gela-
tine/ITO microscope slide) is difficult to determine and thus, the biological interpreta-
tion not possible at present. However, as a proof of concept, it has been shown that the
microfabricated cell culture devices remained sterile for up to 4 days and the require-
ments defined in section 1.4.3.1 were met. Seeding in the split microfluidic chip has
been proven to be difficult, even when the seeding lid is used. Either cells accumulated
in one part of their compartment or, when tried to seed cells without the seeding lid,
mixed with the cells from the other compartment.
Air bubbles were a frequent occurrence in the microfabricated cell culture devices
blocking the microchannel network, thus preventing medium reaching the cells. As a
consequence of the increase in fluidic resistance in a blocked device by air bubbles the
flow rates in the other cell culture devices has been raised. Besides this issue, the in-
dividual fluidic interconnection of each microfabricated cell culture device offered also
an experimental advantage over integrated microfluidic systems. The affected micro-
fabricated cell culture device could be disconnected and the flow rate in the unaffected
devices accordingly adjusted. Failure of one or more microfabricated cell culture de-
vices did therefore not affect or scrutinise the entire experiment, albeit the ability to
obtain a triplicate was lost.
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Figure 4.12: Time-lapsed image sequence of mESC Oct-4 GFPs - The time-lapse
images of mESC Oct-4 GFPs in the single culture chamber of the cell culture device reveal
the movement in phase images (A-C) and the pluripotency in fluorescent images (D, E).
All images are taken at 10× magnification. The scale bar is 200 µm long.
130
4.5 Summary of findings
4.5 Summary of findings
An automated microfluidic platform with time-lapse imaging has been developed that
can be used for stem cell bioprocessing. The microfluidic platform consisted of two
modular sub-assemblies, a microscope module and a media handling module. The
microscope module contained all microfabricated cell culture devices while the media
handling module kept the pumping solution and media reservoirs.
The pumping solution presented for the microfluidic platform is reproducible and
also enables to aerate the medium at the same time. To maintain a constant culture
temperature in the microfabricated cell culture device, a transparent heater has been
incorporated into the existing microfabricated cell culture device presented in chapter
3.
A LabView routine controls and records all relevant parameters such as tempera-
ture, flow rate and image capture frequency. Furthermore, the routine allowed to read
in a sequence of setpoint commands for all parameters or when necessary, manually
changed. The pumping system and the heaters have been characterised for repeata-
bility and accuracy. In experiments using mESCs, the microfluidic platform has been
tested on an inverted microscope. Images were taken every 15 min and showed the
movement of mESC under continuous flow with major changes within 5 h for example.
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5Conclusion
Stem cells are the subject of a remarkable scientific and commercial interest due to
their ability to differentiate into tissue-specific functional cells. Paramount to the suc-
cessful manufacture of any stem cell based product is the thorough understanding of
the bioprocess conditions and parameters involved.
Microfluidic cell culture devices will ring in a new era of micro-scale bioprocessing
of stem cells for applications such as regenerative medicine and drug discovery. These
devices can be used as an advanced experimentation tool to dynamically probe multi-
ple conditions due to their ability to be parallelised, all on a small footprint, for the
development of stem cell bioprocesses.
However, a greater understanding of the cellular processes which drive stem cell
proliferation or differentiation pathways is still required. Additionally, a number of
stem cells are still not fully characterised.
The aim of this thesis was therefore to develop a multiplexed microfluidic cell cul-
ture device which can alter the soluble microenvironment of stem cells. The presented
microfluidic device offers the flexibility to incorporate and adapt present culture proto-
cols and future research findings, and to define the basis for scaling and comparison of
experimental outcomes. Combining the experimental adaptability and comparability
with an innovative image-based monitoring system enables the generation of data-rich
experimental sets which can be correlated to different important culture parameters
such as flow rate or temperature. All these requirements have been met with the
microfluidic platform presented within this thesis.
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Given the lack of standardised packaging and fabrication solutions for microflu-
idic devices, the need for the required design flexibility has been addressed with the
development of a holistic rapid prototyping approach for microfluidic devices.
The system consists of a casting method to deliver PDMS microfluidic prototype
chips within 2 days and a modular, robust, and adhesive-free interconnect and packag-
ing for rapid testing of the PDMS microfluidic prototype chips. The geometry param-
eters of the interconnect and packaging system have been varied and their influence on
performance such as burst pressure and flow rate elucidated.
The prototyping approach presented separates packaging from the microfluidic chip,
thus facilitating the rapid testing of microfluidic design concepts. The microfluidic
chip and the packaging system do not require any particular fabrication knowledge or
specialised environments such as cleanrooms. Thus, it is also suitable for a range of
different users with non-engineering backgrounds.
The seeding and culture in a microfluidic cell culture device are both critical steps
in obtaining reliable and data-rich experimental sets. Scalability and comparability
criteria have been defined to implement current cell culture protocols for embryonic
stem cells in a microfluidic cell culture device. The holistic rapid prototyping approach
has been used to fabricate microfluidic cell culture devices specifically for the culture of
these cells. Direct access to the cell culture chamber of the microfluidic device enabled
the translation of the seeding sequence of current cell culture protocols with the same
liquid height. Furthermore, the modularity of the microfluidic cell culture device also
enabled the use of an industry standard TC-PS microscope slide to provide the same
surface properties found in T-25 flasks. These results represent the first results obtained
for human embryonic stem cells grown in microfluidic cell culture devices which are
specifically designed to be scaled.
Sealing of the cell culture chamber of the microfluidic device with a lid permits to
switch from static seeding to continuous cell culture. Hydrodynamic shear stress levels
in the cell culture chamber have been engineered to prevent a wash out of viable hESC
colonies which were used as model. Under these conditions, continuous culture of hESC
in a microfluidic system has been demonstrated for the first time without a washout of
cells. Positive Oct-4, Tra-1-81 and SSEA-3 stains confirm that hESC colonies cultured
within the microfluidic cell culture device retain their self-renewal capability. These
133
results are thus important indicators that continuous culture experiments with ESCs
are worth pursuing.
The flexibility to easily change parts of the microfluidic cell culture device and
the positive results obtained with continuous culture have set the stage to monitor
cell culture in the microfluidic device using an image-based approach. A microflu-
idic platform has been developed and tested for three microfluidic cell culture devices.
Functionalities of the platform included cooled media storage, media pumping and an
inverted microscope fitted with a camera. This platform has been controlled with a
LabView routine, which allows to carry out experiments either automatically with pre-
defined experimental protocols or permits the manual intervention to adjust a specific
parameter.
Using time-lapse imaging, cell morphology and pluripotency of mESC with a Oct-
4 GFP expression system have been monitored. The results have shown that mESC
move around within the microfluidic cell culture device under flow (approx. 300 µl
h−1). These results demonstrate that stem cell bioprocesses require an advanced mon-
itoring approach to directly observe the fate of stem cells. This information would be
lost using traditional bioreactors such as T-flasks where continuous monitoring is not
possible. However, to fully exploit the experimental advantages of the microfluidic cell
culture platform, all factors which can affect the outcome of a microfluidic cell cul-
ture experiment need to be tested so that the results obtained can be correlated with
manipulated parameters such as flow or temperature.
This work represents the first step and serves as basis towards a microfluidic cell
culture tool for stem cell bioprocess development and optimisation. The design and the
development of such a microfluidic framework is an iterative process and many practical
problems associated with microfluidic cell culture devices have been addressed. How-
ever, further technical efforts need still to be made to generate relevant and validated
results for stem cell bioprocessing.
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6Future Work
The design and the development of a novel experimental tool is usually an iterative
process and the microfluidic cell culture device presented in this thesis is no exception.
Many problems such as efficient seeding or low hydrodynamic shear stress in the cul-
ture chamber of the device have been addressed. However, other engineering challenges
emerged for which improvements and solutions need to be found. The cell culture
device for stem cell bioprocess development in this work offers therefore a range of ex-
citing research and engineering opportunities from microfluidic device development and
optimisation, characterisation and validation of the multiplexed cell culture platform
to micro-scale stem cell bioprocess development and optimisation.
The main aims of current research are to increase the usability of microfluidic chips
for stem cell bioprocessing, and the impact of different culture modes on stem cell
bioprocess outcomes. By characterising the physical performance of the microfluidic
platform such as temperature, flow patterns and mass transfer of nutrients and oxygen,
the interpretation of experimental outcomes of cells is facilitated and thus the obtained
experimental data sets.
The current packaging and fabrication system is reliable, but some improvements
can already be seen:
• The disposable microfluidic chip is currently made from PDMS in a casting pro-
cess. However, it has been pointed out by (Regehr et al., 2009) that PDMS may
not be ideal for cell culture applications and thus, another material would have
to be found. For example, biomedical materials such as polyurethane or medical
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grade silicone could be used to replace PDMS, but fabrication processes would
need either to be adapted or to be developed and characterised first.
• In the latest iteration of the packaging system, the frame is made from alu-
minium and the interface plate is made from poly(carbonate) or poly(methyl
methacrylate). While these materials are fine and easy to machine for proto-
types, mechanically stiffer materials with higher glass temperatures Tg such as
poly(sulfone) would be better suited for repeated sterilisation with an autoclave
to provide long-term mechanical stability.
• The packaging system uses currently screws to secure the stack of interface plate,
microfluidic chip and frame. While the number of screws has been already re-
duced, a solution without screws would greatly benefit handling, for example in
a laminar flow cabinet. The system could then be expanded into a disposable
cartridge system.
• Although multiple inlet and outlet configurations have been explored, high den-
sity arrays of inlet and outlet ports have not been explored. Such high density
interconnects would allow the integration of pneumatically actuated pumps and
valves as shown by Quake and colleagues for on-chip control of flow for example,
but represent a considerable challenge to the fabrication engineering.
Along with improvements to the fabrication and packaging system, another possible
area of future work is more concerned with exploring cell culture within the microfluidic
device:
• It has been demonstrated that seeding in a open culture chamber using a pipette
is possible even with delicate and rare cells such as hESCs. This could be further
expanded to seeding in a microfluidic cell culture device with multiple compart-
ments and different types of cells to explore co-culturing for example, as has been
shown in a similar approach by Chin et al. (2004). This would allow to obtain
well defined and separated cell populations while cellular signalling is maintained
for example for the guided differentiation of stem cells.
• The modularity of the microfluidic cell culture device allows the inclusion of
any slides in microscope format. In preliminary experiments, a micro-milling
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machine has been used to pattern a TC-PS slide to restrict cell growth within the
microfluidic bioreactor by removing the specially treated cell growth surface (Hu,
2008). The open configuration of the microfluidic cell culture device would also
enable the seeding of ESCs for example, to form well defined embryoid bodies in
wells in a microscope slide.
• The open access to the cell culture compartment would also enable surface pat-
terning using a stamp. Such a stamp could be used to precisely define cell growth
surfaces within the microfluidic cell culture device, with well-established surface
modifications as shown by Tang et al. (2010) or Se´guin et al. (2010).
• Two types of low hydrodynamic shear stress microfluidic chips have been currently
tested and used for ESC culture. These microfluidic chips could be further refined
and optimised in a virtual prototyping setting using a similar design approach
using tree-like inlet architectures to adjust the flow velocity in the cell culture
chamber as proposed by Saias et al. (2011).
• At this stage, the low hydrodynamic shear stress microfluidic chips have been
analysed using FEM. These simulations would need to be verified in experiments,
for example using micro particle image velocimetry (µPIV) experiments.
• A recurring issue during priming and filling of a microfluidic system is the occa-
sional inclusion of air bubbles in the system. The microfluidic cell culture device
presented is no exception and therefore, an on-chip bubble trap would facilitate
priming of the microfluidic cell culture device and maintain a bubble-free oper-
ation for the entire duration of an experiment. A system has been presented to
remove air bubbles from a designated chamber with a vacuum which could be
adapted for the microfluidic cell culture device (Skelley & Voldman, 2008). Such
a solution for air bubble removal would be more gentle on the cells in the cell
culture chamber than pushing out air bubbles by applying pressure at the inlet.
Only the microfluidic cell culture device has been considered in this chapter so far. The
microfluidic platform is functional, but would also need some degree of refinement and
improvements to achieve reproducible experiments:
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• The microscope module has currently to be moved manually on the inverted
microscope. Integration of a motorised microscope stage and z-axis to adjust
focus would further automate the existing microfluidic platform. The system
could be therefore expanded to multiple microfluidic cell culture devices (more
than three) to probe different cell culture conditions at the same time.
• Time-lapsed images are taken in the current setup, but a real-time image analysis
algorithm is missing in the current setup to determine key culture parameters such
as cell density and pluripotency. The generation of these processed data would
allow the linking of the input parameters such as temperature and flow rate with
the experimental outcomes.
• A feedback loop to control the flow rate would allow the precise control of hydro-
dynamic shear stress and medium residence time in the cell culture chamber of
the microfluidic cell culture device.
• Integration of different sensors, for example to measure the oxygen tension levels
at various locations in the microfluidic cell culture device, would complement the
data-rich experimentation with stem cells.
• In the current setup, an ITO microscope glass slide is used to maintain the temper-
ature in the microfluidic cell culture device. A custom-made resistive polystyrene
slide as heater would better suit the imposed scalability and comparability cri-
teria. Integrating a temperature sensor with the slide would also facilitate the
experimental procedure to connect the heater/temperature sensor unit.
• A multiplexed system would also require an improved experimental procedure
to set up and prime the system with media. The system would preferably use
an automated procedure to ensure experimentation reproducibility. Automation
of the seeding procedure using pipette robots would also greatly support these
efforts (Puccinelli et al., 2010).
Finally, a fair amount of future work may be carried out to prove the usefulness of the
microfluidic technology for stem cell bioprocess development:
• Experiments with intermittent and continuous flow in the microfluidic cell culture
device using stem cells could demonstrate their implications for proliferation or
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differentiation. For intermittent flow, the lid to close the cell culture chamber of
the microfluidic device may need to be fitted with an gas permeable membrane
to provide enough oxygen to the cells.
• Dynamic soluble signalling could be studied using the platform by switching be-
tween the individual media reservoirs in a similar manner as shown by Azizi &
Mastrangelo (2008) or Paliwal et al. (2008).
• The microfluidic cell culture device has been successfully tested with human and
murine ESCs. Adult stem cells such as MSCs or other adherent cells could be
used to test the microfluidic cell culture device to demonstrate its capability as a
stem cell bioprocess development and optimisation tool.
• The modularity of the microfluidic cell culture device and the open access would
also be suitable for three dimensional cultures of cells in gels or entire tissue
biopsies as shown by Huang et al. (2011) and Webster et al. (2010).
The work presented in this thesis serves as the basis to implement these further
steps. The microfluidic cell culture platform is functional and many challenges of work-
ing with microfluidic systems (for example a standardised packaging and fabrication
method) have been addressed.
It is necessary now to move from the proof-of-concept setting to a real tool for
stem cell bioprocessing. The points outlined above present some ideas how the devel-
opment of the microfluidic framework might lead to such a tool for stem cell bioprocess
development.
The route to a functional microfluidic tool would encompass first the optimisation
and experimental verification of the microfluidic chip layout and the integration of an
efficient bubble trap, whether on- or off-chip needs to be determined. The next develop-
ment step would address the multiplexing and increased automation of the microfluidic
platform by integrating a motorised stage and z-axis. Alongside the refinement of the
microfabricated cell culture device and the extension of a refined multiplexed platform,
a consolidated software package which allows the integration of a real-time kinetic
growth measurement routine with the existing automation routine would complement
the technical efforts made towards a truly useful microfluidic stem cell bioprocess devel-
opment platform. In such an advanced platform configuration, it should be technically
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feasible to assess the influence of soluble signalling of stem cell on proliferation and
monolayer differentiation.
A few design criteria and requirements have been derived from existing cell culture
bioreactors, for example the ability to use TC-PS with the microfabricated cell culture
device. Whether or not TC-PS is required for use in a microfluidic cell culture device,
would need thorough testing of the materials and ECM coatings used using surface
chemistry characterisation methods such as time of flight mass spectroscopy or X-ray
photoelectron spectroscopy and then the surface characteristics compared with those
of T-flasks. This study would then facilitate to decide whether TC-PS in a microflu-
idic stem cell bioprocess development platform could be made obsolete and therefore
potentially further simplify the fabrication and packaging of the microfabricated cell
culture device.
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Appendix A
Calculations for forces acting on
a PDMS microfluidic layer
A.1 Calculation of axial force in a screw
To determine the force acting on the PDMS microfluidic chip, it is necessary to calculate
the axial force of a screw, which is used to clamp the microfluidic chip between the top
plate and the frame.
Figure A.1: Infinitesimal unit and the acting forces on the screw
MT = Fu · d2
2
(A.1)
where MT is the applied screw torque, Fu is the perimetric force and d2 the pitch
diameter.
Fu = F · (tan(α)− µ)
(A.2)
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A.2 Calculation of compression of the PDMS microfluidic chip
where F is the axial force in the screw, α the pitch angle and µ the friction coefficient
between screw and thread.
Fu = F ·
(
p
d2 · pi − µ
)
(A.3)
where p is the pitch and d2 is the pitch diameter.
MT = F ·
(
p
d2 · pi − µ
)
· d2
2
(A.4)
after rearranging and solving for F :
F = MT · 1(
p
d2 · pi − µ
) · 2
d2
(A.5)
F = MT · 2( p
pi
− µ · d2
) (A.6)
The relationship between torque and axial force for a M3 screw as used to hold the
packaging system described in chapter 2.2 is given in figure A.2.
A.2 Calculation of compression of the PDMS microfluidic
chip
Figure A.3: Forces acting on the top plate and the resulting force on the PDMS microflu-
idic chip
The following assumptions were made: i) the top plate, the glass slide and the frame
are rigid bodies, ii) the problem is two dimensional and iii) gravitational forces are
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A.2 Calculation of compression of the PDMS microfluidic chip
Figure A.2: Axial force F generated by sinking a M3 screw as a function of applied torque
MT . A friction factor of 0.47 is assumed between aluminium (frame) and steel (screw).
neglected. The force acting on the PDMS microfluidic chip FPDMS was calculated by
modelling the top plate as a beam (see Figure A.3). The sum of all forces in each
direction and momentums has to be zero. In this case, no momentum is applied and
no forces are acting in the X-direction , therefore:∑
Fy = 0 (A.7)
where Fy is the sum of all forces acting in the Y-direction.
FPDMS − F − F = 0 (A.8)
where FPDMS is the force acting on the PDMS microfluidic chip and F is the axial
force generated in the screw. After rearranging and solving for FPDMS :
FPDMS = 2 · F (A.9)
axial stress can be calculated by:
σ =
FPDMS
APDMS
(A.10)
where APDMS is the area of the PDMS chip the force is acting on.
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A.2 Calculation of compression of the PDMS microfluidic chip
To calculate the strain PDMS , Hooke’s law is used as an approximate model:
σ = EPDMS ·  (A.11)
where σ is mechanical stress and  the strain. axial stress is replaced and from the
following equation the axial strain is calculated:
FPDMS
APDMS
= EPDMS ·  (A.12)
where EPDMS is the Young’s modulus of PDMS.
 =
FPDMS
APDMS · EPDMS (A.13)
To compute the deformation of a PDMS microfluidic layer in the Z-direction:
 =
4h
h
(A.14)
where h is the undeformed height of the PDMS microfluidic layer and 4h the deforma-
tion of the PDMS microfluidic layer. After rearranging the equation, the deformation
in height can be computed:
4h =  · h (A.15)
The same calculations can be made for the lateral deformation of the PDMS microfluidic
layer.
l = −ν ·  = 4w
w
(A.16)
where w is the undeformed width of the PDMS microfluidic layer and 4w the defor-
mation of the PDMS microfluidic layer in lateral direction.
4w = l · w (A.17)
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Appendix B
Drawings & part list
B.1 Material and part list & drawings for the first gener-
ation packaging system
Material and part list required to fabricate and assemble the first generation packaging
system described in chapter 2.2.1.
Table B.1: Part list for the first generation packaging system
Part Cat. No. Supplier
Poly(carbonate) sheet 2 mm thick 258-6613 RS Components
Poly(carbonate) sheet 3 mm thick 681-637 RS Components
Dow Corning Sylgard 184 634165S VWR International
M3×6 Stainless Steel Socket Head Cap
Screw
187-1207 RS Components
M3×6 Stainless Steel Countersink Screw 304-4788 RS Components
Steel parallel dowel pin 2.5 mm × 10 mm 270-524 RS Components
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B.1 Material and part list & drawings for the first generation packaging
system
Figure B.1: Socket for fitting - Type A - Dimensions in mm.
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B.1 Material and part list & drawings for the first generation packaging
system
Figure B.2: Interface plate for the first generation packaging system - Dimensions
in mm.
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B.1 Material and part list & drawings for the first generation packaging
system
Figure B.3: Frame for the first generation packaging system - Dimensions in mm.
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B.1 Material and part list & drawings for the first generation packaging
system
Figure B.4: Microfluidic layer for the first generation packaging system - Di-
mensions in mm.
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B.2 Material and part list & drawings for the second generation packaging
system
B.2 Material and part list & drawings for the second gen-
eration packaging system
Material and part list required to fabricate and assemble the second generation pack-
aging system described in chapter 2.2.2.
Table B.2: Part list for the second generation packaging system
Part Cat. No. Supplier
Poly(carbonate) sheet 3 mm thick 681-637 RS Components
Dow Corning Sylgard 184 634165S VWR International
M3×6 Stainless Steel Socket Head Cap
Screw
187-1207 RS Components
M3×6 Stainless Steel Countersink Screw 304-4788 RS Components
150
B.2 Material and part list & drawings for the second generation packaging
system
Figure B.5: Socket for fitting - Type B - Dimensions in mm.
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B.2 Material and part list & drawings for the second generation packaging
system
Figure B.6: Socket for fitting - Type C - Dimensions in mm.
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B.2 Material and part list & drawings for the second generation packaging
system
Figure B.7: Interface plate for the second generation packaging system - Di-
mensions in mm.
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B.2 Material and part list & drawings for the second generation packaging
system
Figure B.8: Frame for the second generation packaging system - Dimensions in
mm.
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B.2 Material and part list & drawings for the second generation packaging
system
Figure B.9: Microfluidic layer for the second and third generation packaging
system - Dimensions in mm.
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B.3 Material and part list & drawings for the third generation packaging
system
B.3 Material and part list & drawings for the third gen-
eration packaging system
Material and part list required to fabricate and assemble the third generation packaging
system described in chapter 2.2.3.
Table B.3: Part list for the third generation packaging system
Part Cat. No. Supplier
Poly(methylmethacrylate) sheet 5 mm
thick
824-525 RS Components
Poly(methylmethacrylate) sheet 6 mm
thick
680-886 RS Components
Aluminium sheet 3 mm thick ALU-35 HABA
Dow Corning Sylgard 184 634165S VWR International
M3×6 Stainless Steel Socket Head Cap
Screw
187-1207 RS Components
M3×8 Stainless Steel Countersink Screw 187-1213 RS Components
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B.3 Material and part list & drawings for the third generation packaging
system
Figure B.10: Socket for fitting - Type D - Dimensions in mm.
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B.3 Material and part list & drawings for the third generation packaging
system
Figure B.11: Interface plate for the third generation packaging system - Dimen-
sions in mm.
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B.3 Material and part list & drawings for the third generation packaging
system
Figure B.12: Frame for the third generation packaging system - Dimensions in
mm.
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B.3 Material and part list & drawings for the third generation packaging
system
160
B.4 Drawings for the 3-D microfluidic demonstrator and the staggered
herringbone mixer
B.4 Drawings for the 3-D microfluidic demonstrator and
the staggered herringbone mixer
Figure B.13: Layer 1 of the 3-D microfluidic demonstrator - Dimensions in mm.
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B.4 Drawings for the 3-D microfluidic demonstrator and the staggered
herringbone mixer
Figure B.14: Layer 2 of the 3-D microfluidic demonstrator - Dimensions in mm.
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B.4 Drawings for the 3-D microfluidic demonstrator and the staggered
herringbone mixer
Figure B.15: Mould for staggered herringbone mixer - Jointly developed with Dr.
B. O’Sullivan. Dimensions in mm.
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B.5 Material and part list & drawings for the microfabricated cell culture
device used in chapter 3
B.5 Material and part list & drawings for the microfabri-
cated cell culture device used in chapter 3
Material and part list required to fabricate and assemble the microfabricated cell culture
device and the low hydrodynamic shear stress microfluidic layer used in chapter 3.
Please note that the frame and the sockets for the fittings are the same as the ones
used for the second generation packaging system (compare with section B.2).
Table B.4: Part list for the microfabricated cell culture device used in chapter
3
Part Cat. No. Supplier
Poly(carbonate) sheet 3 mm thick 681-637 RS Components
Poly(carbonate) sheet 5 mm thick 681-659 RS Components
Dow Corning Sylgard 184 634165S VWR International
M3×6 Stainless Steel Socket Head Cap
Screw
187-1207 RS Components
M3×8 Stainless Steel Countersink Screw 187-1213 RS Components
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B.5 Material and part list & drawings for the microfabricated cell culture
device used in chapter 3
Figure B.16: Interface plate for the third generation packaging system - Dimen-
sions in mm.
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B.5 Material and part list & drawings for the microfabricated cell culture
device used in chapter 3
Figure B.17: Closing lid for the microfabricated cell culture device used in
chapter 3 - Dimensions in mm.
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B.5 Material and part list & drawings for the microfabricated cell culture
device used in chapter 3
Figure B.18: PDMS gasket for the microfabricated cell culture device used in
chapter 3 - Dimensions in mm.
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B.5 Material and part list & drawings for the microfabricated cell culture
device used in chapter 3
Figure B.19: First generation microfluidic layer used in chapter 3 - Dimensions
in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
B.6 Material and part list & drawings for the microfluidic
platform used in chapter 4
Material and part list required to fabricate and assemble the microfabricated cell cul-
ture device used for the platform, improved versions of the low hydrodynamic shear
stress microfluidic layer used in chapter 3, the preheat section and the bubble trap.
Please note that the sockets for the fittings are the same as the ones used for the third
generation packaging system (compare with section ??).
Table B.5: Part list for the microfabricated cell culture device used in chapter
4
Part Cat. No. Supplier
Poly(carbonate) sheet 3 mm thick 681-637 RS Components
Poly(carbonate) sheet 5 mm thick 681-659 RS Components
Poly(carbonate) sheet 8 mm thick 258-6629 RS Components
Aluminium sheet 3 mm thick ALU-35 HABA
Dow Corning Sylgard 184 634165S VWR International
M3×8 Stainless Steel Socket Head Cap
Screw
187-1213 RS Components
M3×10 Stainless Steel Socket Head Cap
Screw
660-4636 RS Components
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
B.6.1 Microfabricated cell culture device
Figure B.20: Interface plate for the microfluidic platform - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.21: Frame for the microfluidic platform - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.22: Closing lid for the microfabricated cell culture device used in
chapter 4 - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.23: Closing lid for the microfluidic chip used in chapter 4 - Dimensions
in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.24: Seeding lid for the split microfluidic chip used in chapter 4 -
Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.25: Second generation microfluidic layer used in chapter 4 - Dimensions
in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.26: Split microfluidic layer used in chapter 4 - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
B.6.2 Bubble trap
Figure B.27: Bubble trap used in chapter 4 - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
B.6.3 Preheat
Figure B.28: Part A of the preheat used in chapter 4 - Dimensions in mm.
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B.6 Material and part list & drawings for the microfluidic platform used in
chapter 4
Figure B.29: Part B of the preheat used in chapter 4 - Dimensions in mm.
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B.7 Electrical circuits
B.7 Electrical circuits
Table B.6: Parts for thermistor circuit - PCB board and wires are not included.
Part Cat. No. Supplier
LM324N 268-0002 RS Components
2N2907 349-9043 RS Components
2 way PCB vertical mount terminal 220-4260 RS Components
IC Socket 16 pins 226-3843 RS Components
Figure B.30: Circuit to read out a thermistor - Standard circuit to read out ther-
mistors on the microfabricated cell culture device, preheat and the cooling plate.
Table B.7: Parts for valve circuit - PCB board and wires are not included.
Part Cat. No. Supplier
DS3658N 1652422 Farnell
IC Socket 16 pins 226-3843 RS Components
2 way PCB vertical mount terminal 220-4260 RS Components
3 way PCB vertical mount terminal 220-4276 RS Components
4 way PCB vertical mount terminal 290-1286 RS Components
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B.7 Electrical circuits
Figure B.31: Circuit to control valves of the pump - Circuit to control the pneumatic
valves SMC S070B-6CC in the media handling module. The diode and the transistor are
included in the DS3658N IC.
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Appendix C
Mathematical derivation of the
shear stress equation in a
rectangular microchannel
Microfluidic cell culture devices have to be designed such that viable cells are not washed
out or undergo undesired phenotype changes. The estimation of characteristic numbers
of a bioreactor, such as hydrodynamic shear stress levels and medium residence time
(MRT), is thus a vital tool to predict the performance of a bioreactor or to refine its
design.
To describe the properties and behaviour of a microfluidic system, an appropriate
formulation of the mechanics has to be chosen first. Continuum mechanics can be
applied for Knudsen numbers1 below 0.01, which is the case for microfluidic cell cul-
ture devices (Nguyen, 2004). The discussion of conservation of mass and momentum
for incompressible flows of Newtonian fluids2 is accurate enough to describe the flow
properties in microfluidic devices.
For instance, the density ρ is constant in the flow field, which means that the
equation for conservation of mass simplifies from
∇ · (ρu) = 0 (C.1)
1The Knudsen number is the dimensionless ratio of the mean free path to the representative physical
lenght scale. If the ratio is close to 1 or bigger than 1, the continuum assumption is no longer an accurate
enough approximation.
2A Newtonian fluid is a fluid which has a linear relationship between stress and strain rate.
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to
∇ · u = 0 (C.2)
where ρ is the density of the fluid and u the velocity field.
Newton’s second law of motion is used to derive the governing equations for mi-
crofluidics:
m
dv
dt
= F (C.3)
where m is the mass of the object, dvdt is the acceleration and F is the net force acting
on the object. The net force may consist of gravitational forces, pressure and viscous
stresses. The conservation of linear momentum is described by the Cauchy momentum
equation:
ρ
Du
Dt
= ρg︸︷︷︸
BodyForce
−∇P +∇ · τ︸ ︷︷ ︸
StressTensor
(C.4)
where ρ is the density of the continuum, u the velocity vector field which depends on
time and space, g the gravitational acceleration, −∇P the pressure tensor and ∇ · τ
the deviatoric stress tensor.
For Newtonian fluids, i.e. fluids which show a linear relationship between viscous
stress and rate of strain, the rate-of-strain tensor τ relates viscous stresses with ma-
terial properties such as the dynamic viscosity µ and the rate of strain γ. For an
incompressible fluid, the viscous stress is represented by:
τ = 2µΓ = µ[∇v + (∇v)t] (C.5)
An important special case is that of a Newtonian fluid with constant density and
viscosity, where the shear tensor can be written thus as:
∇ · τ = µ∇2v (C.6)
By replacing the expression for viscous stresses in C.4 with C.6, the Navier-Stokes
equation is obtained:
ρ
Du
Dt
= ρg−∇P + µ∇2v (C.7)
These equations are the basis for deriving analytical solutions for flow in microchan-
nels, and to predict, for example, hydrodynamic shear stress levels and distribution
within a microchannel.
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C.0.1 Analytical solutions for unidirectional flow in rectangular mi-
crochannels
To design microfluidic devices with low hydrodynamic shear stress, analytical solutions
of the Navier-Stokes equations can be used to predict shear stress levels in a first
approximation. Analytical solutions for different cross-sectional channel geometries
have been derived (Bruus, 2004). The microchannel cross-sections for a microfluidic
bioreactor will be rectangular due to the fabrication method used. The derivation of
the analytical solutions is therefore limited to a rectangular cross-section.
Considering a microchannel with the dimension h,w << l and h << w and flow
in positive y direction, the solution of the Navier-Stokes equation is reduced to the y
component because vx = vz = 0 and can be expressed with a Fourier expansion as:
vy(x, z) =
4 · h2
pi3 · µ ·
dp
dy
∞∑
n,odd
1
n3
[
1− cosh
(
n · pi · yh
)
cosh
(
n · pi · w2h
)] · sinh(n · pi · z
h
)
(C.8)
For simplicity however, the velocity profile is well approximated by infinite, parallel
plates, particularly for microchannels with high channel aspect ratios (> 10). The flow
is considered steady and fully developed, which simplifies the Navier-Stokes equations
to:
0 = −dP
dy
+ µ · ∂
2vy
∂z2
∂2vy
∂z2
=
dP
dy
· 1
µ
(C.9)
and with no slip at the boundaries vy(0) = vy(h) = 0, so the velocity can be expressed
after rearranging and integration as:
vy(z) =
1
2 · µ
dP
dy
[h− z] · z (C.10)
The average velocity in the microchannel can be calculated by integrating the velocity
over the inlet area and dividing by the same:
v =
1
A
∫ w
0
dx
∫ h
0
dz
1
2 · µ
dP
dy
[h− z] · z = h
2
12 · µ
dP
dy
(C.11)
Replacing the pressure gradient in equation C.10 with the expression obtained from
equation C.11, the velocity is then:
vy(z) =
6
h2
· v [h− z] · z (C.12)
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The average velocity can be replaced with the volumetric flow rate Q and equation
C.12 reduces to:
Q = v ·A (C.13)
vy(z) =
6
h3 · w ·Q [h− z] · z (C.14)
Hydrodynamic shear stress is a critical parameter in a microfluidic culture device. The
viscous stress tensor reduces to one dimension in unidirectional flow. Note that the
shear stress τwall 6= 0, even though vy = 0 at the boundaries:
τ = −µ · ∂v
∂z
(C.15)
Shear stress at the wall in a rectangular channel can be expressed as a function of
flow rate Q and channel dimensions h and w by replacing the velocity derivative in z
direction in equation C.15 with the according derivative of equation C.14:
τwall = 6 · µ · Q
h2 · w (C.16)
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Appendix D
Continuous culture of hESC in a
straight channel microfluidic cell
culture device
A first generation packaging system served as basis for the microfluidic cell culture
device which used the same concept described in section 3.3. An interface plate with an
opening allowed access to the TC-PS slide for coating with ECM and seeding of cells.
Once cell seeding was completed and cells attached to the ECM on the cell growth
surface, the interface plate with the opening and the microfluidic gasket was removed
and replaced with a closed interface plate and microfluidic layer. Both microfluidic
layers were made from PDMS in a casting process using moulds (see Figure D.1).
To culture feeder-attached hESCs in the microfabricated cell culture device, inacti-
vated MEFs were seeded on day 1 using a standard laboratory pipette. After one day
of incubation, medium was aspirated and fresh hESC medium added. hESC colonies
were manually dissected and added into the open microfluidic cell culture device on day
2. After another day of incubation, the interface plates and microfluidic layers were
exchanged and continuous culture started (see Figure D.2).
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Figure D.1: Design and configurations of the microfabricated cell culture device
- The straight channel microfluidic cell culture device had two exchangeable lids. One lid
was used for seeding and had an access to the culture plane to seed cells with a pipette
(A). Once feeder cells and hESC colonies were attached, the seeding lid was replaced by
the perfusion lid (B) and perfusion started. The seeding gasket and the microfluidic seal
were both casted using a micro-milled mould (C)
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Figure D.2: Seeding and continuous culture experiments in a straight channel
with hESC - Inactivated MEFs were seeded on day 1 in the open configuration on a 0.1
% (w/v) gelatine coated TC-PS slide (A). hESC colonies were seeded on d2 (B). On d3,
hESC colonies attached and started growing (C). On d3, hESC colonies were washed out
with flow rates as low as 100 µl h−1 (D)
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Appendix E
Additional characterisation
E.1 Fabrication characterisation of moulds
Characterisation of the aluminium mould to cast first generation microfluidic low shear
layers demonstrated a high spatial fidelity and accuracy (see figure E.1). Profilometer
measurements have shown that the flow restrictors and dividers in the mould had a
height of 202 µm +/- 1 µm, which represented an error of 1% of the nominal height
of 200 µm. The PDMS microfluidic chip cast from the mould had a channel height
of 202 µm +/- 1 µm, corresponding to the measurements of the mould. These results
compare well with the results obtained in section 2.4.2. Scanning electron microscopy
(SEM) was used to inspect the moulds for burrs and surface quality. Burrs caused
by milling were minimal and did not affect the de-moulding of the PDMS microfluidic
chip, resulting in 100% yield of PDMS microfluidic chips (see figure E.2).
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E.1 Fabrication characterisation of moulds
Figure E.1: Profilometer measurements of the flow restrictors in the PDMS
cast - The dashed line in the picture indicates the scan from left to right.
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E.2 Thermal imaging of an ITO microscope glass slide
Figure E.2: SEM images mould - Characterisation of the first generation low hydro-
dynamic shear stress microfluidic layer. (A) shows a SEM picture of a section of the flow
restrictors in the mould and (B) one flow restrictor. No burrs were observed at the inlet
(C). However, some burrs (indicated by arrow) occurred at the flow splitter (D). The scale
bar is 200 µm long.
E.2 Thermal imaging of an ITO microscope glass slide
The knowledge on the temperature distribution across an indium tin oxide (ITO) mi-
croscope slide was limited during development of the heater for the microfluidic biore-
actor. However, it was important to determine where to position the thermocouple in
the microfluidic bioreactor and if cells would be exposed to a temperature gradient.
A thermal imaging handheld camera (ThermaCAM SC360, FLIR Systems, Sweden)
was used to visualise the infrared signature of an ITO microscope slide (see figure
E.3). Images were analysed using ImageJ (Version 1.43, NIH, USA). Temperature
distribution was measured in x and y direction. For each direction, 3 measurements
were taken and mean and standard deviation calculated.
In y direction, the temperature only deviated 4.8 % from the average temperature.
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E.2 Thermal imaging of an ITO microscope glass slide
In x direction the temperature deviated approximately 7 % in the relevant area.
Figure E.3: Infrared image of an ITO microscope slide used as a heater - The
temperature distribution where the cell culture chamber is located varies in y direction
only 4.8 % and in x direction 7 %. The black tape holds the thermocouple in place and
appears therefore as cold area.
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E.3 FEM analysis of microfluidic layers used in chapter 4
E.3 FEM analysis of microfluidic layers used in chapter 4
A FEM analysis with the same parameters described in chapter 3 was conducted to
verify that the modification of the inlet and outlet manifold of the second generation
microfluidic layer has not affected hydrodynamic shear stress levels.
Figure E.4: Hydrodynamic shear stress in the improved microfluidic chip - To
measure the influence of different channel heights, the microfluidic chip was analysed in a
basic configuration (A, B), the basic design and a recessed cell culture plane (C, D) and
the basic design with a recessed cell culture plane and lid (E, F). Due to symmetry, only
one half of the chip was simulated. Flow rate was chosen 300 µl h−1.
193
E.4 Flow rate generated in a syringe pump versus the proposed pump
E.4 Flow rate generated in a syringe pump versus the
proposed pump
The flow rate generated in the pressurised medium reservoir has been compared to a
standard laboratory syringe pump (Model 100, KD Scientific, USA). Compared to the
syringe pump, the pump described in chapter 4 responds immediately and is able to
follow changes immediately. The syringe pump is troubled by lag times of up to 15
minutes to generate the dialled flow rate or stop flow. Water has been used as medium
for both pumps.
Figure E.5: Comparison of flow rates generated in a syringe pump and the
pump described in chapter 4 - Both pumps were turned on, left running for an hour
and then stopped. The red line depicts the temporal course of the flow rate generated
by the syringe pump, while the blue line represents the temporal course of the flow rate
generated by the pump presented in chapter 4
194
Appendix F
Calibration of thermistors & PID
heater settings
F.1 Calibration of thermistors
Thermistor coefficients have been calculated using the Stein-Hart equation in two point
or three point calibrations by measuring the resistance of the thermistor when exposed
to three different temperatures. Temperatures included 0°C, room temperature and
37°C of a water bath. The calibration values were optimised using the least-square
error method.
1
T
= A+B · ln(R) + C · (ln(R))3 (F.1)
Table F.1: Thermistor calibration - Thermistor coefficients obtained in a two point
calibration at room temperature and 37°C
Cooling element Preheat Element MB 1 MB 2 MB 3
A 0.00097536 0.00117487 0.000491747 0.000491747 0.000491747
B 0.00025823 0.00023688 0.000310421 0.000310421 0.000310421
C 0.00000000 0.00000000 0.000000000 0.000000000 0.000000000
F.2 PID heater settings
PID settings were obtained by using the auto-tuning routine developed by (Li, 2008b).
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F.2 PID heater settings
Table F.2: PID settings for all heaters and cooling elements
Cooling element Preheat Element MB 1 MB 2 MB 3
P 388436.40418 44.5415 67.437 57.465 67.437
I 8.000951 18.6748 3.585 2.914 3.585
D 1.60019 3.73496 0.717 0.583 0.717
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Appendix G
Publications
Results of this thesis have been presented in several conference proceedings of interna-
tional conferences. The holistic rapid prototyping approach described and characterised
in chapter 2 has been presented at the 6th international conference on the microtech-
nologies in medicine and biotechnology (MMB) 2011 in Lucerne, Switzerland.
The results of chapter 3 have been published in conference proceedings of the 13th
international conference on micro total analysis (mTAS) 2009 in Jeju, Korea and of the
6th international conference on the microtechnologies in medicine and biotechnology
(MMB) 2011 in Lucerne, Switzerland.
The microfluidic platform described in chapter 4 has been presented in the pro-
ceedings of the 14th international conference on micro total analysis (mTAS) 2010 in
Groningen, The Netherlands and of the 6th international conference on the microtech-
nologies in medicine and biotechnology (MMB) 2011 in Lucerne, Switzerland.
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HUMAN EMBRYONIC STEM CELL CULTURING IN 
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REVERSIBLY SEALABLE LID
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ABSTRACT
We present a modularly configured microfluidic system for human embryonic 
stem cells (hESC) enabling controlled seeding of intact hESC colonies, continuous 
perfusion of hESC colonies cultured on feeder cells without cell wash-out, and 
seamless integration with standard analytical methods for endpoint assays. 
Immunocytochemistry performed after 48 hours of continuous medium perfusion 
indicates for the first time that co-cultured hESCs remain pluripotent during 
continuous perfusion. 
KEYWORDS: Microfluidic perfusion, human embryonic stem cells, pluripotent 
proliferation
INTRODUCTION
Human embryonic stem cells (hESCs) can be expanded indefinitely and can 
retain their pluripotency, i.e. the ability to differentiate into any of the three germ 
layers. Thus, they potentially allow to obtain specialised cells in unlimited quantity 
for developmental biology research, drug discovery, and cell based therapies. 
Parallelised microfluidic cell culture systems with their potentially greater control 
over the culture conditions than, for example, automated microwell platforms [1] 
could be an ideal tool to investigate the complex interplay between culturing 
conditions and stem cell properties. Previously, different seeding techniques for 
hESCs have been demonstrated, including the seeding of hESCs suspensions from 
an upstream port into a cell culture chamber via microfluidic channels and 
microfluidic selection ports [2, 3], and direct cell seeding of hESCs into ‘open’ 
chambers [4]. Microfluidic culturing of hESCs was performed with periodic stop-
flow medium feeds, microwells recessed in microchannels, and hESCs encapsulated 
in gels, but pluripotency was not shown [2, 4]. Recently, pluripotent proliferation of 
hESCs was reported using intermittent medium re-feed schedules [3], but the use of 
intermittent medium re-feed schedules to maintain pluripotency prevents the study of 
hESC behaviour under continuous perfusion, hence under steady-state conditions.
DESIGN AND OPERATION OF THE MICROFLUIDIC SYSTEM
The modular microfluidic perfusion system consists of a reusable interface 
system and a disposable microfluidic chip (Figure 1). The microfluidic 
poly(dimethylsiloxane) (PDMS) chip contains a culture chamber with a rectangular 
footprint (4 mm x 13 mm), a microfluidic manifold using flow equalisation barriers 
[5] for uniform culture medium perfusion over the entire chamber, and the cell 
culture is recessed with respect to the medium flow plane to reduce the hydro-
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dynamic shear stress on the cells. The reusable interface system includes a top plate 
and a bottom frame made from polycarbonate (PC) which press the microfluidic chip 
on a tissue culture polystyrene (TC-PS) slide when they are clamped together. The 
interface also hosts 2 interconnects (Aluminium) to link the chip with external 
medium feed, and a lid (PC) and gasket (PDMS) to reversibly seal the chamber. 
Figure 1.  (A) Rendering of the modular microfluidic perfusion system shown in 
exploded view. (B) Top view of the microfluidic chip architecture.
Using the reversibly sealable lid, the system can be configured to ‘open’ culture 
chamber mode for cell seeding with standard laboratory pipettes (Figure 2). We 
coated the TC-PS slide with a 0.1% gelatine solution and seeded approximately 
20’000 growth-arrested fibroblasts in 200 µ! of medium. The fibroblasts were 
allowed to attach to the gelatine for 24 hours. Then 6-8 hESC colonies were pipetted 
into the chamber and allowed to attach to the growth-arrested fibroblasts. On the 
third day, the culture chamber was closed with the lid and medium perfusion started. 
A syringe pump delivered medium via gas permeable tubing at a flowrate of 
300 "!/h, resulting in complete medium exchange approximately every 5 minutes.
Figure 2. Illustration of the seeding operation with an ‘open’ microfluidic system 
using standard laboratory pipettes (A1), and perfusion with the ‘closed’ microfluidic 
system (B). After seeding, the cells were allowed to attach in the open configuration 
within a Petri-dish (A2). 
RESULTS AND DISCUSSION
The fibroblasts attached and uniformly spread across the culture chamber to 
attain their characteristic morphology within 24 hours. After seeding of the hESC 
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colonies, the hESCs attached to the fibroblasts and their morphology was similar to 
the one of the hESCs in the static control dishes. During perfusion of the hESCs for 
48 hours, no wash-out of hESC colonies or feeder cells was observed and hESC 
colonies maintained a similar colony shape and morphology compared to the static 
control dishes (Figure 3A). Finally, after 48 hours of perfusion, the hESC colonies 
stained positively for different pluripotency markers which strongly indicates that 
the hESCs retained their pluripotency (Figure 3B).
Figure 3. (A) Comparison of morphology of microfluidic perfusion system and 
control dish. (B) Images of hESC colonies in the microfluidic perfusion system in 
phase contrast, stained for DAPI and pluripotency markers OCT-4 and Tra-1-81. 
Scale bars are 200!m long.
CONCLUSIONS
The results obtained indicate that continuous perfusion of intact hESC colonies 
on typical cell growth substrate can be performed in the presented microfluidic 
system. 
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AN AUTOMATED AND MULTIPLEXED MICROFLUIDIC BIOREACTOR 
PLATFORM WITH TIME-LAPSE IMAGING FOR CULTIVATION OF  
EMBRYONIC STEM CELLS AND ON-LINE ASSESSMENT OF  
MORPHOLOGY AND PLURIPOTENCY MARKERS 
Marcel Reichen, Farlan Singh Veraitch, Nicolas Szita* 
University College London, Biochemical Engineering, UNITED KINGDOM 
 
ABSTRACT 
An automated and multiplexed microfluidic bioreactor platform with time-lapse imaging for cultivation of embryonic 
stem (ES) cells is reported.  Media temperature is controlled in the storage container and before entering the microbiore-
actors. Furthermore, the temperature in the microbioreactor is regulated to maintain cells at culture temperature over pro-
longed periods of time. Flow control is implemented in the platform to vary flowrates and to switch between two differ-
ent media bottles in one experiment. Morphology and pluripotency of mouse embryonic stem (mES) cells were 
monitored with the integrated time-lapse imaging. 
 
KEYWORDS: Time-lapse imaging, microbioreactor, embryonic stem cells (ESCs), cell culture monitoring 
 
INTRODUCTION 
Data-rich experimentation requires monitoring and controlling of important process parameters. Various input pa-
rameters such as media composition, medium replacement times and temperature affect the proliferation or differentation 
of embryonic stem (ES) cells. Output from the cells, for example changes in their morphology and pluripo-
tency/differentiation needs thus to be monitored/controlled to correlate the results with the tested parameter. To monitor 
and control all these input and output parameters, particularly for long-term experiments, automated fluid handling, time 
lapse imaging and tight control of the microenvironment are required. Different systems have been developed, which ad-
dress the optical monitoring, but do not include automated liquid handling. For example, a microfluidic culture system 
compatible with plate readers has been recently reported to measure fluorescent intensities [1]. However, analysis of cell 
morphology, a daily routine task in cell culture, has to be carried out on a microscope. A charged-coupled device (CCD) 
has also been directly attached to a microfluidic cell culture device for counting cells [2]. For high quality imaging, a mi-
crofluidic culture chamber with a transparent heater has been implemented on an inverted microscope to monitor HeLa 
cell cultures at defined temperatures [3]. We present a multiplexed microfluidic platform which combines automated 
brightfield and fluorescent imaging with flow control. This will allow the on-line study of the complex and dynamic cel-
lular processes, under controlled culture conditions. 
 
EXPERIMENTAL 
The platform consists of a ‘microscope module’ and a ‘media handling module’, both automated via a LabView™ 
routine as shown in Figure 1A. The microscope module includes three microfluidic bioreactors, a flow splitter to feed the 
three microfluidic bioreactors, a media preheat element to heat up cooled media and a box for the temperature control of 
the microbioreactors as shown in Figure 1B.  
 
 
Figure 1: (A) schematic representation of all modules and components of the microfluidic ES cell culture platform. (B) 
shows the microscope module and its components. 
The microfluidic bioreactors used for this platform are based on a previously presented design where we demon-
strated perfusion culture of feeder-attached human ES cells [4]. In this design as shown in Figure 2A and 2B, the tem-
perature in each microfluidic bioreactor can be controlled individually. An indium tin oxide (ITO) microscope slide is 
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used as a resistive heating element and - coated with gelatin - serves as the culture surface for ES cells. A temperature 
feedback control loop implemented in LabView™ monitors and controls the resistive heating by pulse-width modulation. 
The culture chamber of each bioreactor is split in two compartments to accommodate two mESC lines with a different 
green fluorescent protein (GFP) marker each.  
 
 
Figure 2: (A) Exploded view of all parts of the microfluidic bioreactor for the cell culture platform. (B) shows the two 
modes of operation, seeding and culture mode of the microbioreactor [4], and the corresponding lid. The microfluidic 
bioreactor has two compartments to seed different populations, and both compartments can be directly accessed with 
standard laboratory pipettes. 
 
The media handling module includes two media bottles, a cooling plate, a pressure regulator and a set of valves as 
shown in figure 1A. To avoid media decomposition during long term cultures, the media bottles are stored on the cooling 
plate (using the same temperature control loop as for the microbioreactors). The pressure regulator is used to control the 
head pressure in the media bottle and therefore the media flow. A set of valves is used to switch between the media bot-
tles. An inverted microscope with a CCD camera was used for imaging cell morphology and fluorescent markers. Phase 
contrast images were automatically taken every 15 minutes with a LabView™ routine. Images of the fluorescent markers 
were taken daily. 
All three microbioreactor and medium flasks were autoclaved before each experiment. Tubing was sterilized by flow-
ing ethanol through for 20 min followed by a PBS wash. Sterile filters were used to seal the inlet and outlet for the pres-
surized gas. Prior to seeding, an 0.1% (w/v) gelatine solution was used to coat the glass slides. Two mESC lines were 
used, an Oct4-GFP reporter line to monitor pluripotency seeded in one compartment, and a Sox-1-GFP reporter line for 
early neuronal differentiation in the other. Cells were statically seeded with a pipette to a seeding density of approxi-
mately 100,000 cells/cm2. 24h after seeding, the microbioreactors were changed from seeding mode into culture mode by 
sealing the culture chambers with a lid. Tubing was connected first to the media bottles and then to the microbioreactors, 
which had been placed into the microscope module in a laminar flow hood. After priming, the microscope module was 
transferred to the inverted microscope and mounted on the microscope stage. The temperature for all microbioreactors 
was set at 37°C and the flowrate controlled to maintain approximately 300 µl/h in each microbioreactor . 
 
RESULTS AND DISCUSSION 
The microfluidic bioreactor platform consists of 6 culture chambers. Each chamber can be accessed individually with 
a laboratory pipette and different types of cells can be seeded without cross-contamination. Culture programs with physi-
cal parameters such as temperatures and flow rates can be automatically read into the LabView™ routine and altered 
manually during the experiments. Flow rates and temperatures can be accurately controlled as shown in Figure 3A and B. 
 
Figure 3: Flow rates after the flow splitter using bottle 2 at different head pressures measured with a flow sensor (A). 
Temperature of the culture surface in a microfluidic bioreactor (B). 
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Preliminary results with the microfluidic platform show that the cells grow under low shear perfusion and that cell 
proliferation and marker expression can be monitored (Figure 4A and B). During culture, cells moved over the culture 
area as shown in Figure 4C and D. Such information on cell migration and proliferation can only be obtained from real 
time cell culture monitoring, which illustrates the importance of an automated time-lapse imaging routine.   
 
 
Figure 4: Representative images of a cell culture compartment. Phase contrast images at different time points (A,C,D) 
and fluorescent Oct-4 marker image (B). 
 
CONCLUSION 
An automated, versatile microfluidic platform for long-term cell culture has been devoloped to monitor cell morphol-
ogy, migration and proliferation from phase contrast images, and pluripotency and differentiation markers from fluores-
cence images. The microbioreactors have a culture chamber with two compartments which allows to monitor simultane-
ously and under identical culture conditions two GFP-reporter mES cell line. A deeper insight in cellular processes and 
data-rich experiments can be gained by modulating flow, extracellular matrix and media composition using such a micro-
fluidic platform with its integrated optical monitoring. Future work includes the implementation of advanced imaging al-
gorithms for on-line analysis and long-term experiments. 
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ABSTRACT 
A microfluidic bioreactor platform for the automated cultivation of embryonic stem cells is presented. The 
individual microbioreactors have a reversibly sealable culture chamber and seamlessly integrate with typical laboratory 
procedures: cells are seeded in static culture, e.g. on gelatin-coated tissue culture (TC-PS); for end-point assays, cells can 
be fixed on a standard microscope slide. The automated platform includes the temperature control for the individual 
microbioreactors, the delivery of culture medium at desired flow rates and the on-line time-lapse imaging of cell 
morphology and pluripotency markers on an inverted microscope. 
 
KEY WORDS: Microbioreactor, Embryonic Stem Cells (ESCs), Time-Lapse Imaging, Modular Microfluidics 
 
INTRODUCTION 
Numerous biological, physical and chemical factors influence stem cell fate [1, 2]. Therefore, a large number of 
multivariable experiments will be needed to precisely define what combination of factors are required, the relative 
contribution of each during target cell derivation, and how these factors are best controlled. Microfluidic bioreactors 
offer greater control over the cellular microenvironment than, for example, automated microwells. To perform these 
multivariable experiments, it is necessary to precisely control (and monitor) the operational parameters of the 
microfluidic bioreactor. These include the culture medium flow rate, cell culture temperature, the culture medium 
composition (including the gaseous tensions), as well as cell seeding densities, use of culture substrate and deposited 
extracellular matrices. These operational parameters must then be correlated with the output from the cells, for example 
their changes in morphology and level of expression markers, and potentially the composition of the spent medium. 
Different systems have been developed, which address the optical monitoring of cells, but do not include automated 
liquid handling. For example, a microfluidic culture system compatible with plate readers has been recently reported to 
measure fluorescent intensities [3]. For high quality imaging, a microfluidic culture chamber with a transparent heater 
has been implemented on an inverted microscope to monitor HeLa cell cultures at defined temperatures [4]. We present a 
multiplexed microfluidic platform that combines automated brightfield and fluorescent imaging with flow control, and 
microbioreactors where different culture substrates can be integrated.  
 
DESIGN AND OPERATION OF THE MICROBIOREACTOR 
 
 
Figure 1: (A) Exploded view of all parts of the microbioreactors. (B) shows the two modes of operation, seeding and 
culture/perfusion mode of the microbioreactor. The culture chamber of the microbioreactors can be directly accessed 
with standard laboratory pipettes [5]. (C) Images of hESC colonies (following static seeding and subsequent 2-day 
perfusion) in phase contrast, stained for DAPI, and pluripotency marker OCT-4. 
 
The microbioreactor consists of a disposable microfluidic chip made of poly(dimethylsiloxane) (PDMS), a culture 
slide in microscope slide format, and a reusable interface (Fig. 1A). The microfluidic chip made of 
poly(dimethylsiloxane) (PDMS) defines the sidewalls of the cell culture chamber, and the microfluidic structures that 
control the fluid flow of the culture medium through the chamber. The reusable interface provides all interfaces with the 
macro-world, aligns all parts, and enables reliable operation of the reactor. It is made of several parts including an 
interface plate made of polycarbonate (PC), a bottom frame, two interconnects sockets (PC), and finally a lid (PC) with a 
corresponding gasket (PDMS). The lid allows repeated access to the culture chamber for cell protocols (Fig. 1B), for 
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example cell seeding according to typical laboratory procedures. Perfusion experiments in an incubator with an external 
syringe drive demonstrated that hESC colonies are not washed out of the microbioreactor and retain the expression of 
pluripotency markers (Fig. 1C) [5]. 
 
AUTOMATED CULTIVATION PLATFORM WITH TIME-LAPSE IMAGING 
Three microbioreactors fit into the platform which is designed to fit onto a stage of an inverted fluorescence 
microscope. To separate flow control and cell culture imaging, the platform consists of a ‘microscope module’ and a 
‘media handling module’, both automated via a LabView™ routine (Figure 2). Medium is delivered from a pressurized 
reservoir via a flow splitter to the three microfluidic bioreactors. To enable long-term perfusion without medium 
degradation, the reservoirs can be cooled. Prior to reaching the cell culture, the medium is preheated to the desired 
temperature. Preliminary results are shown in Figure 2C. Cells started to proliferate and were pluripotent (Oct-4) after 
seeding. Real-time information about the growth and proliferation of cells can only be obtained with an automated cell 
culture platform and the time-lapse imaging routines. 
 
Figure 2: (A) schematic representation of all modules and components of the microfluidic ES cell culture platform. (B) 
shows the microscope module and its components. (C) Representative images of a cell culture in the microbioreactor 
showing phase contrast images and fluorescent Oct-4 marker images at different time points (0h, 18h, and 21h).  
 
CONCLUSION 
An automated, versatile microfluidic platform for long-term cell culture has been developed to monitor cell morphology, 
migration and proliferation from phase contrast images, and pluripotency and differentiation markers from fluorescence 
images. The microbioreactors have a reversibly sealable culture chamber which enables seamless integration with the 
typically employed seeding protocols and end-point assays in cell culture laboratories. A deeper insight into cellular 
processes and data-rich experiments can be gained by modulating flow, extracellular matrix and media composition 
using such a microfluidic platform with its integrated optical monitoring. Future work includes the implementation of 
advanced imaging algorithms for on-line analysis and long-term experiments. 
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A MODULAR PACKAGING SYSTEM WITH A RAPID FABRICATION 
METHOD OF DISPOSABLE MICROFLUIDIC CHIPS  
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ABSTRACT 
We present a rapid prototyping method for the fabrication of polymeric microfluidic devices which consist of a 
disposable, fully customisable silicone microfluidic chip, and a modular, reusable, interconnect and packaging system. 
All device components and mould masters were fabricated with a low-cost, readily available micro-milling machine. The 
short turnaround time (two days) from design to finished working prototype allows rapid verification of microfluidic 
design concepts. To demonstrate the abilities and flexibility of our prototyping approach, we fabricated devices with 
multiple inlets and outlets, three-dimensional chips and staggered herringbone mixers.  
 
KEY WORDS: Rapid Prototyping, Packaging, World-to-Chip Interface, PDMS, Micro-Milling 
 
INTRODUCTION 
In order to increase the uptake of microfluidic techniques by biologists and other non-engineering specialists, there must 
be readily available microfluidic devices that have reliable and robust world-to-chip interfaces, packaging and 
standardised chips, but that also allow the researcher some flexibility in designing their microfluidic system [1]. 
Currently, the casting of polydimethylsiloxane (PDMS) in moulds created by 
photolithographic techniques is a commonly used fabrication method for 
disposable microfluidic chips, offering the ability to fabricate highly 
customised microfluidic network layouts [2]. However, the need for special 
equipment such as a mask aligner for photolithography and the lack of a 
standardised world-to-chip interface and packaging solutions discourage 
potential end-users of employing microfluidic technology. Functional 
microfluidic blocks and units made from thermoplastics allow a simple and 
rapid assembly for microfluidic systems, but the customisation and 
optimisation of individual blocks is difficult to implement rapidly [3,4]. 
A rapid prototyping approach which combined simple fabrication of 
customisable microfluidic channel networks with stadardised world-to-chip 
interfaces and packaging, would open up the world of microfluidics to non-
specialists, allowing them to design, build and optimise their own systems, 
tailoring the microfluidics to their own research interests. (see figure 1). 
 
DESIGN AND FABRICATION METHOD 
The microfluidic system presented 
consists of a reusable interface plate (5 
mm PMMA) and a bottom frame (2 mm 
aluminium) and a disposable PDMS 
microfluidic chip (see figure 2A). The 
packaging of the microfluidic chip is 
based on the compression of the 
microfluidic chip. Leak-tight fluidic 
connection with the microfluidic chip is 
ensured by a boss in the interface plate 
(see figure 2B). The critical dimensions 
are the diameter and height of the boss 
(D, H), and the depth of the recess in 
the interface plate (DR) and the height 
of the microfluidic layer (HML). The 
sockets can be used with different 
fitting types, for example standard 
adapters (figure 2A, 3), or they can be 
modified for custom-made inter-connects if required. All parts can be precisely fabricated using a low-cost micro-milling 
machine. To cast a PDMS microfluidic chip, a mould (including all channel features including inlet and outlet ports) is 
machined from a rigid substrate such as aluminium, brass or PMMA. The mould also defines the outer dimensions of the 
microfluidic chip thus facilitating alignment of multiple layers in multi-layer chips. After casting and curing the PDMS, 
the layer can be released from the mould without the need for further post-processing. The dimensional fidelity of micro-
milled parts and moulds was characterized by contact profilometry and image analysis.  
 
Figure 2: (A) Exploded view of the microfluidic system with the reusable 
parts of the interconnect system and the disposable microfluidic chip 
consisting of a PDMS layer bonded to a microscope slide. (B) Schematic of 
the interconnect, showing dimensions of the boss (D, H) and recess (DR, HML).   
 
Figure 1: An ideal microfluidic rapid 
prototyping approach offers a high 
degree of customisation and a short 
assembly time due to standardisation. 
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RESULTS 
The standardised packaging 
design and corresponding 
rapid fabrication method 
enables the rapid, reliable 
implementation of a wide 
range of microfluidic designs, 
without having to re-develop 
and re-test the world-to-chip 
interfaces and packaging for 
every new device. The 
packaging system enables the 
simple insertion and 
alignment of disposable 
PDMS/glass chips (see figure 
3). The system is compatible with the standard microscope slide format (3 x 1 inches), which could be employed to use 
different commercially available materials, such as tissue culture polystyrene (TC-PS). The latter is particularly useful 
for microfluidic devices for cell culture where a growth substrate consisting of TC-PS is desirable. The packaging does 
not rely on adhesives, which are often not biocompatible. The micro-milling fabrication method delivers accurate and 
precise microfluidic chips with a deviation of less than 7.5% from the nominal dimension (obtained with a low-cost 
micromilling machine). Burst pressures as high as 7.26 bar have been achieved by varying the dimensions of the boss. 
Moulds and PDMS with feature sizes smaller than 35 µm were created using our fabrication method by reproducing 
staggered herringbone mixer structures (see figure 4). As 
an example for the degree of complexity the fabrication 
and packaging approach allows, we have developed 
three-dimensional chips with through holes. The well-
defined, outer dimensions of the two PDMS layers allow 
a precise and simple alignment of the two PDMS layers. The turnaround time from the design idea to this working 
prototype was 2 days (see figure 5). 
 
CONCLUSION 
An integrated rapid prototyping approach has been developed and characterised, which offers a simple but 
comprehensive route to large numbers of ready-to-use microfluidic devices. The system consists of a casting method to 
deliver microfluidic prototype chips within two days, and a modular, robust, and adhesive-free interconnect and 
packaging system to rapidly test microfluidic chips. All materials and tools are widely available and at low cost, opening 
up the possibilities of microfluidic device design to non-specialists such as biologists or chemists.   
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Figure 3: (A) An assembled microfluidic system in a basic packaging configuration with 
different types of fittings. (B) Multiple ports can be realised, for example for mixer chips 
with different mixing lengths i), ii) and with added passive mixer structure iii). 
 
Figure 5: From the design idea to a working prototype in 2 
days. Rapid fabrication of the mould and casting of PDMS 
chips (step 1) and subsequent bonding (Step 2) on day 1. 
Assembly in the multiple port packaging system (step 3) 
allows the testing of microfluidic chips (step 4) on day 2. 
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